None(e1,e2)	16	24	use in conjunction with other antiepileptic drugs : the addition of felbatol to antiepileptic drugs ( aeds ) affects the steady-state plasma concentrations of aeds .
None(e1,e2)	10	14	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic_amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
advise(e1,e2)	0	29	videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	7	25	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
None(e1,e2)	38	40	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
effect(e1,e2)	4	26	in patients receiving nonselective monoamine_oxidase_inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	76	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	1	5	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv_protease_inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
effect(e1,e2)	3	10	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
None(e1,e2)	16	29	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	29	47	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
mechanism(e1,e2)	19	56	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	18	ketoconazole : coadministration of ketoconazole ( 200 mg/day for 14 days ) with a 15-mg single dose of aripiprazole increased the auc of aripiprazole and its active metabolite by 63 % and 77 % , respectively .
None(e1,e2)	37	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
mechanism(e1,e2)	8	13	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	13	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	78	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	12	mercaptopurine/azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric_acid .
None(e1,e2)	11	15	folic acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
advise(e1,e2)	0	11	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
mechanism(e1,e2)	8	15	pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of gleevec , increased gleevec oral-dose clearance by 3.8-fold , which significantly ( p 0.05 ) decreased mean cmax and auc ( 0-8 ) .
effect(e1,e2)	8	35	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
None(e1,e2)	28	101	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	25	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	10	20	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate mofetil , and muromonab-cd3 .
None(e1,e2)	0	49	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	15	19	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	21	25	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	77	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	19	ampicillin /amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
None(e1,e2)	28	97	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	34	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	1	19	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid_preparations .
None(e1,e2)	28	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	28	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
effect(e1,e2)	2	4	antagonism between lincomycin and erythromycin in vitro has been demonstrated .
None(e1,e2)	11	16	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
None(e1,e2)	26	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	7	19	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	8	22	vitamin a : because of the relationship of accutane to vitamin a , patients should be advised against taking vitamin supplements containing vitamin_a to avoid additive toxic effects
None(e1,e2)	1	26	since fondaparinux does not markedly inhibit cyp450s ( cyp1a2 , cyp2a6 , cyp2c9 , cyp2c19 , cyp2d6 , cyp2e1 , or cyp3a4 ) in vitro , fondaparinux_sodium is not expected to significantly interact with other drugs in vivo by inhibition of metabolism mediated by these isozymes .
None(e1,e2)	16	29	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	19	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	23	27	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	10	18	in study 1 , patients with colorectal cancer were given irinotecan /5-fu/leucovorin ( bolus-ifl ) with or without avastin .
None(e1,e2)	52	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	48	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	24	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	22	35	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	22	25	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	21	27	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	21	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	5	14	non-nucleoside reverse transcriptase inhibitors ( nnrtis ) : nevirapine may decrease plasma levels of combination_hormonal_contraceptives ;
None(e1,e2)	10	13	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron-containing preparations .
None(e1,e2)	22	37	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	4	cyclosporine : administration of nonsteroial_anti-inflammatory_drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
None(e1,e2)	0	19	hydrochlorothiazide : a study in normal healthy volunteers has shown that concomitant administration of dynacirc ( isradipine ) and hydrochlorothiazide does not result in altered pharmacoktnetics of either drug .
None(e1,e2)	24	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	105	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	133	150	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	29	should it be decided to discontinue therapy in patients receiving beta-blockers and clonidine concurrently , the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of clonidine .
None(e1,e2)	21	37	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	24	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	31	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	50	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	24	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	62	70	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	14	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	81	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	65	82	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
mechanism(e1,e2)	5	7	aspirin : concurrent administration of aspirin and flurbiprofen resulted in 50 % lower serum flurbiprofen concentrations .
None(e1,e2)	57	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	45	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	9	40	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	3	4	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	2	10	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	0	15	dicumarol : it has been reported that allopurinol prolongs the half-life of the anticoagulant , dicumarol .
None(e1,e2)	33	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	2	antacids or h_2_-receptor_antagonists : the effect of increased gastric ph on the bioavailability of ceftibuten was evaluated in 18 healthy adult volunteers .
None(e1,e2)	7	15	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic_acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	7	32	coadministration of single , oral doses of zaleplon with erythromycin ( 10 mg and 800 mg , respectively ) , a strong , selective cyp3a4 inhibitor produced a 34 % increase in zaleplon s maximal plasma concentrations and a 20 % increase in the area under the plasma concentration-time curve .
None(e1,e2)	85	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	6	10	if you are also using a steroid inhaler , take bitolterol first and then wait about 15 minutes before using the steroid inhaler .
effect(e1,e2)	9	28	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	11	38	fifteen to 30 minutes of exposure to 1.25 mac isoflurane or enflurane had minimal effects on the duration of action of initial doses of nimbex and therefore , no adjustment to the initial dose should be necessary when nimbex is administered shortly after initiation of volatile agents .
None(e1,e2)	0	4	antacids containing magnesium , aluminum , or calcium ;
None(e1,e2)	9	12	ketoconazole tablets may alter the metabolism of cyclosporine , tacrolimus , and methylprednisolone , resulting in elevated plasma concentrations of the latter drugs .
advise(e1,e2)	22	38	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium channel blockers , and beta-blockers . )
None(e1,e2)	1	3	prednisone/ prednisolone : rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .
None(e1,e2)	33	40	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	25	37	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	34	38	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	29	31	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	66	132	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	16	27	resins : since bile acid sequestrants may bind other drugs given concurrently , patients should take tricor at least 1 hour before or 4-6 hours after a bile_acid_binding_resin to avoid impeding its absorption .
None(e1,e2)	9	14	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	0	5	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	0	9	alcohol : it should be borne in mind that alcohol ingestion may increase the danger inherent in any intentional or unintentional sinequan overdosage .
None(e1,e2)	35	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	14	29	in addition , drugs that are actively secreted via this route ( e.g. , triamterene , metformin and amiloride ) should be co-administered with care as they might increase dofetilide levels .
None(e1,e2)	20	27	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	11	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	116	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	72	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	13	selective_serotonin_reuptake_inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
None(e1,e2)	6	8	platelet inhibitors : drugs such as acetylsalicylic_acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	0	2	doxorubicin : doxorubicin caused a decrease in zalcitabine phosphorylation ( 50 % inhibition of total phosphate formation ) in u937/molt 4 cells .
advise(e1,e2)	6	31	caution should be exercised if an hmg-coa_reductase_inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as ketoconazole , spironolactone , and cimetidine .
None(e1,e2)	7	9	anticholinesterases ( neostgmine , physostigmine ) , lignocaine , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .
None(e1,e2)	9	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	21	31	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic_antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	15	17	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	87	93	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	7	13	while the effects of chronic phenytoin or carbamazepine therapy on the action of nimbex are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
None(e1,e2)	1	33	if desipramine_hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	29	32	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	0	11	paroxetine : coadministration of single doses of eszopiclone 3 mg and paroxetine 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction .
None(e1,e2)	14	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	10	28	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	4	20	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	92	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	33	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	51	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	15	an increase in serum lithium concentration has been reported during concomitant administration of lithium with atacand , so careful monitoring of serum lithium levels is recommended during concomitant use .
None(e1,e2)	35	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	13	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	44	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	23	in vitro data in human plasma indicate that doxazosin mesylate has no effect on protein binding of digoxin , warfarin , phenytoin or indomethacin .
None(e1,e2)	10	20	there have been case reports of increased steady-state levels of quinidine , procainamide , and phenytoin during concomitant therapy with amiodarone .
None(e1,e2)	81	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	8	10	initial doses of adrenergic agents , such as dopamine or epinephrine , should be reduced and titrated to achieve the desired response .
None(e1,e2)	30	34	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	0	14	lithium - coadministration of racemic citalopram ( 40 mg/day for 10 days ) and lithium ( 30 mmol/day for 5 days ) had no significant effect on the pharmacokinetics of citalopram or lithium .
None(e1,e2)	5	10	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
None(e1,e2)	25	29	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
None(e1,e2)	17	19	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	8	16	anticoagulants , oral : co-administration of corticosteroids and warfarin usually results in inhibition of response to warfarin , although there have been some conflicting reports .
None(e1,e2)	6	13	anticholinergics : concurrent administration of certain anticholinergic_compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	85	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	28	40	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	10	60	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	6	12	methadone : coadministration of amprenavir and methadone can decrease plasma levels of methadone .
None(e1,e2)	12	19	eprosartan has been shown to have no effect on the pharmacokinetics of digoxin and the pharmacodynamics of warfarin and glyburide .
None(e1,e2)	0	29	cimetidine ( 400 mg b.i.d . ) had no effect on vardenafil bioavailability ( auc ) and maximum concentration ( cmax ) of vardenafil when co-administered with 20 mg vardenafil in healthy volunteers .
effect(e1,e2)	10	21	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace_inhibitors .
effect(e1,e2)	1	7	when mefloquine is taken concurrently with oral live_typhoid_vaccines , attenuation of immunization can not be excluded .
None(e1,e2)	79	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	5	7	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	76	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	0	11	propranolol attenuated the heart rate increase following administration of immediate release nisoldipine .
None(e1,e2)	23	58	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic_acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	6	9	specific effects of felbatol on other antiepileptic_drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
mechanism(e1,e2)	9	17	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
None(e1,e2)	18	20	in addition , the beneficial effects of levodopa in parkinsons disease have been reported to be reversed by phenytoin and papaverine .
mechanism(e1,e2)	40	63	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	4	6	the concomitant use of heparin or aspirin during the first 24 hours following symptom onset were prohibited in the ninds t-pa stroke trial .
None(e1,e2)	69	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	22	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	71	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	14	18	serious cardiac dysrhythmias , some resulting in death , have occurred in patients receiving terfenadine concomitantly with other macrolide_antibiotics .
None(e1,e2)	13	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	38	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal_anti-inflammatory_drugs ( nsaids ) without evidence of clinically significant adverse interactions .
mechanism(e1,e2)	14	21	in 5 other schizophrenic patients treated with oral haloperidol and rifampin , discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations .
None(e1,e2)	15	17	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	17	23	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	25	44	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	1	2	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	14	24	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	26	31	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	7	31	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	4	35	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	32	38	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	117	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	102	109	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	92	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	85	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	5	hctz 50 mg qd or hctz /triamterene 50/100 mg qd was co-administered with tikosyn ( 500 mcg bid ) for 5 days ( following 2 days of diuretic use at half dose ) .
None(e1,e2)	36	43	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	8	18	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
effect(e1,e2)	7	21	magnesium : magnesium-containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin_d by patients on chronic renal dialysis .
effect(e1,e2)	4	6	tablets simultaneous administration of sucralfate and furosemide tablets may reduce the natriuretic and antihypertensive effects of furosemide .
None(e1,e2)	0	12	coumarin_anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	4	11	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	10	12	other : there appears to be no pharmacokinetic interaction between acitretin and cimetidine , digoxin , or glyburide .
None(e1,e2)	31	54	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic_acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	6	13	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	13	21	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	64	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	33	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	48	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
int(e1,e2)	7	9	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	8	18	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
None(e1,e2)	19	36	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl_estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	0	3	phenytoin : serum phenytoin levels may be increased by aspirin .
None(e1,e2)	5	19	another oral azole antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
None(e1,e2)	26	29	because of foscarnets tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin_b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
None(e1,e2)	76	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	15	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	2	42	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	9	23	benzthiazide may interact with alcohol , blood thinners , decongestant_drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	16	19	loratadine ( 10 mg once daily ) has been coadministered with therapeutic doses of erythromycin , cimetidine , and ketoconazole in controlled clinical pharmacology studies in adult volunteers .
None(e1,e2)	20	30	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	23	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	66	93	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	34	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	12	24	in a study in hypertensive patients , addition of isradipine to existing hydrochlorothiazide therapy did not result in any unexpected adverse effects , and isradipine had an additional antihypertensive effect .
None(e1,e2)	12	22	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	30	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	5	ace_inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of angiotensin converting enzyme ( ace ) inhibitors .
None(e1,e2)	52	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	65	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	14	sulfapyridine may interact with any of the following : - acetaminophen ( e.g. , tylenol ) ( with long-term , high-dose use ) or
None(e1,e2)	0	2	inh ( isoniazid ) is also reported to affect ketoconazole concentrations adversely .
advise(e1,e2)	11	15	there is insufficient experience to assess the safety and efficacy of orencia administered concurrently with anakinra , and therefore such use is not recommended .
None(e1,e2)	90	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	38	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	8	lotensin has been used concomitantly with beta-adrenergic-blocking_agents , calcium-channel-blocking_agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
None(e1,e2)	1	6	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
None(e1,e2)	0	2	acebutolol , atenolol , and nadolol ( low hepatic clearance or no first-pass metabolism ) are unlikely to be affected .
None(e1,e2)	11	15	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	2	12	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
effect(e1,e2)	4	8	with simultaneous dosing of vardenafil 20 mg and terazosin 10 mg , 2 of 9 subjects experienced a standing systolic blood pressure of less than 85 mm hg .
None(e1,e2)	0	13	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
None(e1,e2)	0	4	maalox * coadministration of maalox_tc had no effect on nicardipine hcl absorption .
None(e1,e2)	20	26	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
advise(e1,e2)	2	40	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	0	9	fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole .
None(e1,e2)	73	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	57	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	33	43	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	17	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	26	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	6	18	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	33	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	19	25	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	17	47	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	5	22	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	8	23	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	12	15	there have been case reports of increased steady-state levels of quinidine , procainamide , and phenytoin during concomitant therapy with amiodarone .
None(e1,e2)	71	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	43	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	32	45	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
None(e1,e2)	2	8	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	42	54	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	26	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	14	18	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	10	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	33	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	15	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic_acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	26	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	40	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	5	9	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine
None(e1,e2)	3	28	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	39	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal_anti-inflammatory_agents ] is contraindicated .
None(e1,e2)	73	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	7	ergotamine : concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	43	45	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	22	24	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	13	41	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	34	61	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	6	8	there is no pharmacokinetic interaction between zaleplon and diphenhydramine following the administration of a single dose ( 10 mg and 50 mg , respectively ) of each drug .
None(e1,e2)	24	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	23	digoxin : coadministration of digoxin , a p-glycoprotein substrate , with oral conivaptan resulted in a reduction in clearance and an increase in digoxin cmax and auc values .
None(e1,e2)	0	4	antacids : administration of flurbiprofen to volunteers under fasting conditions , or with antacid suspension yielded similar serum flurbiprofen time profiles in young subjects ( n=12 ) .
None(e1,e2)	10	17	in a study in normal volunteers , concomitant administration of buspirone_hcl and haloperidol resulted in increased serum haloperidol concentrations .
None(e1,e2)	38	40	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	58	85	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic_acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	26	41	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	12	20	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	6	15	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	15	20	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	24	36	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	44	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
int(e1,e2)	6	8	thus , the interaction observed between erythromycin and terfenadine is not expected for dirithromycin .
None(e1,e2)	52	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	51	55	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	5	7	when itraconazole was coadministered with phenytoin , rifampin , or h2antagonists , reduced plasma concentrations of itraconazole were reported .
None(e1,e2)	2	9	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
None(e1,e2)	5	25	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	59	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	10	pyrantel ( e.g. , antiminth ) - taking piperazine and pyrantel together may decrease the effects of piperazine .
None(e1,e2)	33	63	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	81	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	81	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	5	14	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	13	15	a clinical study in healthy male volunteers ( n=24 ) demonstrated that mixing novolog with nph_human_insulin immediately before injection produced some attenuation in the peak concentration of novolog , but that the time to peak and the total bioavailability of novolog were not significantly affected .
None(e1,e2)	26	28	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol_hydrochloride , ferrous_sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	2	12	drug/laboratorytest interactions dactinomycin may interfere with bioassay procedures for the determination of antibacterial_drug levels .
None(e1,e2)	24	28	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	16	21	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin_converting_enzyme_inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
advise(e1,e2)	27	38	because changes in glucose concentrations with valdecoxib coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dl , dose adjustment for glyburide ( 5 mg qd and 10 mg bid ) with valdecoxib coadministration ( up to 40 mg qd ) is not indicated .
None(e1,e2)	8	13	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	35	37	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	16	33	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	0	52	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
None(e1,e2)	10	30	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate mofetil , and muromonab-cd3 .
None(e1,e2)	4	21	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	59	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	9	19	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
mechanism(e1,e2)	19	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	52	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	3	16	in clinical studies propofol had no effect on the duration of action or dosing requirements for nimbex .
None(e1,e2)	28	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	13	23	at a median follow-up of 33 months , the combination of arimidex and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation .
None(e1,e2)	0	10	ranitidine 150 mg twice daily did not interact significantly with nisoldipine ( auc was decreased by 15-20 % ) .
None(e1,e2)	27	29	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	15	34	cimetidine : a study in 6 healthy volunteers has shown a significant increase in peak nifedipine plasma levels ( 80 % ) and area-under-the-curve ( 74 % ) after a 1 week course of cimetidine at 1000 mg per day and nifedipine at 40 mg per day .
effect(e1,e2)	41	50	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	17	19	in vitro data in human plasma indicate that doxazosin mesylate has no effect on protein binding of digoxin , warfarin , phenytoin or indomethacin .
None(e1,e2)	8	17	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
None(e1,e2)	25	32	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
None(e1,e2)	9	23	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	41	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	9	14	particular caution should be exercised in using preparations containing sulfur , resorcinol , or salicylic_acid in combination with differin gel .
mechanism(e1,e2)	0	5	sucralfate administered 2 hours before lomefloxacin resulted in a slower absorption ( mean c max decreased by 30 % and mean t max increased by 1 hour ) and a lesser extent of absorption ( mean auc decreased by approximately 25 % ) .
None(e1,e2)	33	35	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	22	36	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	16	18	ampicillin/amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
None(e1,e2)	4	13	therefore , monitoring of theophylline plasma levels should be considered and dosage of theophylline adjusted as required .
None(e1,e2)	30	37	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic_acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	16	25	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	16	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	21	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	27	37	methotrexate vioxx 12.5 , 25 , and 50 mg , each dose administered once daily for 7 days , had no effect on the plasma concentration of methotrexate as measured by auc0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis .
None(e1,e2)	33	40	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	46	67	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	59	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	8	14	in patients taking an anticonvulsant ( eg , valproic_acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	9	14	non-selective monoamine oxidase ( mao ) inhibitors - including phenelzine_sulfate , tranylcypromine sulfate and pargyline hc1 .
None(e1,e2)	69	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	8	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
advise(e1,e2)	4	11	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	2	5	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	20	22	rhabdomyolysis has been observed in patients receiving hmg-coa reductase inhibitors administered alone ( at recommended dosages ) or concomitantly with immunosuppressive_drugs including cyclosporine .
None(e1,e2)	16	30	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	23	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
effect(e1,e2)	3	17	tablets : the benzodiazepines , including lorazepam , produce cns-depressant effects when administered with such medications as barbiturates or alcohol .
None(e1,e2)	76	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	18	in addition , certain drugs that are metabolized by this isozyme , including many antidepressants ( clozapine , selective_serotonin_reuptake_inhibitors , and others ) , may inhibit the activity of this isozyme , and thus may make normal metabolizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interaction .
None(e1,e2)	2	23	- a steroid_medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	20	30	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	109	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
mechanism(e1,e2)	4	6	separating the doses of antacid and lomefloxacin minimizes this decrease in bioavailability ;
None(e1,e2)	13	62	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	16	32	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	1	15	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	9	17	interactions for vitamin d analogues ( vitamin d2 , vitamin_d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	50	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	4	21	furthermore , rifampin , phenytoin , phenobarbital , and other inducers of cytochrome p450 3a4 may cause a reduction in plasma bexarotene concentrations .
None(e1,e2)	7	30	zebeta should be used with care when myocardial_depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	1	8	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	0	2	cimetldine : cerivastatin plasma concentrations were not affected by co-administration of cimetidine .
None(e1,e2)	4	13	coadministration of gly-buride and metformin did not result in any changes in either metformin pharmacokinetics or pharmaco-dynamics .
None(e1,e2)	13	28	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	19	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	137	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	31	45	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	35	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	33	39	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	19	cardiac glycosides : in a study of young healthy male subjects no evidence of a direct pharmacokinetic captopril - digoxin interaction could be found .
None(e1,e2)	9	20	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace_inhibitor therapy .
None(e1,e2)	2	15	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	38	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	21	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	39	41	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
int(e1,e2)	0	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	3	5	the intake of furosemide and sucralfate should be separated by at least two hours .
None(e1,e2)	7	31	midazolam : aprepitant increased the auc of midazolam , a sensitive cyp3a4 substrate , by 2.3-fold on day 1 and 3.3-fold on day 5 , when a single oral dose of midazolam 2 mg was coadministered on day 1 and day 5 of a regimen of aprepitant 125 mg on day 1 and 80 mg/day on days 2 through 5 .
None(e1,e2)	32	36	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	8	20	other antiarrhythmic drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	20	29	warfarin : in a study in healthy volunteers , no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin ( 0.7 mg/kg body weight ) were administered during 11 days of multipledose treatment with 5 mg b.i.d . isradipine .
advise(e1,e2)	0	17	cerubidine should not be used in patients who have previously received the recommended maximum cumulative doses of doxorubicin or cerubidine .
None(e1,e2)	14	25	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	21	24	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	100	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	42	45	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
None(e1,e2)	15	27	drug interactions , general : although there have been no formal interaction studies , intravenous fenoldopam has been administered safely with drugs such as digitalis and sublingual nitroglycerin .
None(e1,e2)	39	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	30	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	21	oral hypoglycemic_agents : in pharmacokinetic studies of mevacor in hypercholesterolemic noninsulin dependent diabetic patients , there was no drug interaction with glipizide or with chlorpropamide
None(e1,e2)	19	45	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	59	65	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	9	11	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
None(e1,e2)	21	23	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	19	21	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric_acid_derivatives , niacin ( nicotinic acid ) , erythromycin , azole antifungals .
None(e1,e2)	38	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	22	37	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer_acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer_acetate .
None(e1,e2)	0	20	magnesium /aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/ aluminum -containing antacid products .
None(e1,e2)	23	30	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	48	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	5	14	concomitant administration of an aluminum-containing antacid had no significant effect in the bioavailability of 6mna .
mechanism(e1,e2)	18	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	2	12	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	5	11	colestipol : plasma concentrations of atorvastatin decreased approximately 25 % when colestipol and atorvastatin were coadministered .
None(e1,e2)	42	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	40	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	8	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	29	54	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	8	28	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 3a4 enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
None(e1,e2)	30	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
effect(e1,e2)	4	10	animal experience indicates that clorazepate_dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol , increases the inhibitory effects of chlorpromazine , but does not exhibit monoamine oxidase inhibition .
effect(e1,e2)	3	5	concomitant use of digoxin and sympathomimetics increases the risk of cardiac arrhythmias .
None(e1,e2)	30	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	44	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
None(e1,e2)	4	8	pyrantel ( e.g. , antiminth ) - taking piperazine and pyrantel together may decrease the effects of piperazine .
None(e1,e2)	0	11	antacids : concomitant administration of antacids may reduce plasma levels of diflunisal .
None(e1,e2)	4	33	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	12	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	90	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	32	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	13	26	the hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive_drugs , including ganglionic blocking agents , negative inotropic agents , and inhaled anesthetics .
None(e1,e2)	6	9	diphenhydramine hydrochloride has additive effects with alcohol and other cns_depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	13	15	on the basis of the metabolism of bexarotene by cytochrome p450 3a4 , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 3a4 would be expected to lead to an increase in plasma bexarotene concentrations .
None(e1,e2)	33	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	35	42	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	0	2	amphotericin_b or potassium-depleting_diuretics ( benzothiadiazines and related drugs , ethacrynic acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	104	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	6	certain antibiotics , especially neomycin , streptomycin and kanamycin , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
None(e1,e2)	6	11	drug-drug interactions between keppra and other antiepileptic_drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	23	25	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	9	19	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	44	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	30	since cholestyramine resin may bind other drugs given concurrently , it is recommended that patients take other drugs at least 1 hour before or 4 to 6 hours after cholestyramine resin ( or at as great an interval as possible ) to avoid impeding their absorption .
None(e1,e2)	8	10	other antiarrhythmic drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	7	43	may interact with addictive medications , especially central_nervous_system_(_cns_)_depressants with habituating potential ( prolonged concurrent use may increase the risk of habituation ) , alcohol or cns depression producing medications ( concurrent use may increase the cns depressant effects of either these medications or ethinamate ) .
None(e1,e2)	21	23	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	6	8	certain antibiotics , especially neomycin , streptomycin and kanamycin , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
effect(e1,e2)	6	38	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	10	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	0	39	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	18	22	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
advise(e1,e2)	30	39	although clinical studies have not been performed , based on the involvement of the cytochrome p-450 3a family in clonazepam metabolism , inhibitors of this enzyme system , notably oral antifungal_agents , should be used cautiously in patients receiving clonazepam .
None(e1,e2)	17	44	in a placebo-controlled trial in normal volunteers , the administration of a single 1 mg dose of doxazosin on day 1 of a four-day regimen of oral cimetidine ( 400 mg twice daily ) resulted in a 10 % increase in mean auc of doxazosin ( p=0.006 ) , and a slight but not statistically significant increase in mean cmax and mean half-life of doxazosin .
None(e1,e2)	11	34	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	8	13	no pharmacokinetic interactions between dexmedetomidine and isoflurane , propofol , alfentanil , and midazolam have been demonstrated .
None(e1,e2)	5	9	pharmacokinetic interactions between nisoldipine and beta-blockers ( atenolol , propranolol ) were variable and not significant .
None(e1,e2)	14	18	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	0	4	tricyclic_antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	10	14	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	12	14	concomitant single dose administration of valdecoxib 20 mg with multiple doses of ketoconazole and fluconazole produced a significant increase in exposure of valdecoxib .
effect(e1,e2)	0	22	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone sodium , alcohol or codeine .
None(e1,e2)	0	4	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	1	8	since invirase is coadministered with ritonavir , the ritonavir label should be reviewed for additional drugs that should not be coadministered .
None(e1,e2)	73	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	19	digoxin keppra ( 1000 mg twice daily ) did not influence the pharmacokinetics and pharmacodynamics ( ecg ) of digoxin given as a 0.25 mg dose every day .
None(e1,e2)	0	43	pimozide and celexa - in a controlled study , a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in qtc values of approximately 10 msec compared to pimozide given alone .
advise(e1,e2)	3	5	therefore , when inspra and nsaids are used concomitantly , patients should be observed to determine whether the desired effect on blood pressure is obtained .
None(e1,e2)	13	40	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	7	9	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
effect(e1,e2)	10	17	inhibitors of endogenous prostaglandin synthesis it has been reported that indomethacin may reduce the antihypertensive effect of captopril , especially in cases of low renin hypertension .
None(e1,e2)	37	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	13	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	41	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	3	5	concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	2	4	- a monoamine_oxidase_inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	31	50	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic_acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	36	44	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	15	20	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
None(e1,e2)	22	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	14	care should be taken if labetalol is used concomitantly with calcium_antagonist s of the verapamil type .
effect(e1,e2)	14	19	in patients with mild to moderate hypertension , administration of 25 mg daily of vioxx with the ace inhibitor benazepril , 10 to 40 mg for 4 weeks , was associated with an average increase in mean arterial pressure of about 3 mm hg compared to ace inhibitor alone .
None(e1,e2)	19	31	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen .in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	10	20	aspirin : in normal volunteers , a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly .
mechanism(e1,e2)	2	11	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	2	9	synergism between xanthine_bronchodilators ( e.g. , theophylline ) , ephedrine , and other sympathomimetic bronchodilators has been reported .
None(e1,e2)	28	86	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	29	56	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	6	14	- a sulfa-based drug such as sulfamethoxazole -trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	13	16	specific studies have confirmed these effects with sevoflurane , isoflurane , propofol , alfentanil , and midazolam .
None(e1,e2)	24	36	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	1	16	and calcium_channel_antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	74	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
mechanism(e1,e2)	13	20	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
None(e1,e2)	34	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	35	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	13	pimozide and celexa - in a controlled study , a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in qtc values of approximately 10 msec compared to pimozide given alone .
None(e1,e2)	38	40	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium_channel_blockers , and beta-blockers . )
None(e1,e2)	12	16	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
mechanism(e1,e2)	16	34	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	7	11	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
mechanism(e1,e2)	8	14	probenecid : as with other b-lactam antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
None(e1,e2)	102	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	25	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic_acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	34	55	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	51	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	15	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	22	24	drug-drug interactions given the primary cns effects of aripiprazole , caution should be used when abilify is taken in combination with other centrally_acting_drugs and alcohol .
None(e1,e2)	22	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	13	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	15	22	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
effect(e1,e2)	7	17	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic_antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	44	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	61	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	36	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	26	28	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	45	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	11	23	effects of gabitril on other antiepilepsy drugs ( aeds ) : phenytoin : tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy .
None(e1,e2)	23	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	38	51	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	11	13	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine_oxidase_inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	1	5	analgesic/ anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	7	23	may interact with addictive medications , especially central_nervous_system_(_cns_)_depressants with habituating potential ( prolonged concurrent use may increase the risk of habituation ) , alcohol or cns depression producing medications ( concurrent use may increase the cns depressant effects of either these medications or ethinamate ) .
None(e1,e2)	28	36	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
mechanism(e1,e2)	0	23	starlix is a potential inhibitor of the cyp2c9 isoenzyme in vivo as indicated by its ability to inhibit the in vitro metabolism of tolbutamide .
None(e1,e2)	18	20	drug-drug interactions : no clinically significant drug interactions have been found with theophylline at a low dose , azithromycin , pseudoephedrine , ketoconazole , or erythromycin .
effect(e1,e2)	2	38	isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	7	29	in em individuals treated with paroxetine or fluoxetine , the auc of atomoxetine is approximately 6- to 8-fold and css , max is about 3- to 4-fold greater than atomoxetine alone .
None(e1,e2)	46	56	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
effect(e1,e2)	7	18	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	10	22	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
mechanism(e1,e2)	7	14	agents that induce cyp3a4 ( eg , carbamazepine ) could cause an increase in aripiprazole clearance and lower blood levels .
mechanism(e1,e2)	8	10	extended release tablets : administration of nifedipine with digoxin increased digoxin levels in 9 of 12 normal volunteers .
None(e1,e2)	36	38	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
int(e1,e2)	0	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	13	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
None(e1,e2)	20	31	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	10	14	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	13	46	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	23	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	2	5	coadministration of nizoral tablets with midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
None(e1,e2)	7	11	paroxetine : coadministration of single doses of eszopiclone 3 mg and paroxetine 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction .
None(e1,e2)	13	15	mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic_agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	52	54	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
None(e1,e2)	28	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	10	40	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	13	15	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine_oxidase_inhibitors or other antidepressants .
None(e1,e2)	10	20	other antiarrhythmic drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	28	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	24	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	10	26	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	24	36	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	24	26	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	10	antipyrine : because atorvastatin does not affect the pharmacokinetics of antipyrine , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .
None(e1,e2)	78	124	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	25	40	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei /arb ) .
None(e1,e2)	7	21	dopamine antagonists : since apomorphine is a dopamine_agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	17	23	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
None(e1,e2)	19	25	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	2	4	digoxin , methotrexate , cyclosporine : diclofenac , like other nsaids , may affect renal prostaglandins and increase the toxicity of certain drugs .
None(e1,e2)	11	15	more than 600 parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa/dopa decarboxylase inhibitor .
None(e1,e2)	3	11	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	26	31	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
effect(e1,e2)	16	18	the mean qt c interval ( msec ) was 369 with terfenadine alone and 367 with terfenadine plus dirithromycin .
mechanism(e1,e2)	10	12	although no studies have been conducted , concomitant administration of itraconazole and phenytoin may alter the metabolism of phenytoin ;
None(e1,e2)	50	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	11	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
None(e1,e2)	15	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	21	28	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	1	8	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	26	33	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	12	39	hypotension was more likely to occur if the calcium antagonist were a dihydropyridine_derivative , e.g. , nifedipine , while left ventricular failure and av conduction disturbances , including complete heart block , were more likely to occur with either verapamil or diltiazem .
None(e1,e2)	10	12	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
mechanism(e1,e2)	0	24	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	8	41	hypotension was more likely to occur if the calcium_antagonist were a dihydropyridine derivative , e.g. , nifedipine , while left ventricular failure and av conduction disturbances , including complete heart block , were more likely to occur with either verapamil or diltiazem .
None(e1,e2)	1	14	because ritonavir is coadministered , prescribers should also refer to the prescribing information for ritonavir regarding drug interactions associated with this agent .
None(e1,e2)	30	46	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	1	13	if tykerb is administered with drugs that inhibit pgp , increased concentrations of lapatinib are likely , and caution should be exercised .
mechanism(e1,e2)	16	20	the effect of toradol on plasma lithium has not been studied , but cases of increased lithium plasma levels during toradol therapy have been reported .
mechanism(e1,e2)	2	13	mao inhibitors maoi_antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
None(e1,e2)	4	15	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	11	13	sinus bradycardia has been reported with oral amiodarone in combination with lidocaine ( cyp3a4 substrate ) given for local anesthesia .
None(e1,e2)	124	126	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	3	dimenhydrinate may decrease emetic response to apomorphine .
None(e1,e2)	8	26	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	15	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	32	34	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	9	mercaptopurine /azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid .
None(e1,e2)	15	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	31	43	however , a crossover study in healthy subjects receiving either tagamet 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( theo-dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .
advise(e1,e2)	4	11	antacids : enteric coated aspirin should not be given concurrently with antacids , since an increase in the ph of the stomach may effect the enteric coating of the tablets .
None(e1,e2)	19	23	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	15	18	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	17	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	2	hmg-coa_reductase_inhibitors : lovastatin , simvastatin warning potential for serious reactions such as risk of myopathy including rhabdomyolysis .
None(e1,e2)	32	38	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	18	22	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	8	19	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	52	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	38	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	9	19	erythromycin : in healthy individuals , plasma concentrations of atorvastatin increased approximately 40 % with coadministration of atorvastatin and erythromycin , a known inhibitor of cytochrome p450 3a4 .
None(e1,e2)	18	22	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	29	31	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
advise(e1,e2)	0	21	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	6	34	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	39	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	60	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	3	21	ketoconazole ) , macrolide_antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	7	13	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	32	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	3	14	concurrent administration of etanercept ( another tnf -blocking agent ) and anakinra ( an interleukin-1_antagonist ) has been associated with an increased risk of serious infections , and increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
None(e1,e2)	7	19	on the basis of the metabolism of bexarotene by cytochrome p450 3a4 , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 3a4 would be expected to lead to an increase in plasma bexarotene concentrations .
None(e1,e2)	0	20	iron_supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
advise(e1,e2)	0	11	tracrium should not be administered until a patient has recovered from succinylcholine -induced neuromuscular block .
effect(e1,e2)	0	39	curariform_muscle_relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin_m parenteral .
None(e1,e2)	5	18	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace_inhibitors , and with some angiotensin ii receptor antagonists .
None(e1,e2)	15	45	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	33	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	10	13	no pharmacokinetic interactions between dexmedetomidine and isoflurane , propofol , alfentanil , and midazolam have been demonstrated .
effect(e1,e2)	6	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	1	12	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
None(e1,e2)	29	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	1	3	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	22	24	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate_hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	5	11	warfarin : the effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin .
None(e1,e2)	13	15	beta-adrenergic blocking agents : the effect of flurbiprofen on blood pressure response to propranolol and atenolol was evaluated in men with mild uncomplicated hypertension ( n = 10 ) .
mechanism(e1,e2)	0	10	nonsteroidal_anti-inflammatory_drugs have been reported to decrease the tubular secretion of methotrexate and to potentiate its toxicity .
None(e1,e2)	14	18	such individuals are referred to as poor metabolizers of drugs such as debrisoquin , dextromethorphan , and the tricyclic_antidepressants .
mechanism(e1,e2)	19	41	on the basis of the metabolism of bexarotene by cytochrome p450 3a4 , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 3a4 would be expected to lead to an increase in plasma bexarotene concentrations .
None(e1,e2)	18	30	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	11	41	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
effect(e1,e2)	9	20	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin_sodium .
mechanism(e1,e2)	6	25	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	30	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	4	8	effects of erythromycin on felbatol the coadministration of erythromycin ( 1000 mg/day ) for 10 days did not alter the pharmacokinetic parameters of cmax , cmin , auc , ci/kg or tmax at felbamate daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy .
None(e1,e2)	13	25	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	55	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	23	33	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	6	46	particular caution is necessary when using romazicon in cases of mixed drug overdosage since the toxic effects ( such as convulsions and cardiac dysrhythmias ) of other drugs taken in overdose ( especially cyclic antidepressants ) may emerge with the reversal of the benzodiazepine effect by flumazenil .
None(e1,e2)	6	13	anesthetics/sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	0	12	monoamine_oxidase_inhibitors : coadministration of moclobemide resulted in a 27 % decrease in almotriptan clearance and an increase in cmax of approximately 6 % .
None(e1,e2)	18	33	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	5	7	phenytoin/phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
int(e1,e2)	4	10	possible drug interactions of humorsol with succinylcholine or with other anticholinesterase_agents .
mechanism(e1,e2)	11	31	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	2	40	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	0	6	warfarin : multiple oral doses of sonata ( 20 mg q24h for 13 days ) did not affect the pharmacokinetics of warfarin ( r+ ) - or ( s- ) -enantiomers or the pharmacodynamics ( prothrombin time ) following a single 25-mg oral dose of warfarin .
None(e1,e2)	38	45	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
mechanism(e1,e2)	0	11	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
effect(e1,e2)	8	46	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	1	7	when sympathomimetic_drugs are given to patients receiving monoamine_oxidase_inhibitors , hypertensive reactions , including hypertensive crises , may occur .
None(e1,e2)	2	36	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	1	36	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	11	41	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	18	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	18	33	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	124	143	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	5	barbiturates , carbamazepine , and phenytoin decrease the half-life of doxycycline .
None(e1,e2)	9	13	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a 30 % increase in the rate of flecainide elimination .
None(e1,e2)	20	32	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl_alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	0	14	furosemide : when aliskiren was co-administered with furosemide , the auc and cmax of furosemide were reduced by about 30 % and 50 % , respectively .
None(e1,e2)	33	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	34	51	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	15	17	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
effect(e1,e2)	2	6	adrenergic blockers adrenergic_blockers are inhibited by amphetamines .
effect(e1,e2)	20	29	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and/or a tricyclic antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
None(e1,e2)	10	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	17	21	ibandronate should be taken at least 60 minutes before any oral medications containing multivalent cations ( including antacids , supplements or vitamins ) .
None(e1,e2)	71	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	28	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
effect(e1,e2)	11	28	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	0	2	calcium_channel_blockers , dihydropyridine : e.g. , felodipine , nifedipine , nicardipine
None(e1,e2)	76	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
mechanism(e1,e2)	4	15	the mean clearances of dofetilide were 16 % and 15 % lower in patients on thiazide_diuretics and inhibitors of tubular organic cation transport , respectively .
None(e1,e2)	29	31	caution should be taken when enablex is used concomitantly with medications that are predominantly metabolized by cyp2d6 and which have a narrow therapeutic window , such as flecainide , thioridazine and tricyclic_antidepressants ( see clinical pharmacology ) .
None(e1,e2)	9	12	no data are available for the coadministration of invirase/ ritonavir or fortovase/ ritonavir and garlic capsules .
None(e1,e2)	28	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	6	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .
None(e1,e2)	17	37	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	1	9	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	96	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	35	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	24	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	19	85	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	11	19	sinus bradycardia has been reported with oral amiodarone in combination with lidocaine ( cyp3a4 substrate ) given for local anesthesia .
None(e1,e2)	10	22	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
effect(e1,e2)	0	16	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	32	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	78	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	41	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	21	31	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	1	22	ampicillin/ amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
None(e1,e2)	32	34	concomitant administration of diflunisal and acetaminophen in dogs , but not in rats , at approximately 2 times the recommended maximum human therapeutic dose of each ( 40 to 52 mg/kg/day of diflunisal / acetaminophen ) resulted in greater gastrointestinal toxicity than when either drug was administered alone .
None(e1,e2)	26	30	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine_oxidase_(_mao_)_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	0	2	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	37	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	28	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	49	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	27	44	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	4	23	digoxin : coadministration of digoxin , a p-glycoprotein substrate , with oral conivaptan resulted in a reduction in clearance and an increase in digoxin cmax and auc values .
None(e1,e2)	29	33	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	3	17	effects of other antiepileptic_drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	20	24	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	0	8	antacids or h 2 receptor antagonists : when dirithromycin is administered immediately following antacids or h 2 -receptor antagonists , the absorption of dirithromycin is slightly enhanced .
None(e1,e2)	0	11	anticoagulants : potentiation of warfarin-type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	14	46	in patients with mild to moderate hypertension , administration of 25 mg daily of vioxx with the ace inhibitor benazepril , 10 to 40 mg for 4 weeks , was associated with an average increase in mean arterial pressure of about 3 mm hg compared to ace_inhibitor alone .
effect(e1,e2)	6	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	11	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	9	18	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
advise(e1,e2)	10	16	thus in order to avoid bleeding , reduced dosage of heparin is recommended during treatment with antithrombin_iii ( human ) .
None(e1,e2)	19	25	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central_nervous_system_depressant effects .
effect(e1,e2)	3	9	phenytoin : serum phenytoin levels may be increased by aspirin .
None(e1,e2)	0	34	hiv_protease_inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
None(e1,e2)	6	20	no interaction was noted with the mao-b_inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/ dopa_decarboxylase_inhibitor ( n=29 ) .
None(e1,e2)	21	50	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	19	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	51	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	32	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	43	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	14	17	due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and frova within 24 hours of each other should be avoided ( see a href= frova_od.htm # ci contraindications ) .
mechanism(e1,e2)	7	27	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
None(e1,e2)	41	45	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	85	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	30	34	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	2	33	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	15	18	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic agents , including antidepressants such as selective_serotonin_reuptake_inhibitors ( ssris ) , have been reported .
None(e1,e2)	26	30	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	18	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	2	12	when a diuretic is added to the therapy of a patient receiving prinivil , an additional antihypertensive effect is usually observed .
None(e1,e2)	0	18	cimetidine : co-administration with high doses of cimetidine [ 800 mg twice daily ] increased the cmax of rofecoxib by 21 % , the auc0-120hr by 23 % and the t1/2 by 15 % .
None(e1,e2)	16	18	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
mechanism(e1,e2)	5	7	metoclopramide : when coadministered with monurol , metoclopramide , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of fosfomycin .
None(e1,e2)	12	20	there have been case reports of increased steady-state levels of quinidine , procainamide , and phenytoin during concomitant therapy with amiodarone .
None(e1,e2)	7	9	population pharmacokinetic analyses revealed that mtx , nsaids , corticosteroids , and tnf blocking agents did not influence abatacept clearance .
None(e1,e2)	2	26	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	85	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	50	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	25	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	8	12	no data are available for the coadministration of invirase /ritonavir or fortovase/ ritonavir and garlic capsules .
None(e1,e2)	4	6	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	5	13	hyperpyrexia has been reported when amitriptyline_hcl is administered with anticholinergic agents or with neuroleptic drugs , particularly during hot weather .
None(e1,e2)	0	31	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic_acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
advise(e1,e2)	5	15	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	0	40	aspirin /acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
advise(e1,e2)	0	13	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
None(e1,e2)	13	19	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	29	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	4	10	salicylic acid : combination hormonal_contraceptives may increase the clearance of salicylic_acid .
None(e1,e2)	39	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	28	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	65	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	11	the concomitant administration of quinolones including norfloxacin with glyburide ( a sulfonylurea_agent ) has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	6	25	steroids enhance the renal toxicity of edetate_calcium_disodium in animals . 7 edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc . 7
int(e1,e2)	0	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	13	if phenytoin or other hepatic enzyme inducers are taken concurrently with norpace or norpace_cr , lower plasma levels of disopyramide may occur .
advise(e1,e2)	2	7	therefore when central_nervous_system_depressants are administered concomitantly with hydroxyzine their dosage should be reduced .
None(e1,e2)	2	12	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	0	5	norpace does not increase serum digoxin levels .
int(e1,e2)	9	28	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	6	8	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	32	36	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	26	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	104	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	27	44	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	6	27	if signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly , physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately .
None(e1,e2)	40	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	18	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	8	anesthetics/ sedatives /hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	0	8	antidepressants ( tricyclic ) , atropine or other anticholinergic_agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	14	15	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	28	34	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	78	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	20	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
effect(e1,e2)	18	39	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
int(e1,e2)	0	10	sulfapyridine may interact with any of the following : - acetaminophen ( e.g. , tylenol ) ( with long-term , high-dose use ) or
None(e1,e2)	6	8	may interact with the following : cholestyramine , colestipol ( use with thiazide diuretics may prevent the diuretic from working properly ;
None(e1,e2)	69	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	31	39	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	14	16	in addition , under the influence of sympatholytic medicinal products such as beta-blockers , clonidine , guanethidine , and reserpine , the signs of hypoglycemia may be reduced or absent .
None(e1,e2)	0	2	meperidine : amphetamines potentiate the analgesic effect of meperidine .
None(e1,e2)	38	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	13	28	digoxin : in a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , ketoprofen did not alter the serum levels of digoxin .
advise(e1,e2)	3	15	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
None(e1,e2)	2	22	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	0	6	antibiotics ( e.g. , erythromycin , trimethoprim and sulfamethoxazole , amoxicillin ) .
advise(e1,e2)	25	27	although a causal mechanism and a cause-and-effect relationship have not been established , current evidence suggests that renal function should be monitored in patients on thiazide_diuretics and allopurinol even in the absence of renal failure , and dosage levels should be even more conservatively adjusted in those patients on such combined therapy if diminished renal function is detected..
None(e1,e2)	11	32	however , because bleeding has been reported when ibuprofen and other nonsteroidal_anti-inflammatory_agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	3	11	the pharmacokinetics of ethanol were not affected by multiple-dose administration of tiagabine .
effect(e1,e2)	4	19	the administration of local anesthetic_solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	18	44	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide_diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	28	32	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	12	20	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	7	20	oral contraceptives : multiple dose administration of tiagabine ( 8 mg/day monotherapy ) did not alter the pharmacokinetics of oral contraceptives in healthy women of childbearing age .
None(e1,e2)	0	2	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	46	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	18	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
effect(e1,e2)	23	29	h2 blockers/proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	51	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	0	12	netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination .
None(e1,e2)	17	22	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	0	5	potassium-sparing_diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	14	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	4	21	anticoagulants : potentiation of warfarin -type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	28	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	67	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	21	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	28	43	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	38	40	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	8	14	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	0	5	aminoglycosides : the mixing of piperacillin with an aminoglycoside in vitro can result in substantial inactivation of the aminoglycoside .
None(e1,e2)	9	11	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	59	69	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa_reductase_inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	18	36	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
mechanism(e1,e2)	56	73	tolbutamide : aprepitant , when given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , decreased the auc of tolbutamide ( a cyp2c9 substrate ) by 23 % on day 4 , 28 % on day 8 , and 15 % on day 15 , when a single dose of tolbutamide 500 mg was admini , stered orally prior to the administration of the 3-day regimen of aprepitant and on days 4,8 , and 15 .
None(e1,e2)	34	40	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	6	20	and calcium channel antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	5	25	since the concomitant administration of warfarin with amiodarone increases the prothrombin time by 100 % after 3 to 4 days , the dose of the anticoagulant should be reduced by one-third to one-half , and prothrombin times should be monitored closely .
None(e1,e2)	18	36	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	104	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	17	22	ethanol / nutrition / herb interactions : food : cns effects of caffeine may be enhanced if combination_hormonal_contraceptives are used concurrently with caffeine .
None(e1,e2)	6	8	clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in inr or warfarin dose ( baseline vs. end of the clinical studies ) , and the need to change the warfarin dose during the trials due to changes in inr or due to adverse events was similar among bosentan- and placebo-treated patients .
None(e1,e2)	16	48	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	41	63	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	12	14	lotensin has been used concomitantly with beta-adrenergic-blocking agents , calcium-channel-blocking agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
effect(e1,e2)	14	22	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	33	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	78	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	31	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	5	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	15	18	caution should be exercised when taking this medicine certain antibiotics , such as erythromycin , clarithromycin , or azithromycin .
None(e1,e2)	1	28	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	20	26	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac_tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	6	12	- vitamin k ( e.g. , aquamephyton , synkayvite ) use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood
None(e1,e2)	2	20	increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased indinavir metabolism due to efavirenz .
None(e1,e2)	4	36	- when bezalip or bezalip_retard is used concurrently with anion-exchange resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
None(e1,e2)	79	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	28	- lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	2	36	lithium : valdecoxib 40 mg bid for 7 days produced significant decreases in lithium serum clearance ( 25 % ) and renal clearance ( 30 % ) with a 34 % higher serum exposure compared to lithium alone .
None(e1,e2)	62	64	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	5	21	when amiodarone is added to flecainide therapy , plasma flecainide levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .
None(e1,e2)	2	21	co-administration of nelfinavir at steady-state with a single dose of azithromycin ( 2 x 600 mg tablets ) results in increased azithromycin serum concentrations .
None(e1,e2)	10	17	when the stadol ns was administered 30 minutes after the sumatriptan nasal spray , the auc of butorphanol increased 11 % and cmax decreased 18 % .
None(e1,e2)	10	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	11	13	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac_glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	13	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	23	28	in a ten-subject study , coadministration of diltiazem ( 120 mg bid ) with lovastatin resulted in a 3-4 times increase in mean lovastatin auc and cmax vs. lovastatin alone ;
effect(e1,e2)	14	21	transient delirium has been reported in patients who were treated with one gram of ethchlorvynol and 75 - 150 mg of amitriptyline_hcl .
mechanism(e1,e2)	2	9	selegiline : combination_hormonal_contraceptives may increase the serum concentration of selegiline .
advise(e1,e2)	3	14	- lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	0	2	non-nucleoside_reverse_transcriptase_inhibitors ( nnrtis ) : nevirapine may decrease plasma levels of combination hormonal contraceptives ;
mechanism(e1,e2)	9	20	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	10	16	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	0	12	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	0	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	118	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	12	diuretics : studies in normal volunteers have shown that flurbiprofen like other nonsteroidal_anti-inflammatory_drugs , can interfere with the effects of furosemide .
None(e1,e2)	35	39	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	2	aspirin / acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	27	29	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac_glycosides and tricyclic_anti-depressants .
effect(e1,e2)	0	7	labetalol_hcl blunts the reflex tachycardia produced by nitroglycerin without preventing its hypotensive effect .
mechanism(e1,e2)	5	10	isoflurane , enflurane , and halothane decrease the ed50 of nuromax by 30 % to 45 % .
None(e1,e2)	77	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	19	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	0	2	probenecid : probenecid increases both free and bound ketoprofen by reducing the plasma clearance of ketoprofen to about one-third , as well as decreasing its protein binding .
None(e1,e2)	51	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	1	41	as mhd , the predominant plasma substrate , is only a weak inducer of udp-glucuronyl transferase , it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through udp-glucuronyl transferase ( e.g. , valproic acid , lamotrigine ) .
None(e1,e2)	7	32	inhibitors of cyp1a2 : concomitant use of duloxetine with fluvoxamine , an inhibitor of cyp1a2 , results in approximately a 6-fold increase in auc and about a 2.5-fold increase in cmax of duloxetine .
None(e1,e2)	26	33	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	3	12	the pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide
None(e1,e2)	0	7	clonidine : concomitant administration of clonidine with agents_with_b-blocking_properties may potentiate blood-pressure- and heart-rate-lowering effects .
None(e1,e2)	10	12	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
advise(e1,e2)	21	27	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
advise(e1,e2)	2	4	accordingly , diazepam and fluvoxamine should not ordinarily be co-administered .
None(e1,e2)	16	35	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	9	15	clearance of hydrodolasetron decreased by about 27 % when dolasetron_mesylate was administered intravenously concomitantly with atenolol .
None(e1,e2)	30	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	6	14	administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50 % .
None(e1,e2)	9	18	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic acid , phenylbutazone , and diazepam .
None(e1,e2)	13	15	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
None(e1,e2)	73	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	48	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	49	63	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic_acid .
None(e1,e2)	27	31	may interact with the following : beta-adrenergic blocking agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
advise(e1,e2)	39	49	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	43	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	87	117	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	23	experience with co-administration of hmg-coa_reductase_inhibitors and fentanyl in patients is limited , therefore , consideration should be given to temporarily suspending use of hmg-coa_reductase_inhibitors in patients receiving fentanyl .
None(e1,e2)	0	6	phenytoin /phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
None(e1,e2)	40	55	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	42	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	37	evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam .
int(e1,e2)	9	19	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	0	18	rifampin : coadministration of rifampin and mepron suspension results in a significant decrease in average steady- state plasma atovaquone concentrations .
None(e1,e2)	22	40	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	32	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	32	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	16	19	as with other agents with b-blocking properties , if coreg is to be administered orally with calcium_channel_blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	16	29	conversely , decreases in plasma levels of the tricyclic antidepressants have been reported upon discontinuation of cimetidine which may result in the loss of the therapeutic efficacy of the tricyclic_antidepressant 6 .
mechanism(e1,e2)	4	11	since the pharmacokinetics of busulfex were studied in patients treated with phenytoin , the clearance of busulfex at the recommended dose may be lower and exposure ( auc ) higher in patients not treated with phenytoin .
None(e1,e2)	8	18	the most significant drug interactions following administration of cerebyx are expected to occur with drugs that interact with phenytoin .
None(e1,e2)	87	123	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	1	3	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine .
None(e1,e2)	22	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	40	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	63	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	21	no interaction was noted with the mao-b inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/ dopa_decarboxylase_inhibitor ( n=29 ) .
None(e1,e2)	5	13	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	0	2	theophylline : ethinyl_estradiol may inhibit the metabolism of theophylline , leading to increased plasma concentrations .
None(e1,e2)	19	145	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	9	13	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	8	12	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	16	18	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
effect(e1,e2)	3	13	quinolones , including nalidixic_acid , may enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	114	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	29	49	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	36	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	0	3	phospholine_iodide potentiates other cholinesterase_inhibitors such as succinylcholine or organophosphate and carbamate insecticides .
None(e1,e2)	32	53	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	26	84	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	12	15	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	15	36	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	6	29	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
None(e1,e2)	12	15	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	3	4	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	21	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	6	9	the mean percentage increase in the glipizide auc after fluconazole administration was 56.9 % ( range : 35 to 81 ) .
None(e1,e2)	40	50	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	16	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	18	36	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium_antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic_agents , such as disopyramide , are used concurrently .
None(e1,e2)	0	2	potassium-sparing_diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	46	51	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	15	39	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl_estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	8	20	notably , systemic exposure ( auc0-12 ) of dapsone_hydroxylamine ( dha ) was more than doubled in the presence of tmp /smx .
None(e1,e2)	120	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	22	39	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic antidepressants
effect(e1,e2)	8	18	the time to onset of maximum block following nimbex is approximately 2 minutes faster with prior administration of succinylcholine .
None(e1,e2)	31	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	33	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	10	12	the use of antacids should be considered in place of h2_blockers or proton_pump_inhibitors in patients receiving sprycel therapy .
None(e1,e2)	9	29	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	38	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
advise(e1,e2)	14	16	vitamin a and oral retinoids : concomitant administration of vitamin a and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
None(e1,e2)	29	41	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
advise(e1,e2)	2	10	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	76	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	7	human_growth_hormone - concomitant use of l-glutamine and human_growth_hormone may enhance nutrient absorption in those with severe short bowel syndrome .
None(e1,e2)	12	30	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl_trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	41	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	16	25	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	0	4	amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55 % and 33 % , respectively .
None(e1,e2)	45	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	22	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	19	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton pump inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	48	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	20	31	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	83	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	21	antiepileptic drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic drugs ( phenytoin , carbamazepine ) .
advise(e1,e2)	0	9	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	14	32	lithium - coadministration of racemic citalopram ( 40 mg/day for 10 days ) and lithium ( 30 mmol/day for 5 days ) had no significant effect on the pharmacokinetics of citalopram or lithium .
None(e1,e2)	47	56	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	14	21	caution should be exercised when the following drugs are administered concomitantly with lodosyn ( carbidopa ) given with levodopa or carbidopa- levodopa combination products .
None(e1,e2)	11	16	these would include a variety of preparations which contain androgens , estrogens , progestins , or glucocorticoids .
effect(e1,e2)	4	30	diuretics : patients on diuretics , especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with lotensin .
advise(e1,e2)	8	17	however , interactions may be expected , and uroxatral should not be used in combination with other alpha-blockers .
None(e1,e2)	28	32	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	13	21	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	9	heparin_sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
None(e1,e2)	14	25	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	14	21	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	8	19	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
None(e1,e2)	37	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	22	erythromycin ( 500 mg t.i.d ) produced a 4-fold increase in vardenafil auc and a 3-fold increase in cmax when co-administered with vardenafil 5 mg in healthy volunteers .
None(e1,e2)	38	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	18	methotrexate : ibuprofen , as well as other nonsteroidal anti-inflammatory drugs , probably reduces the tubular secretion of methotrexate based on in vitro studies in rabbit kidney slices .
None(e1,e2)	13	31	rifampicin : in a study in healthy volunteers , a six-day course of rifampicin at 600 mg/day followed by a single 5 mg dose of isradipine resulted in a reduction in isradipine levels to below detectable limits .
None(e1,e2)	23	35	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	24	50	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	8	15	valproic acid : the mean steady-state trough serum valproic_acid concentrations prior to and during concomitant gabapentin administration ( 400 mg tid ;
None(e1,e2)	8	24	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	38	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	18	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	4	13	no pharmacokinetic interactions between dexmedetomidine and isoflurane , propofol , alfentanil , and midazolam have been demonstrated .
mechanism(e1,e2)	4	16	total body clearance of simulect was reduced by an average 22 % and 51 % when azathioprine and mycophenolate mofetil , respectively , were added to a regimen consisting of cyclosporine , usp ( modified ) and corticosteroids .
None(e1,e2)	32	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	70	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	4	7	if concomitant treatment with axert and an ssri is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	0	8	bismuth : bismuth subsalicylate , given concomitantly with enoxacin or 60 minutes following enoxacin administration , decreased enoxacin bioavailability by approximately 25 % .
None(e1,e2)	14	26	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	23	25	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	7	24	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	0	8	cimetidine : cimetidine can inhibit the metabolism of chloroquine , increasing its plasma level .
None(e1,e2)	11	37	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	63	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	7	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	15	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	41	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	0	7	ethopropazine may interact with alcohol or other cns_depressants , causing increased sedative effects .
None(e1,e2)	59	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	13	clonidine hydrochloride may enhance the cns-depressive effects of alcohol , barbiturates or other sedatives .
None(e1,e2)	3	29	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	15	19	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type_1c_antiarrhythmics propafenone and flecainide ) .
effect(e1,e2)	8	59	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	9	antacids , kaolin -pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
advise(e1,e2)	22	28	because both of these drugs have negative inotropic properties and the effects of coadministration with tambocor are unknown , neither disopyramide nor verapamil should be administered concurrently with tambocor unless , in the judgment of the physician , the benefits of this combination outweigh the risks .
None(e1,e2)	20	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	22	preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving indinavir in combination with ritonavir than those receiving crixivan 800 mg q8h .
advise(e1,e2)	6	36	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	115	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	78	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	20	methenamine therapy : urinary excretion of amphetamines is increased , and efficacy is reduced , by acidifying agents used in methenamine therapy .
None(e1,e2)	41	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	37	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	38	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	9	19	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	57	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	15	heparin : since heparin is contraindicated in patients with heparin-induced thrombocytopenia , the co-administration of argatroban and heparin is unlikely for this indication .
None(e1,e2)	0	36	digoxin : in controlled studies in healthy volunteers , bepridil hydrochloride either had no effect ( one study ) or was associated with modest increases , about 30 % ( two studies ) in steady-state serum digoxin concentrations .
None(e1,e2)	1	7	oral anticoagulant_agents : pharmacokinetic drug-drug interactions between argatroban and warfarin ( 7.5 mg single oral dose ) have not been demonstrated .
None(e1,e2)	11	23	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	105	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	13	cimetidine - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram auc and cmax of 43 % and 39 % , respectively .
mechanism(e1,e2)	8	24	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective serotonin reuptake inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
None(e1,e2)	41	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	116	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	33	35	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	12	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	0	28	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3_antagonist_class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	11	14	in patients who have been reported to be well controlled on tricyclic_antidepressants receiving concurrent cimetidine therapy , discontinuation of cimetidine has been reported to decrease established steady-state serum tricyclic antidepressant levels and compromise their therapeutic effects .
None(e1,e2)	20	40	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	25	33	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	4	6	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	15	45	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
None(e1,e2)	10	22	ketoconazole : co-administration of bosentan 125 mg b.i.d . and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately 2-fold .
None(e1,e2)	13	27	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
advise(e1,e2)	6	13	considerable caution should be exercised if peganone is administered concurrently with phenurone ( phenacemide ) since paranoid symptoms have been reported during therapy with this combination .
None(e1,e2)	14	18	therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
mechanism(e1,e2)	10	17	rifampin : following concomitant administration of a single dose of arava to subjects receiving multiple doses of rifampin , m1 peak levels were increased ( ~40 % ) over those seen when arava was given alone .
effect(e1,e2)	1	27	several tricyclic_antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
None(e1,e2)	71	77	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	24	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	12	24	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	12	25	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic_analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	5	12	concurrent administration of hexalen and antidepressants_of_the_mao_inhibitor_class may cause severe orthostatic hypotension . cimetidine , an inhibitor of microsomal drug metabolism , increased altretamines half-life and toxicity in a rat model .
mechanism(e1,e2)	3	5	antacid : when atorvastatin and maalox_tc suspension were coadministered , plasma concentrations of atorvastatin decreased approximately 35 % .
None(e1,e2)	15	27	in view of the potential risk of dehydration secondary to vomiting and/or diarrhea induced by camptosar , the physician may wish to withhold diuretics during dosing with camptosar and , certainly , during periods of active vomiting or diarrhea .
None(e1,e2)	13	17	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	17	19	the following drugs have been coadministered with kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , chlorthalidone , and hydrochlorothiazide .
None(e1,e2)	2	6	aspirin : ketoprofen does not alter aspirin absorption ;
None(e1,e2)	6	53	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	9	33	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	37	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	20	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ ethinyl_estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	64	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	154	156	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim / sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	36	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	0	17	theophylline vioxx 12.5 , 25 , and 50 mg administered once daily for 7 days increased plasma theophylline concentrations ( auc ( 0- ) ) by 38 to 60 % in healthy subjects administered a single 300-mg dose of theophylline .
None(e1,e2)	20	47	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	8	12	patients receiving other narcotic analgesics , antipsychotics , antianxiety_agents , or other cns_depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	0	8	cholestyramine : cholestyramine may increase the clearance of corticosteroids .
None(e1,e2)	23	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	8	10	other significant inhibitors of cyp2d6 , such as fluoxetine or paroxetine , would be expected to have similar effects and , therefore , should be accompanied by similar dose reductions .
advise(e1,e2)	2	13	alternatives to rifampin should be considered during the course of pcp treatment with mepron .
mechanism(e1,e2)	4	13	co-administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin .
None(e1,e2)	14	19	hydrochlorothiazide : a study in normal healthy volunteers has shown that concomitant administration of dynacirc ( isradipine ) and hydrochlorothiazide does not result in altered pharmacoktnetics of either drug .
None(e1,e2)	3	7	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	2	4	effect of probenecid : probenecid is a blocker of renal tubular secretion .
None(e1,e2)	38	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	9	20	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac_tromethamine protein binding .
mechanism(e1,e2)	5	11	serum concentration of digoxin and digitoxin may increase when patients take antithyroid_agents .
None(e1,e2)	19	25	a similar association , though less marked , has been suggested with barbiturates , phenyl-butazone , phenytoin sodium , carbamazepine and possibly with griseofulvin , ampicillin , and tetracyclines ( 72 )
None(e1,e2)	30	34	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	44	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	15	24	drugs that cause significant sustained elevation in gastric ph ( histamine h2-receptor antagonists such as ranitidine or cimetidine ) may reduce plasma concentrations of iressa and therefore potentially may reduce efficacy .
None(e1,e2)	13	15	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	44	47	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	50	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	13	27	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	2	29	steady-state plasma felbamate concentrations were found to be 29 % lower than the mean concentrations of a group of newly diagnosed subjects with epilepsy also receiving 2400 mg of felbamate a day .
None(e1,e2)	41	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	4	9	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	49	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	42	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	19	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	13	19	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	38	42	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	bismuth : bismuth_subsalicylate , given concomitantly with enoxacin or 60 minutes following enoxacin administration , decreased enoxacin bioavailability by approximately 25 % .
None(e1,e2)	65	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	16	fluconazole : concomitant administration of fluconazole at 200 mg qd resulted in a two-fold increase in celecoxib plasma concentration .
None(e1,e2)	33	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	29	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic_analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns_depressants , causing increased cns depression .
None(e1,e2)	6	8	anticoagulants : potentiation of warfarin-type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	33	46	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant_drugs .
None(e1,e2)	0	10	broad-spectrum_antibiotics -broad-spectrum antibiotics may sterilize the bowel and decrease the vitamin_k contribution to the body by the intestinal microflora .
None(e1,e2)	13	44	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	10	14	other : there appears to be no pharmacokinetic interaction between acitretin and cimetidine , digoxin , or glyburide .
None(e1,e2)	6	30	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	59	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	35	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine_oxidase_inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	7	13	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	39	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	81	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	11	61	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	8	9	the in vitro interaction between nevirapine and the antithrombotic_agent warfarin is complex .
None(e1,e2)	13	16	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
None(e1,e2)	15	39	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	36	46	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium_channel_blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
mechanism(e1,e2)	10	22	drugs that cause significant sustained elevation in gastric ph ( histamine_h2-receptor_antagonists such as ranitidine or cimetidine ) may reduce plasma concentrations of iressa and therefore potentially may reduce efficacy .
advise(e1,e2)	5	12	aspirin : as with other nsaids , concomitant administration of ponstel and aspirin is not generally recommended because of the potential of increased adverse effects .
None(e1,e2)	15	18	methadone levels may be decreased ; increased dosages may be required to prevent symptoms of opiate withdrawal . methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly .
None(e1,e2)	1	12	cephalosporins- cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
advise(e1,e2)	0	15	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	36	39	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	25	30	increases in plasma levels of tricyclic antidepressants , and in the frequency and severity of side effects , particularly anticholinergic , have been reported when cimetidine was added to the drug regimen .
None(e1,e2)	7	9	the risk of a potential interaction between novoseven and coagulation_factor concentrates has not been adequately evaluated in preclinical or clinical studies .
None(e1,e2)	16	21	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	92	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	10	12	no data are available for the coadministration of invirase/ritonavir or fortovase / ritonavir and garlic capsules .
None(e1,e2)	16	21	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin_sodium was used concomitantly with angiotensin-_converting_enzyme_(_ace_)_inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	15	21	as with other drugs that block angiotensin ii or its effects , concomitant use of potassium-sparing_diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , or salt substitutes containing potassium may lead to increases in serum potassium .
None(e1,e2)	8	13	mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	6	26	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
effect(e1,e2)	7	9	pharmacological/pharmacodynamic interactions with carbamazepine concomitant administration of carbamazepine and lithium may increase the risk of neurotoxic side effects .
None(e1,e2)	26	39	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	28	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	34	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	28	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	0	3	tetracycline , a bacteriostatic_antibiotic , may antagonize the bactercidal effect of penicillin and concurrent use of these drugs should be avoided .
None(e1,e2)	32	39	this observed increase in the bioavailability of fexofenadine may be due to transport-related effects , such as p-glycoprotein . in vivo animal studies also suggest that in addition to enhancing absorption , ketoconazole decreases fexofenadine gastrointestinal secretion , while erythromycin may also decrease biliary excretion .
None(e1,e2)	9	24	the concentrations of sn38 , the active metabolite of irinotecan , were on average 33 % higher in patients receiving bolus-ifl in combination with avastin when compared with bolus-ifl alone .
effect(e1,e2)	11	27	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	14	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	3	10	the use of antacids should be considered in place of h2_blockers or proton pump inhibitors in patients receiving sprycel therapy .
None(e1,e2)	13	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	69	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	16	dose adjustment is not recommended.levetiracetam had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or lamotrigine .
None(e1,e2)	40	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	2	10	lithium : nonsteroidal_anti-inflammatory_agents have been reported to increase steadystate plasma lithium levels .
None(e1,e2)	11	34	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	6	8	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	90	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	2	8	patients on rifampin should receive 70 mg of cancidas daily .
None(e1,e2)	5	10	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
None(e1,e2)	17	23	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
mechanism(e1,e2)	1	7	oral neomycin inhibits the gastrointestinal absorption of penicillin_v , oral vitamin b-12 , methotrexate and 5-fluorouracil .
None(e1,e2)	33	53	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	2	13	administration of diltiazem_hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50 % .
mechanism(e1,e2)	17	27	concurrent administration of hexalen and antidepressants of the mao inhibitor class may cause severe orthostatic hypotension . cimetidine , an inhibitor of microsomal drug metabolism , increased altretamine s half-life and toxicity in a rat model .
None(e1,e2)	7	8	antacids , sucralfate , metal cations , multivitamins quinolones form chelates with alkaline earth and transition metal cations .
None(e1,e2)	27	31	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	22	24	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	60	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	4	11	concomitant administration of other sympathomimetic_agents may potentiate the undesirable effects of foradil .
None(e1,e2)	27	55	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	61	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	21	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	11	19	other interactions : vardenafil had no effect on the pharmacodynamics of glyburide ( glucose and insulin concentrations ) and warfarin ( prothrombin time or other pharmacodynamic parameters ) .
None(e1,e2)	35	50	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	36	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	20	32	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	2	9	magnesium- and aluminum -containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	12	14	in addition , under the influence of sympatholytic medicinal products such as beta-blockers , clonidine , guanethidine , and reserpine , the signs of hypoglycemia may be reduced or absent .
None(e1,e2)	32	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	21	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	8	10	it is recommended to avoid concurrent administration of ethambutol with aluminum_hydroxide containing antacids for at least 4 hours following ethambutol administration .
None(e1,e2)	102	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	12	epinephrine should not be administered concomitantly with other sympathomimetic_drugs ( such as isoproterenol ) because of possible additive effects and increased toxicity .
None(e1,e2)	108	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	28	38	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	5	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
None(e1,e2)	67	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	14	nonsteroidal anti-inflammatory drugs ( nsaids ) -a drug interaction study of eplerenone with an nsaid has not been conducted .
None(e1,e2)	16	24	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
mechanism(e1,e2)	11	18	a 30 to 45 % increase in auc and cmax of nisoldipine was observed with concomitant administration of cimetidine_400_mg twice daily .
effect(e1,e2)	32	38	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin_b .
effect(e1,e2)	0	19	anagrelide alone had no effect on platelet aggregation , but did slightly enhance the inhibition of platelet aggregation by aspirin .
effect(e1,e2)	2	9	use of prinivil with potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
None(e1,e2)	139	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	19	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	13	19	therefore , close monitoring of prothrombin time is recommended and adjustment of the anticoagulant dose may be necessary when eulexin capsules are administered concomitantly with warfarin .
None(e1,e2)	19	21	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	20	28	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	13	psychoactive_drugs : hallucinations have been reported when toradol was used in patients taking psychoactive_drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	29	30	metoprolol - administration of 20 mg/day lexapro for 21 days in healthy volunteers resulted in a 50 % increase in cmax and 82 % increase in auc of the beta-adrenergic_blocker metoprolol ( given in a single dose of 100 mg ) .
None(e1,e2)	5	11	colestipol-concomitant intake of colestipol and vitamin_k may reduce the absorption of vitamin_k .
None(e1,e2)	10	26	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
int(e1,e2)	0	5	sulfacetamide preparations are incompatible with silver preparations .
None(e1,e2)	0	7	antidepressants : in vitro data indicate that nefazodone inhibits the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	32	33	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
None(e1,e2)	26	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	34	beta_blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	24	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	0	14	lotensin has been used concomitantly with beta-adrenergic-blocking agents , calcium-channel-blocking agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
advise(e1,e2)	6	19	consequently , it is recommended that fluvoxamine not be used in combination with either terbinafine , astemizole , or cisapride .
None(e1,e2)	10	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	28	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	24	35	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	17	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	21	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	42	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	106	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	23	25	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic_acid ) , erythromycin , azole antifungals .
None(e1,e2)	21	32	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	24	26	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	18	33	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	21	23	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	22	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	2	15	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
None(e1,e2)	12	14	such individuals are referred to as poor metabolizers of drugs such as debrisoquin , dextromethorphan , and the tricyclic antidepressants .
effect(e1,e2)	4	11	the hypoglycemic effect of tolbutamide has been reported to increase when atromid-s is given concurrently .
None(e1,e2)	13	19	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	0	15	prednisone /prednisolone : rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .
None(e1,e2)	27	46	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	59	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	37	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
mechanism(e1,e2)	0	9	erythromycin has been reported to decrease the clearance of triazolam and midazolam and thus may increase the pharmacologic effect of these benzodiazepines .
None(e1,e2)	31	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	26	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	16	19	there are rare reports , however , from marketing experiences , of changes in effects of insulin or oral hypoglycemic_agents in the presence of diclofenac that necessitated changes in the doses of such agents .
None(e1,e2)	0	14	amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55 % and 33 % , respectively .
None(e1,e2)	8	14	in case of theophylline toxicity and/or elevated serum theophylline levels , the dose of theophylline should be reduced while the patient is receiving concomitant erythromycin therapy .
None(e1,e2)	0	13	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	31	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	5	13	probenecid : as with other b-lactam_antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
int(e1,e2)	0	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	17	25	because of the possible additive effects of drugs that may depress the nervous system , ethanol or triazolam should be used cautiously in combination with tiagabine .
None(e1,e2)	16	18	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim /sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	2	14	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
None(e1,e2)	10	12	the incidence of upper gastrointestinal events in patients concomitantly taking aspirin or nsaids was similar in patients taking ibandronate 2.5 mg daily ( 21.7 % ) and 150 mg once monthly ( 22.0 % ) .
None(e1,e2)	42	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	28	47	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	48	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	6	24	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	15	19	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
effect(e1,e2)	3	5	patients treated with proton_pump_inhibitors and warfarin concomitantly may need to be monitored for increases in inr and prothrombin time .
None(e1,e2)	17	49	warfarin : in a study in healthy volunteers , no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin ( 0.7 mg/kg body weight ) were administered during 11 days of multipledose treatment with 5 mg b.i.d . isradipine .
mechanism(e1,e2)	0	15	fluvoxamine has also been shown to inhibit p450 1a2 , an isoform also involved in tca metabolism .
None(e1,e2)	43	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	24	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
mechanism(e1,e2)	11	27	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
advise(e1,e2)	0	18	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium_antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	0	2	amphotericin_b or corticosteroids or corticotropin ( acth )
None(e1,e2)	48	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	4	colchicine para-aminosalicylic_acid and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin b12 .
None(e1,e2)	85	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
advise(e1,e2)	2	4	patients taking isoniazid when disulfiram is given should be observed for the appearance of unsteady gait or marked changes in mental status ;
None(e1,e2)	51	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	33	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	12	patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine , to approximately 1/3 to 1/4 the usual dose .
None(e1,e2)	14	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
mechanism(e1,e2)	24	38	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	8	10	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp/aza and aminosalicylates .
None(e1,e2)	16	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	34	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	14	16	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin_sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	22	26	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	11	13	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	24	33	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	23	42	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	74	81	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	40	although clinical studies have not been performed , based on the involvement of the cytochrome p-450 3a family in clonazepam metabolism , inhibitors of this enzyme system , notably oral antifungal agents , should be used cautiously in patients receiving clonazepam .
None(e1,e2)	23	25	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	13	31	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline_hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	9	11	interactions for vitamin d analogues ( vitamin d2 , vitamin_d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	102	110	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	23	human pharmacokinetic data indicate that oral ketoconazole markedly inhibits the metabolism of cisapride , resulting in a mean eight-fold increase in auc of cisapride .
None(e1,e2)	3	7	the amount of metformin absorbed while taking acarbose was bioequivalent to the amount absorbed when taking placebo , as indicated by the plasma auc values .
None(e1,e2)	110	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	19	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	14	33	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	16	31	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
None(e1,e2)	44	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	56	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	50	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	19	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
advise(e1,e2)	18	29	in addition , drugs that are actively secreted via this route ( e.g. , triamterene , metformin and amiloride ) should be co-administered with care as they might increase dofetilide levels .
effect(e1,e2)	1	20	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	16	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	17	29	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet_inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	6	25	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	59	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	68	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	2	13	monitoring for amiodarone toxicity and serial measurement of amiodarone serum concentration during concomitant protease_inhibitor therapy should be considered .
mechanism(e1,e2)	3	8	magnesium- and aluminum-containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	37	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	23	33	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	151	160	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
effect(e1,e2)	0	5	corticosteroids : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration and may reduce serum salicylate levels .
None(e1,e2)	69	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	14	results from human in vitro metabolism studies and nonclinical studies show that revlimid ( lenalidomide ) is neither metabolized by nor inhibits or induces the cytochrome p450 pathway suggesting that lenalidomide is not likely to cause or be subject to p450-based metabolic drug interactions in man .
None(e1,e2)	6	15	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	3	21	potential interactions between taxol , a substrate of cyp3a4 , and protease inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	15	19	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
None(e1,e2)	15	22	antimycobacterial agents : rifampin contraindicated since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .
None(e1,e2)	5	10	increases of 22 % with mhd and 47 % with oxcarbazepine were observed .
None(e1,e2)	38	44	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	0	19	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	35	40	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	29	31	although the specific drug interaction was not studied in a clinical trial , there have been more than 50 episodes of concomitant use of antifibrinolytic therapies ( i.e. , tranexamic_acid , aminocaproic_acid ) and novoseven .
mechanism(e1,e2)	7	23	praziquantel : in the fed state , praziquantel ( 40 mg/kg ) increased mean maximum plasma concentration and area under the curve of albendazole_sulfoxide by about 50 % in healthy subjects ( n=10 ) compared with a separate group of subjects ( n=6 ) given albendazole alone .
None(e1,e2)	0	13	dopamine -induced renal and mesenteric vasodilation is not antagonized by either alpha- or beta-adrenergic_blocking_agents .
effect(e1,e2)	9	36	hypotension - patients on diuretic therapy : patients on diuretics , and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with prinivil .
None(e1,e2)	7	24	metoclopramide : when coadministered with monurol , metoclopramide , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of fosfomycin .
None(e1,e2)	34	49	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	3	5	patients taking low-dose aspirin plus ibuprofen were not studied .
None(e1,e2)	17	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	13	19	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	6	11	there is limited experience with concomitant antihypertensive_agents such as alpha-blockers , calcium_channel-blockers , ace inhibitors , and diuretics ( both thiazide-like and loop ) .
None(e1,e2)	24	47	in vivo studies : nitrates : the blood pressure lowering effects of sublingual nitrates ( 0.4 mg ) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1 , 4 and 8 hours were potentiated by a 20 mg dose of vardenafil in healthy middle-aged subjects .
None(e1,e2)	9	19	particular caution should be exercised in using preparations containing sulfur , resorcinol , or salicylic acid in combination with differin gel .
None(e1,e2)	46	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	17	25	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
effect(e1,e2)	6	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	67	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	17	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	38	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	46	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	11	25	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
None(e1,e2)	8	48	this drug may interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	16	43	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	26	30	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic_acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	10	21	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta_blockers .
mechanism(e1,e2)	10	27	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
None(e1,e2)	48	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	34	44	however , in another study in healthy volunteers , the pharmacokinetics of butorphanol were significantly altered ( 29 % decrease in auc and 38 % decrease in cmax ) when a 1-mg dose of stadol_ns was administered 1 minute after a 20-mg dose of sumatriptan nasal spray .
None(e1,e2)	10	18	it may be necessary to adjust the dosage of oral anticoagulants upon beginning or stopping disulfiram . since disulfiram may prolong prothrombin time .
None(e1,e2)	0	4	probenecid prolonged action of etomidate
None(e1,e2)	29	46	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	11	13	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon_beta-1a ( avonex 30 mcg im once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
None(e1,e2)	33	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	16	diphenhydramine hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	20	22	serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of crohn s disease including corticosteroids , antibiotics ( metronidazole or ciprofloxacin ) and aminosalicylates .
None(e1,e2)	4	19	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	24	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	30	33	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	3	6	concurrent administration of vasopressor_drugs and of ergot-type_oxytocic_drugs may cause severe , persistent hypertension or cerebrovascular accidents .
None(e1,e2)	83	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	56	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	30	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	32	41	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	31	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	45	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	14	24	epinephrine also should be used cautiously with other drugs ( e.g. , digitalis , glycosides ) that sensitize the myocardium to the actions of sympathomimetic_drugs .
None(e1,e2)	17	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	22	36	lithium : in a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving lithium 450 mg bid with celebrex 200 mg bid as compared to subjects receiving lithium alone .
None(e1,e2)	28	38	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	32	45	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	19	47	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	1	9	other cns_depressant_drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	39	44	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium_sparing_diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	22	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	24	27	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	0	3	quinolones , including cinoxacin , may enhance the effects of oral anticoagulants , such as warfarin or its derivatives .
None(e1,e2)	14	16	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease_inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
effect(e1,e2)	14	49	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	44	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	30	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	31	39	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	47	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	9	24	fifteen to 30 minutes of exposure to 1.25 mac isoflurane or enflurane had minimal effects on the duration of action of initial doses of nimbex and therefore , no adjustment to the initial dose should be necessary when nimbex is administered shortly after initiation of volatile agents .
None(e1,e2)	0	22	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
None(e1,e2)	4	15	potential drug interactions for doxylamine include , increased sedation if doxylamine is combined with other cns_depressant_drugs .
None(e1,e2)	29	45	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	7	24	phase ii clinical trial data , where iressa and vinorelbine have been used concomitantly , indicate that iressa may exacerbate the neutropenic effect of vinorelbine .
None(e1,e2)	32	38	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic_blocking_agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	114	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	3	quinolone_antibiotic s : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	3	12	concomitant administration of norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels .
None(e1,e2)	12	29	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	31	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	26	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	81	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	28	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	2	12	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	18	20	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	2	10	use with allopurinol : the principal pathway for detoxification of azathioprine is inhibited by allopurinol .
None(e1,e2)	7	19	patients with crohn s disease who received immunosuppressants tended to experience fewer infusion reactions compared to patients on no immunosuppressants .
mechanism(e1,e2)	7	12	nonsteroidal anti-inflammatory drugs : the administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin .
advise(e1,e2)	7	11	it is suggested that in patients receiving dopamine_hcl , alternatives to phenytoin should be used if anticonvulsant therapy is needed .
None(e1,e2)	2	7	cholestyramine and colestipol resins : absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins .
None(e1,e2)	1	31	aspirin/ acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	32	38	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	46	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	36	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	28	35	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	15	25	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral_agents , including protease inhibitors , macrolide antibiotics , and azole_antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	42	44	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking_agents , tricyclic_antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	9	13	strong inducers of cytochrome p450 enzymes ( i.e . carbamazepine , phenytoin and phenobarbital ) have been shown to decrease the plasma levels of mhd ( 29-40 % ) .
None(e1,e2)	14	38	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	21	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	27	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	39	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	62	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	29	33	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
advise(e1,e2)	10	24	although specific drug interaction studies have not been conducted with alphagan_p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	20	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	22	24	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
mechanism(e1,e2)	2	20	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
advise(e1,e2)	27	29	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
advise(e1,e2)	2	9	aspirin : celebrex can be used with low dose aspirin .
None(e1,e2)	12	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	41	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	49	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	22	32	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	0	2	pimozide and celexa - in a controlled study , a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in qtc values of approximately 10 msec compared to pimozide given alone .
None(e1,e2)	13	30	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
effect(e1,e2)	0	8	isoflurane potentiates the muscle relaxant effect of all muscle_relaxants , most notably nondepolarizing muscle relaxants , and mac ( minimum alveolar concentration ) is reduced by concomitant administration of n 2o .
None(e1,e2)	7	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	2	18	although trough citalopram plasma levels were unaffected , given the enzyme-inducing properties of carbamazepine , the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered .
None(e1,e2)	6	15	these effects were not observed when vardenafil 20 mg was taken 24 hours before the ntg .
None(e1,e2)	57	69	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	0	2	sumatriptan and d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp should not be taken within 24 hours of each other..
advise(e1,e2)	1	18	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	71	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	12	48	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	13	ganciclovir : administration of videx 2 hours prior to or concurrent with oral ganciclovir was associated with a 111 ( 114 ) % increase in the steady-state auc of didanosine ( n = 12 ) .
None(e1,e2)	28	33	when initiating a multi-day course of grepafloxacin in a patient maintained on theophylline , the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments .
None(e1,e2)	66	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	25	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal_contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
effect(e1,e2)	8	14	seizures have been reported in patients taking another quinolone_class_antimicrobial and the nonsteroidal anti-inflammatory drug fenbufen concurrently .
mechanism(e1,e2)	9	35	digoxin : in controlled studies in healthy volunteers , bepridil_hydrochloride either had no effect ( one study ) or was associated with modest increases , about 30 % ( two studies ) in steady-state serum digoxin concentrations .
None(e1,e2)	77	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	17	ketoconazole : ketoconazole 400 mg daily did not have any clinically important effect on the pharmacokinetics of rofecoxib .
None(e1,e2)	5	13	hctz 50 mg qd or hctz /triamterene 50/100 mg qd was co-administered with tikosyn ( 500 mcg bid ) for 5 days ( following 2 days of diuretic use at half dose ) .
None(e1,e2)	0	3	short-acting_beta2-agonists : aerosol bronchodilators of the short-acting adrenergic stimulant type may be used for relief of breakthrough symptoms while using formoterol .
None(e1,e2)	11	34	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	95	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	36	38	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
advise(e1,e2)	22	40	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium_channel_blockers , and beta-blockers . )
None(e1,e2)	17	29	however , co-administration of duloxetine with aluminum- and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	55	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	6	17	verapamil : coadministration of almotriptan and verapamil resulted in a 24 % increase in plasma concentrations of almotriptan .
None(e1,e2)	32	42	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin_b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	22	26	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
effect(e1,e2)	5	29	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic_analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	26	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	67	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	33	41	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	20	24	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	28	30	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	15	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine -containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	11	13	additive depressant effect when used with general anesthetics , sedatives , antianxiety_drugs , hypnotics , alcohol , and other opiate analgesics .
None(e1,e2)	1	14	micro-dosed progesterone preparations : micro-dosed progesterone preparations ( minipills that do not contain an estrogen ) may be an inadequate method of contraception during accutane therapy .
effect(e1,e2)	8	19	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine_class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	5	16	warfarin : in subjects receiving warfarin , no significant change in clotting time was observed when grepafloxacin was coadministered .
None(e1,e2)	31	42	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	27	40	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	73	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	3	13	antidiabetics : because corticosteroids may increase blood glucose concentrations , dosage adjustments of antidiabetic_agents may be required .
effect(e1,e2)	2	8	administration of epinephrine to patients receiving cyclopropane or halogenated_hydrocarbon_general_anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
None(e1,e2)	6	8	- a sulfa-based drug such as sulfamethoxazole - trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	61	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	28	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	11	15	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	47	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	7	methotrexate : caution should be used if diflunisal is administered concomitantly with methotrexate .
None(e1,e2)	41	113	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	28	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	90	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	25	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
mechanism(e1,e2)	19	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	19	37	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	22	38	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	1	11	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	5	28	combination of amiodarone with other antiarrhythmic therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to amiodarone .
mechanism(e1,e2)	3	30	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
mechanism(e1,e2)	2	17	caffeine : enoxacin is a potent inhibitor of the cytochrome p-450 isozymes responsible for the metabolism of methylxanthines .
None(e1,e2)	43	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	78	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	2	cimetidine : atorvastatin plasma concentrations and ldl-c reduction were not altered by coadministration of cimetidine .
None(e1,e2)	1	54	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	14	24	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	16	22	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic_agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	3	19	example inhibitors include azole_antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	11	15	h-2 antagonists : in studies with human volunteers , co-administration of cimetidine or ranitidine with ibuprofen had no substantive effect on ibuprofen serum concentrations .
effect(e1,e2)	0	11	fluothane may augment the hypotension caused by the ganglionic-blocking effect of tubocurarine .
None(e1,e2)	4	9	however , patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with flolan , which may be clinically significant in patients prone to digoxin toxicity .
None(e1,e2)	9	11	therefore , linezolid has the potential for interaction with adrenergic and serotonergic_agents .
mechanism(e1,e2)	6	8	sulindac : the concomitant administration of diflunisal and sulindac in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third .
mechanism(e1,e2)	9	25	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a 30 % increase in the rate of flecainide elimination .
None(e1,e2)	3	14	the use of nuromax before succinylcholine to attenuate some of the side effects of succinylcholine has not been studied .
None(e1,e2)	0	13	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	0	2	mao_inhibitors : duragesic is not recommended for use in patients who have received maoi within 14 days because severe and unpredictable potentiation by mao inhibitors has been reported with opioid analgesics
None(e1,e2)	66	123	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	22	33	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
advise(e1,e2)	0	7	lithium generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	19	23	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	22	26	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	7	9	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	23	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	9	anesthetics /sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	19	45	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	5	7	co-administration : concomitant use of argatroban with antiplatelet_agents , thrombolytics , and other anticoagulants may increase the risk of bleeding .
None(e1,e2)	0	2	warfarin and anticoagulants : increased prothrombin time , with or without clinical bleeding , has been reported when cefixime is administered concomitantly .
None(e1,e2)	39	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	23	enoxacin does not affect the clearance of the active s-isomer , and changes in clotting time have not been observed when enoxacin and warfarin were coadministered .
None(e1,e2)	2	14	- a steroid_medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	7	14	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	15	34	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum_hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
None(e1,e2)	4	18	although no interaction between mao_inhibitors and levo-dromoran has been observed , it is not recommended for use with mao_inhibitors .
None(e1,e2)	8	15	no interaction was noted with the mao-b inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor ( n=29 ) .
effect(e1,e2)	8	18	beta-blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin .
None(e1,e2)	10	12	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	21	37	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	12	22	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial_agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	17	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	22	41	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	0	32	central_nervous_system_depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	12	21	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	33	35	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	36	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	9	36	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
None(e1,e2)	0	7	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	23	104	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	83	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	12	patients taking disopyramide_phosphate and erythromycin concomitantly may develop increased serum concentrations of disopyramide resulting in excessive widening of the qrs complex and/or prolongation of the q-t interval .
None(e1,e2)	66	128	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	114	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	18	48	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	66	111	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	34	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	11	42	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium_sparing_diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	9	13	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	16	18	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	0	12	furosemide : in normal volunteers , the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of furosemide .
None(e1,e2)	7	15	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	12	41	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
None(e1,e2)	24	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	20	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	4	16	elevated serum levels of cyclosporine have been reported with the concomitant use of some quinolones and cyclosporine .
None(e1,e2)	16	25	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	6	15	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	15	19	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	20	38	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl_alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	23	49	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	17	mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic_agents , tricyclic_antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	126	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	49	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	9	11	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	13	21	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot_alkaloid_class , of which d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	38	40	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
effect(e1,e2)	2	23	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	28	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	0	23	enoxacin does not affect the clearance of the active s-isomer , and changes in clotting time have not been observed when enoxacin and warfarin were coadministered .
None(e1,e2)	74	85	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	23	26	therefore , there is a potential for an interaction with other drugs that are metabolized by cyp 1a2 ( e.g. , amitriptyline , tacrine , and zileuton ) .
None(e1,e2)	0	12	potassium-sparing_diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	32	55	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	37	48	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	17	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	2	4	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	0	2	phenobarbital : amphetamines may delay intestinal absorption of phenobarbital ;
None(e1,e2)	0	20	omeprazole : the rate and extent of absorption of ciprofloxacin was bioequivalent when proquin xr was given alone or when proquin_xr was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .
None(e1,e2)	0	15	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	14	30	isuprel should be used with caution , if at all , when potent inhalational anesthetics such as halothane are employed because of potential to sensitize the myocardium to effects of sympathomimetic_amines .
None(e1,e2)	12	29	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	85	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	65	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	55	57	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	3	ketoconazole /itraconazole , macrolides , including erythromycin
None(e1,e2)	50	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	38	macrolide_antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	35	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	30	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	8	19	vitamin a : because of the relationship of accutane to vitamin a , patients should be advised against taking vitamin_supplements containing vitamin a to avoid additive toxic effects
None(e1,e2)	20	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	46	81	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	45	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	52	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
int(e1,e2)	6	21	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	20	26	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	39	41	conversion could be affected by alterations in the level of phosphatase activity , but given the abundance and wide distribution of phosphatases in the body it is unlikely that drugs would affect this activity enough to affect conversion of fosphenytoin to phenytoin .
None(e1,e2)	15	18	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide_diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	65	67	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	49	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	50	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant_drugs .
None(e1,e2)	28	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	79	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	33	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	10	23	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	35	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	19	42	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	28	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	19	25	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	0	12	potassium-sparing_diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	2	7	drug-drug interactions cimetidine : concomitant use of cimetidine is contraindicated .
mechanism(e1,e2)	26	29	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	16	29	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin_sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	12	24	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	8	10	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	6	16	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	42	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
int(e1,e2)	11	27	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
effect(e1,e2)	14	19	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	43	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	2	phenytoin , phenobarbital and carbamazepine are ge nerally classified as enzyme inducers ;
None(e1,e2)	12	23	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic drug .
None(e1,e2)	21	29	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	27	45	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	95	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	26	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	80	122	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	8	heparin , other anticoagulants , thrombolytics , and anti_platelet_agents are associated with an increase in bleeding .
None(e1,e2)	0	2	warfarin : quinolones may enhance the effects of the oral anticoagulant , warfarin , or its derivatives .
mechanism(e1,e2)	4	20	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	15	25	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	17	mao_inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic_antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	1	20	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ ethinyl_estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	40	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	4	bacteriostatic_antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
None(e1,e2)	50	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	5	59	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	81	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	24	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	7	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	32	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	18	38	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	1	7	certain antibiotics , especially the aminoglycosides and polymyxins ;
None(e1,e2)	81	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	20	47	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	10	21	in 5 other schizophrenic patients treated with oral haloperidol and rifampin , discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations .
None(e1,e2)	15	17	the absorption of lymecycline may be affected by the simultaneous administration of indigestion remedies , iron or zinc supplements .
None(e1,e2)	30	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	19	21	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
effect(e1,e2)	0	14	quinolones , including nalidixic acid , may enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	10	16	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	10	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	2	5	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	3	19	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	24	28	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	96	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	10	29	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	100	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	44	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	4	48	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	63	68	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	17	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	11	exemestane is extensively metabolized by cyp 3a4 , but coadministration of ketoconazole , a potent inhibitor of cyp 3a4 , has no significant effect on exemestane pharmacokinetics .
None(e1,e2)	1	16	oral contraceptives : the effect of oral contraceptives on the pharmacokinetics of d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp has not been studied .
None(e1,e2)	112	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	0	7	aminoglutethimide diminishes the effect of coumarin and warfarin .
None(e1,e2)	65	71	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	30	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	7	40	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist_analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
None(e1,e2)	7	14	the ratios of the aucs of unbound valproate to the aucs of the total valproate were 11.1 % , 13.0 % , and 11.5 % , with coadministration of 0 , 1200 , and 2400 mg/day of felbatol , respectively .
None(e1,e2)	16	18	there does not appear to be an increase in adverse events in subjects who received oral contraceptives and loratadine .
None(e1,e2)	13	33	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
effect(e1,e2)	4	29	certain drugs , including nonsteroidal_anti-inflammatory_agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic_drugs .
effect(e1,e2)	0	14	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	10	16	- drugs that may decrease plasma phenytoin concentrations include : carbamazepine , chronic alcohol abuse , reserpine
advise(e1,e2)	3	5	therefore , when chlorothiazide and non-steroidal_anti-inflammatory_agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained
None(e1,e2)	35	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	4	20	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	0	15	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	73	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	11	results demonstrate that oxcarbazepine and its pharmacologically active 10-monohydroxy metabolite ( mhd ) have little or no capacity to function as inhibitors for most of the human cytochrome p450 enzymes evaluated ( cyp1a2 , cyp2a6 , cyp2c9 , cyp2d6 , cyp2e1 , cyp4a9 and cyp4a11 ) with the exception of cyp2c19 and cyp3a4/5 .
None(e1,e2)	4	6	non-selective mao inhibitors including tranylcypromine_sulfate , phenelzine_sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	27	35	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
mechanism(e1,e2)	0	7	atromid-s may displace acidic drugs such as phenytoin or tolbutamide from their binding sites .
None(e1,e2)	31	43	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	19	32	glyburide : in a randomized , multiple-dose crossover study , patients with type 2 diabetes were administered 120 mg starlix three times a day before meals for 1 day in combination with glyburide 10 mg daily .
None(e1,e2)	39	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	17	these data indicate that levetiracetam does not influence the plasma concentration of other aeds and that these aeds do not influence the pharmacokinetics of levetiracetam .
None(e1,e2)	8	16	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	9	13	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	0	2	anticonvulsants : carbamazepine , phenobarbital , phenytoin
mechanism(e1,e2)	2	9	carbamazepine : felbatol causes a decrease in the steady-state carbamazepine plasma concentrations and an increase in the steady-state carbamazepine epoxide plasma concentration .
None(e1,e2)	28	39	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	21	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	0	24	pletal does not , however , appear to cause increased blood levels of drugs metabolized by cyp3a4 , as it had no effect on lovastatin , a drug with metabolism very sensitive to c.p.a . inhibition .
None(e1,e2)	49	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	7	19	ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan , and erythromycin had no clinically significant effect after oral administration .
None(e1,e2)	8	17	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	0	45	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	33	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	0	22	betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 the effect of alternate-day administration of 0.25 mg of betaseron on drug metabolism in ms patients is unknown .
None(e1,e2)	4	15	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	34	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	12	25	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central_nervous_system_depressant effects .
None(e1,e2)	28	30	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	16	21	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	8	12	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	8	14	cardiovasculars : cardiac glycosides : in patients receiving digoxin therapy , administration of oral amiodarone regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity .
None(e1,e2)	3	5	amphotericin b or corticosteroids or corticotropin ( acth )
None(e1,e2)	6	8	dosage adjustment may be required if cyclosporine , tacrolimus , or methylprednisolone are given concomitantly with nizoral tablets .
None(e1,e2)	32	62	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	39	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	40	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	35	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	19	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	0	13	cimetidine : cimetidine has been demonstrated to interfere with the elimination of other quinolones .
None(e1,e2)	2	19	phenobarbital or primidone : no formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or primidone .
None(e1,e2)	29	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	26	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	14	31	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	28	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	41	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	26	33	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
None(e1,e2)	113	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	0	15	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	47	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	5	25	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	0	15	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	2	8	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
effect(e1,e2)	5	39	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	13	38	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	12	28	interactions with other cns agents : concurrent use of levo-dromoran with all central_nervous_system_depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	4	29	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	71	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	10	18	compounds in these categories result in a decreased efficacy of bromocriptine_mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
None(e1,e2)	13	23	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac_glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal_antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	23	27	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	12	ace_inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of angiotensin_converting_enzyme_(_ace_)_inhibitors .
None(e1,e2)	63	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	46	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	7	23	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	35	39	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	42	61	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	1	46	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine .
None(e1,e2)	0	4	vasopressors , such as dopamine and isoproterenol ;
None(e1,e2)	15	26	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	13	34	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	21	26	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	49	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	11	34	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
effect(e1,e2)	5	7	however , concomitant administration of aspirin with celebrex may result in an increased rate of gi ulceration or other complications , compared to use of celebrex alone .
None(e1,e2)	6	8	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp/aza and aminosalicylates .
mechanism(e1,e2)	13	19	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate_calcium_disodium interferes with the action of zinc_insulin preparations by chelating the zinc . 7
None(e1,e2)	5	17	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet_inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	7	9	albuterol , antihistamines , antidiabetic drugs , diuretics , digitalis .
None(e1,e2)	4	12	no dose adjustment of bosentan is necessary , but increased effects of bosentan should be considered .
None(e1,e2)	3	10	the pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide
None(e1,e2)	0	7	dicumarol : it has been reported that allopurinol prolongs the half-life of the anticoagulant , dicumarol .
None(e1,e2)	7	9	patients taking these drugs with lodosyn and levodopa or carbidopa -levodopa combination products should be carefully observed for loss of therapeutic response .
None(e1,e2)	0	6	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
advise(e1,e2)	8	18	amphotericin b injection and potassium-depleting agents : when corticosteroids are administered concomitantly with potassium-depleting agents ( e.g. , amphotericin_b , diuretics ) , patients should be observed closely for development of hypokalemia .
None(e1,e2)	17	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	2	15	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	35	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	81	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	8	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	32	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	24	35	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	29	40	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic_analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic_antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	21	35	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
effect(e1,e2)	4	17	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	23	27	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	8	10	antibiotics ( e.g. , erythromycin , trimethoprim and sulfamethoxazole , amoxicillin ) .
None(e1,e2)	1	15	prednisone/ prednisolone : rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .
effect(e1,e2)	0	18	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	21	26	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	5	7	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine
None(e1,e2)	0	13	mercaptopurine /azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric_acid .
None(e1,e2)	22	25	clinical studies in healthy volunteers show that the pharmacokinetics of cancidas are not altered by itraconazole , amphotericin b , mycophenolate , nelfinavir , or tacrolimus .
None(e1,e2)	24	26	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	13	15	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
None(e1,e2)	4	16	the concomitant intake of alcohol and acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate .
None(e1,e2)	26	33	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic_acid has been reported to both increase and decrease ethosuximide levels ) .
mechanism(e1,e2)	5	16	in a multiple-dose study , enoxacin caused a dose-related increase in the mean elimination half-life of caffeine , thereby decreasing the clearance of caffeine by up to 80 % and leading to a five-fold increase in the auc and the half-life of caffeine .
None(e1,e2)	46	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	26	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	15	39	- when bezalip or bezalip retard is used concurrently with anion-exchange resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip_retard is impaired
effect(e1,e2)	0	6	tcas decrease the hypotensive effect of guanfacine .
None(e1,e2)	7	9	co-administration : concomitant use of argatroban with antiplatelet_agents , thrombolytics , and other anticoagulants may increase the risk of bleeding .
None(e1,e2)	22	32	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g . certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
None(e1,e2)	94	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	18	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	15	18	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	17	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	3	15	the auc of ciprofloxacin was decreased an average of 15-fold in 12 healthy subjects given ciprofloxacin and didanosine-placebo tablets concurrently .
None(e1,e2)	15	17	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	29	39	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	67	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	16	fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	15	19	the use of dextromethorphan hydrobromide may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
None(e1,e2)	72	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	4	digitalis_glycosides : patients on digitalis_glycosides may be at increased risk of arrhythmias due to hypokalemia .
None(e1,e2)	21	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	15	17	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	4	17	the risk of using bromocriptine_mesylate in combination with other drugs has not been systematically evaluated , but alcohol may potentiate the side effects of bromocriptine mesylate .
None(e1,e2)	26	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
effect(e1,e2)	8	32	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	19	23	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	83	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	18	interactions with other antiretroviral drugs : significant decreases in the auc of delavirdine ( 20 % ) and indinavir ( 84 % ) occurred following simultaneous administration of these agents with videx .
None(e1,e2)	18	44	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	17	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	8	41	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	18	20	other concomitant therapy in healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone .
int(e1,e2)	7	11	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	23	29	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
mechanism(e1,e2)	2	11	antacids containing aluminum_hydroxide and magnesium hydroxide reduce the oral absorption of enoxacin by 75 % .
None(e1,e2)	4	12	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	12	14	dose adjustment is not recommended.levetiracetam had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or lamotrigine .
None(e1,e2)	9	32	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	19	45	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	0	29	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	24	28	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	26	30	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	7	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	19	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	50	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	22	diuretics : studies in normal volunteers have shown that flurbiprofen like other nonsteroidal anti-inflammatory drugs , can interfere with the effects of furosemide .
None(e1,e2)	62	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	23	34	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	50	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	69	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	5	34	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	27	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	12	27	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
effect(e1,e2)	7	12	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	10	19	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
None(e1,e2)	7	12	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	18	20	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	46	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	29	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	21	51	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	32	71	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	21	42	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
mechanism(e1,e2)	16	26	however , the peak plasma level of metformin was reduced by approximately 20 % when taking acarbose due to a slight delay in the absorption of metformin .
None(e1,e2)	34	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	16	26	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic_acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	19	20	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	8	13	therefore , administration of quinolones with antacids containing calcium , magnesium , or aluminum ;
None(e1,e2)	0	2	gemfibrozil other fibrates niacin ( nicotinic acid ) ( =1 g/day )
None(e1,e2)	54	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	13	24	these data indicate that levetiracetam does not influence the plasma concentration of other aeds and that these aeds do not influence the pharmacokinetics of levetiracetam .
effect(e1,e2)	7	12	increased ectopic pacemaker activity can occur when pseudoephedrine is used concomitantly with digitalis .
mechanism(e1,e2)	0	4	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
mechanism(e1,e2)	7	15	dicumarol : it has been reported that allopurinol prolongs the half-life of the anticoagulant , dicumarol .
None(e1,e2)	0	14	coumarin_anticoagulants : there have been rare reports of increased prothrombin time in patients taking coumarin_anticoagulants to whom nifedipine was administered .
None(e1,e2)	76	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	61	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	22	central_nervous_system_depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	15	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	22	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	8	17	nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent diuretics such as furosemide .
None(e1,e2)	45	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	29	45	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
advise(e1,e2)	18	42	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	4	21	co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27 % compared with those achieved with anastrozole alone .
None(e1,e2)	21	23	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	40	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	21	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	30	35	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
int(e1,e2)	4	6	the extent to which ssri - tca interactions may pose clinical problems will depend on the degree of inhibition , and the pharmacokinetics of the ssri involved .
None(e1,e2)	62	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	15	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	15	18	it may be necessary to adjust the dosage of oral anticoagulants upon beginning or stopping disulfiram . since disulfiram may prolong prothrombin time .
None(e1,e2)	0	11	methotrexate : in an interaction study of rheumatoid arthritis patients taking methotrexate , celebrex did not have a significant effect on the pharmacokinetics of methotrexate .
None(e1,e2)	13	19	omeprazole : the rate and extent of absorption of ciprofloxacin was bioequivalent when proquin_xr was given alone or when proquin_xr was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .
mechanism(e1,e2)	0	14	tricyclic_antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination_hormonal_contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	16	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	15	17	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	83	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	45	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	11	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	1	24	because busulfan is eliminated from the body via conjugation with glutathione , use of acetaminophen prior to ( 72 hours ) or concurrent with busulfex may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues .
None(e1,e2)	0	11	hiv_protease_inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
advise(e1,e2)	4	13	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
None(e1,e2)	7	13	because fluvoxamine reduces the clearance of both diazepam and its active metabolite , n-desmethyldiazepam , there is a strong likelihood of substantial accumulation of both species during chronic co-administration .
effect(e1,e2)	9	22	diuretics : studies in normal volunteers have shown that flurbiprofen like other nonsteroidal anti-inflammatory drugs , can interfere with the effects of furosemide .
None(e1,e2)	15	22	because there is a theoretical basis that these effects may be additive , use of ergotamine -containing or ergot-type medications ( like dihydroergotamine or methysergide ) and naratriptan within 24 hours is contraindicated .
None(e1,e2)	18	43	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium_sparing_diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	37	45	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	6	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
None(e1,e2)	32	46	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	36	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	68	81	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	13	15	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine_oxidase_inhibitors or tricyclic_antidepressants may produce severe , prolonged hypertension .
effect(e1,e2)	1	22	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	3	5	insulin or oral hypoglycemics : agents_with_b-blocking_properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
None(e1,e2)	28	41	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	4	15	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	18	47	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic_antidepressants
None(e1,e2)	0	2	histamine_h2-receptor_antagonists : histamine_h2-receptor_antagonists appear to have no significant effect on the bioavailability of ciprofloxacin .
None(e1,e2)	1	23	since amiodarone is a substrate for cyp3a4 , there is the potential that the use of st. john s wort in patients receiving amiodarone could result in reduced amiodarone levels .
None(e1,e2)	149	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	aspirin , warfarin , heparin , nsaids
effect(e1,e2)	3	10	reports suggest that nsaids may diminish the antihypertensive effect of ace_inhibitors , including lisinopril .
None(e1,e2)	59	69	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	22	24	potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated , and concomitant use of vardenafil and nitrates is contraindicated .
None(e1,e2)	12	15	heparin sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
None(e1,e2)	0	13	doxil may interact with drugs known to interact with the conventional formulation of doxorubicin_hcl .
None(e1,e2)	0	6	antacid : the effect of an aluminum_hydroxide - and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	8	18	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective_beta-adrenergic-blocking_agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	78	107	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	9	14	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine_derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	34	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	12	24	nonsteroidal anti-inflammatory drugs : the administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin .
None(e1,e2)	14	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	2	17	coadministration with valdecoxib ( 40 mg bid for 7 days ) resulted in a significant increase in dextromethorphan plasma levels suggesting that , at these doses , valdecoxib is a weak inhibitor of 2d6 .
None(e1,e2)	9	15	the urinary excretion of meclofenamate sodium is unaffected by aspirin , indicating no change in meclofenamate_sodium absorption .
mechanism(e1,e2)	19	42	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	43	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	22	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	56	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	39	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	21	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	16	18	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	35	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	6	furthermore , rifampin , phenytoin , phenobarbital , and other inducers of cytochrome p450 3a4 may cause a reduction in plasma bexarotene concentrations .
None(e1,e2)	19	21	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	6	10	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	34	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	11	13	folic acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
None(e1,e2)	9	18	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace inhibitor therapy .
None(e1,e2)	38	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	10	20	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	9	43	in another study with intravenous administration of midazolam , aprepitant was given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , and midazolam 2 mg iv was given prior to the administration of the 3-day regimen of aprepitant and on days 4 , 8 , and 15 .
None(e1,e2)	24	26	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	2	31	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	24	39	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	31	34	may interact with the following : beta-adrenergic blocking agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
advise(e1,e2)	4	13	patients who are applying panretin gel should not concurrently use products that contain deet ( n , n-diethyl-m-toluamide ) , a common component of insect repellent products .
None(e1,e2)	31	36	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	14	20	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	24	35	however , theophylline plasma concentrations should be monitored , with dosage adjustment as appropriate , in patients whose pulmonary disease requires maintaining a given theophylline plasma concentration for optimal pulmonary function or in patients with theophylline concentrations at the higher end of the therapeutic range .
None(e1,e2)	11	15	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	5	16	concurrent use of butorphanol with central_nervous_system_depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	12	27	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	11	13	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	5	40	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	38	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	20	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	102	126	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	6	the concomitant administration of exjade and aluminum -containing antacid preparations has not been formally studied .
None(e1,e2)	1	3	oral hypoglycemics : diclofenac does not alter glucose metabolism in normal subjects nor does it alter the effects of oral hypoglycemic agents .
None(e1,e2)	0	17	trimethoprim alone or in combination with sulfamethoxazole : concomitant use of trimethoprim alone or in combination with sulfamethoxazole is contraindicated .
mechanism(e1,e2)	0	6	clarithromycin exposure was significantly decreased by nevirapine ;
None(e1,e2)	30	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	10	14	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	44	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim / sulfamethoxazole or zidovudine .
effect(e1,e2)	6	9	glyburide : the concomitant administration of ciprofloxacin with the sulfonylurea glyburide has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	24	27	as with other drugs that block angiotensin ii or its effects , concomitant use of potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , or salt substitutes containing potassium may lead to increases in serum potassium .
None(e1,e2)	15	27	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
effect(e1,e2)	14	35	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
advise(e1,e2)	1	16	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	8	41	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
advise(e1,e2)	3	5	therefore , when hydroflumethiazide and nonsteroidal_anti-inflammatory_agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained . )
mechanism(e1,e2)	2	28	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
advise(e1,e2)	5	12	it is recommended that if casodex is started in patients already receiving coumarin_anticoagulants , prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary .
None(e1,e2)	112	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	12	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	2	31	as most entacapone excretion is via the bile , caution should be exercised when drugs known to interfere with biliary excretion , glucuronidation , and intestinal beta-glucuronidase are given concurrently with entacapone .
None(e1,e2)	24	26	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	57	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	23	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium_antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	15	24	this effect may be mediated by the known inhibition of hepatic cytochrome p- 450 by cimetidine , which could decrease first pass metabolism of nimodipine .
None(e1,e2)	24	29	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	19	27	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic_agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
effect(e1,e2)	1	4	taking amyl_nitrite after drinking alcohol may worsen side effects and may cause severe hypotension and cardiovascular collapse .
None(e1,e2)	35	50	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	43	48	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	104	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	5	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	10	22	because oral anticoagulants may interfere with the hepatic metabolism of phenytoin , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .
None(e1,e2)	43	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	19	49	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	0	8	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	19	27	monoamine oxidase inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine_oxidase_inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
effect(e1,e2)	18	20	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace_inhibitor therapy .
None(e1,e2)	33	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	8	11	marked symptomatic orthostatic hypotension has been reported when calcium_channel_blockers and organic nitrates were used in combination .
effect(e1,e2)	4	7	beta-adrenergic receptor antagonists ( beta-blockers ) and brovana may interfere with the effect of each other when administered concurrently .
None(e1,e2)	41	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	9	13	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
None(e1,e2)	47	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	12	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
mechanism(e1,e2)	0	10	paroxetine ( 20 mg qd ) increased the concentration of duloxetine ( 40 mg qd ) by about 60 % , and greater degrees of inhibition are expected with higher doses of paroxetine .
None(e1,e2)	59	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	57	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	117	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	10	14	in the first study , concomitant administration of 0.2 mg cerivastatin_sodium and 12 g cholestyramine resulted in decreases of more than 22 % for auc and 40 % for cmax when compared to dosing cerivastatin sodium alone .
advise(e1,e2)	11	17	based on clinical and pharmacokinetic results from the atac trial , tamoxifen should not be administered with anastrozole ( see clinical pharmacology drug interactions and clinical pharmacology - clinical studies - adjuvant treatment of breast cancer in postmenopausal women subsections ) .
None(e1,e2)	2	6	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	0	19	estazolam : interaction with drugs that inhibit metabolism via cytochrome p450 3a ( cyp3a ) : the metabolism of estazolam to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other triazolobenzodiazepines is catalyzed by cyp3a .
effect(e1,e2)	0	37	valdecoxib caused a statistically significant increase in plasma exposures of r-warfarin and s-warfarin ( 12 % and 15 % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as inr ) of warfarin .
None(e1,e2)	24	30	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	40	43	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium_channel_blockers , and beta-blockers . )
mechanism(e1,e2)	3	12	concomitant administration of fenofibrate ( equivalent to 145 mg tricor ) with atorvastatin ( 20 mg ) once daily for 10 days resulted in approximately 17 % decrease ( range from 67 % decrease to 44 % increase ) in atorvastatin auc values in 22 healthy males .
None(e1,e2)	56	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	71	101	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	17	these increased exposures of norethindrone and ethinyl estradiol should be taken into consideration when selecting an oral contraceptive for women taking valdecoxib .
None(e1,e2)	7	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	12	23	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa_reductase_inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	0	14	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
None(e1,e2)	50	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	112	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	8	12	additional reductions in blood pressure may occur when flolan is administered with diuretics , antihypertensive agents , or other vasodilators .
None(e1,e2)	26	37	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic_agents , such as disopyramide , are used concurrently .
None(e1,e2)	40	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	6	propoxyphene : the concurrent administration of propoxyphene_hydrochloride does not affect the bioavailability of meclofenamate sodium .
None(e1,e2)	11	27	since the concomitant administration of these two drugs can lead to phenytoin intoxication , prior to administering disulfiram to a patient on phenytoin therapy , a baseline phenytoin serum level should be obtained .
None(e1,e2)	0	6	fluoxetine , fluvoxamine , paroxetine , sertraline ) .
mechanism(e1,e2)	18	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	6	uricosuric_agents : since the excretion of oxipurinol is similar to that of urate , uricosuric agents , which increase the excretion of urate , are also likely to increase the excretion of oxipurinol and thus lower the degree of inhibition of xanthine oxidase .
None(e1,e2)	10	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	44	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	8	26	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	28	32	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	4	23	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	135	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	14	there is limited experience with concomitant antihypertensive_agents such as alpha-blockers , calcium channel-blockers , ace_inhibitors , and diuretics ( both thiazide-like and loop ) .
None(e1,e2)	18	21	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	0	20	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
None(e1,e2)	6	32	in rats , simultaneous ingestion of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .
None(e1,e2)	33	76	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	8	10	in 5 other schizophrenic patients treated with oral haloperidol and rifampin , discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations .
None(e1,e2)	13	26	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	80	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	4	12	methadone : coadministration of amprenavir and methadone can decrease plasma levels of methadone .
None(e1,e2)	15	26	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	26	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	27	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
effect(e1,e2)	4	17	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
None(e1,e2)	23	25	for this reason , the dose of the anticoagulant should be reduced by 30 - 50 % at the start of treatment with bezalip or bezalip retard and then titrated according to the blood clotting parameters
None(e1,e2)	10	21	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	3	10	the response to factrel may be blunted by phenothiazines and dopamine_antagonists which cause a rise in prolactin .
None(e1,e2)	31	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	12	15	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	8	10	no information is available about the interaction of cephalexin and metformin following multiple doses of either drug .
None(e1,e2)	63	69	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	15	28	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	2	10	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	11	19	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	0	9	thrombolytic_agents : the safety and effectiveness of argatroban with thrombolytic_agents have not been established .
None(e1,e2)	7	22	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	27	37	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	4	9	when concomitant administration of ketoconazole with aripiprazole occurs , aripiprazole dose should be reduced to one-half of its normal dose .
None(e1,e2)	34	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	24	42	clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in inr or warfarin dose ( baseline vs. end of the clinical studies ) , and the need to change the warfarin dose during the trials due to changes in inr or due to adverse events was similar among bosentan- and placebo-treated patients .
None(e1,e2)	7	9	specific studies have confirmed these effects with sevoflurane , isoflurane , propofol , alfentanil , and midazolam .
None(e1,e2)	19	25	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic_agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	16	20	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium_channel_blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	0	9	lomefloxacin is unlikely to have a significant effect on phenytoin metabolism .
advise(e1,e2)	13	17	the use of antacids should be considered in place of h2 blockers or proton_pump_inhibitors in patients receiving sprycel therapy .
None(e1,e2)	19	21	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	20	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	12	14	metoclopramide : bioavailability is mildly reduced ( approximately 10 % ) when zalcitabine and metoclopramide are coadministered .
None(e1,e2)	33	46	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	27	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	0	15	amiodarone may suppress certain cyp450 enzymes , including cyp1a2 , cyp2c9 , cyp2d6 , and cyp3a4 .
None(e1,e2)	42	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	10	amphotericin b or potassium-depleting_diuretics ( benzothiadiazines and related drugs , ethacrynic_acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	3	17	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	32	34	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin_b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	0	17	acarbose has been shown to change the bioavailabillty digoxin when they are co-administered , which may require digoxin dose adjustment .
None(e1,e2)	15	17	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
None(e1,e2)	8	13	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
mechanism(e1,e2)	2	27	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	33	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	6	13	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
None(e1,e2)	15	20	- indomethacin : indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide -induced increase in plasma renin activity .
None(e1,e2)	5	14	aspirin : concurrent administration of aspirin and flurbiprofen resulted in 50 % lower serum flurbiprofen concentrations .
effect(e1,e2)	18	29	tolazamide : a case of severe hypoglycemia has been reported in a type ii diabetic patient maintained on tolazamide ( 1 gm/day ) 11 days after the addition of doxepin ( 75 mg/day ) .
None(e1,e2)	21	68	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	62	115	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	25	42	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	0	19	pimozide and celexa - in a controlled study , a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in qtc values of approximately 10 msec compared to pimozide given alone .
None(e1,e2)	52	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	70	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	59	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	29	32	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	144	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	26	31	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol_hydrochloride , ferrous sulfate , sodium_polystyrene_sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	28	31	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	9	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic_antidepressants or sympathomimetic agents ;
None(e1,e2)	1	24	since amiodarone is a substrate for cyp3a4 and cyp2c8 , drugs/substances that inhibit these isoenzymes may decrease the metabolism and increase serum concentration of amiodarone .
None(e1,e2)	12	23	if signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly , physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately .
effect(e1,e2)	7	11	butyrophenones ( such as haloperidol ) and phenothiazines can suppress the dopamine rgic renal and mesenteric vasodilation induced with low dose dopamine infusion .
None(e1,e2)	4	22	ketoconazole : co-administration of bosentan 125 mg b.i.d . and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately 2-fold .
None(e1,e2)	29	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	36	drugs that may have their plasma concentration altered by gleevec gleevec increases the mean cmax and auc of simvastatin ( cyp3a4 substrate ) 2- and 3.5-fold , respectively , suggesting an inhibition of the cyp3a4 by gleevec .
None(e1,e2)	20	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	10	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	0	8	cyclosporine : increased activity of both cyclosporine and corticosteroids may occur when the two are used concurrently .
None(e1,e2)	9	11	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic_acid_hcl , ascorbic acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	14	26	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	11	13	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
None(e1,e2)	87	160	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	17	19	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson_drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
None(e1,e2)	0	12	amiodarone may suppress certain cyp450 enzymes , including cyp1a2 , cyp2c9 , cyp2d6 , and cyp3a4 .
None(e1,e2)	15	18	more than 600 parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa/ dopa_decarboxylase_inhibitor .
None(e1,e2)	48	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	35	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	35	38	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal_anti-inflammatory_drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	30	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	37	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	8	18	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	0	28	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	8	17	patients receiving high doses of salicylates concomitantly with furosemide , as in rheumatic disease , may experience salicylate toxicity at lower doses because of competitive renal excretory sites .
None(e1,e2)	0	29	ganciclovir : administration of videx 2 hours prior to or concurrent with oral ganciclovir was associated with a 111 ( 114 ) % increase in the steady-state auc of didanosine ( n = 12 ) .
None(e1,e2)	9	13	physicians needing to treatpatients co-infected with tuberculosis andusing a nevirapine containing regimen mayuse rifabutin instead .
effect(e1,e2)	31	33	although clinical studies have not established a cause and effect relationship , physicians should be aware that variable effects an blood coagulation have been reported very rarely in patients receiving oral anticoagulants and chlordiazepoxide .
None(e1,e2)	37	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	31	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	13	20	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns_depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	2	6	sedatives and tranquilizers ( e.g. , diazepam ) .
None(e1,e2)	10	17	since there have been conflicting results regarding the effect of digoxin levels , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing diltiazem hydrochloride therapy to avoid possible over- or under-digitalization .
None(e1,e2)	2	61	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	24	30	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	20	25	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
None(e1,e2)	102	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	33	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
None(e1,e2)	31	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	20	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	9	11	these would include a variety of preparations which contain androgens , estrogens , progestins , or glucocorticoids .
None(e1,e2)	48	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	16	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace inhibitors , and with some angiotensin ii receptor antagonists .
None(e1,e2)	22	24	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
mechanism(e1,e2)	3	22	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	22	26	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	54	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
int(e1,e2)	0	16	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	35	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	7	21	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	27	29	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	28	128	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	15	in the case that you are taking digoxin while taking aminosalicylic_acid , higher doses of digoxin may be needed .
None(e1,e2)	35	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	44	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	17	45	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
advise(e1,e2)	0	11	subutex and suboxone should be prescribed with caution to patients on benzodiazepines or other drugs that act on the central nervous system , regardless of whether these drugs are taken on the advice of a physician or are taken as drugs of abuse .
None(e1,e2)	19	23	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	18	26	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
effect(e1,e2)	18	22	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	47	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	42	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	9	41	ritonavir - combined administration of a single dose of ritonavir ( 600 mg ) , both a cyp3a4 substrate and a potent inhibitor of cyp3a4 , and escitalopram ( 20 mg ) did not affect the pharmacokinetics of either ritonavir or escitalopram .
None(e1,e2)	1	16	analgesic/ anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	21	48	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	1	17	oral hypoglycemic_agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	15	23	in view of the potential risk of dehydration secondary to vomiting and/or diarrhea induced by camptosar , the physician may wish to withhold diuretics during dosing with camptosar and , certainly , during periods of active vomiting or diarrhea .
None(e1,e2)	5	27	hctz 50 mg qd or hctz /triamterene 50/100 mg qd was co-administered with tikosyn ( 500 mcg bid ) for 5 days ( following 2 days of diuretic use at half dose ) .
None(e1,e2)	36	41	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
mechanism(e1,e2)	18	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	40	48	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	5	colchicine para-aminosalicylic acid and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin b12 .
None(e1,e2)	1	4	other tnfa-blocking_agents ( including remicade ) used in combination with anakinra may also result in similar toxicities .
None(e1,e2)	6	16	platelet inhibitors : drugs such as acetylsalicylic_acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	57	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	51	61	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	28	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	28	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	2	10	co-administration of nelfinavir at steady-state with a single dose of azithromycin .
None(e1,e2)	0	6	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	12	21	such individuals are referred to as poor metabolizers of drugs such as debrisoquin , dextromethorphan , the tricyclic antidepressants , and clozapine .
None(e1,e2)	24	40	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	7	14	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate analgesics .
None(e1,e2)	104	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	114	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	14	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	41	103	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	5	7	information on concurrent usage of atenolol and aspirin is limited .
None(e1,e2)	39	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	0	5	codeine in combination with other narcotic_analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	0	4	colestipol -concomitant intake of colestipol and vitamin k may reduce the absorption of vitamin k .
None(e1,e2)	8	10	it may also interact with amantadine or other anticholinergic_drugs or maois , which may intensify the anticholinergic action .
None(e1,e2)	28	39	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	11	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	73	79	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	35	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	12	phospholine iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate_insecticide s .
None(e1,e2)	21	34	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	38	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	7	9	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
None(e1,e2)	8	10	antiarrhythmic agents , class i ( such as flecainide , lidocaine , or quinidine ) : concurrent use with arbutamine may have a proarrhythmic effect .
None(e1,e2)	0	2	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
mechanism(e1,e2)	7	27	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	8	12	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv_protease_inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	16	18	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	28	75	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	40	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	7	9	the combination of therapeutic doses of intravenous dantrolene_sodium and verapamil in halothane a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia .
None(e1,e2)	34	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	11	13	other chemotherapy agents in a separate study , concomitant administration of lapatinib with capecitabine did not meaningfully alter the pharmacokinetics of either agent ( or the metabolites of capecitabine ) .
None(e1,e2)	12	22	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	40	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	19	concomitant administration of norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels .
None(e1,e2)	27	31	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
None(e1,e2)	2	5	interaction with central_nervous_system_depressants other than benzodiazepines has not been specifically studied ;
None(e1,e2)	74	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	30	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	4	8	other reported interactions with amiodarone : fentanyl ( cyp3a4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .
None(e1,e2)	6	17	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	15	35	in the first study , concomitant administration of 0.2 mg cerivastatin sodium and 12 g cholestyramine resulted in decreases of more than 22 % for auc and 40 % for cmax when compared to dosing cerivastatin_sodium alone .
None(e1,e2)	0	16	haloperidol : haloperidol blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines .
None(e1,e2)	9	11	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	35	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	12	the pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide
None(e1,e2)	102	104	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	27	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	21	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	80	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	46	in patients with mild to moderate hypertension , administration of 25 mg daily of vioxx with the ace inhibitor benazepril , 10 to 40 mg for 4 weeks , was associated with an average increase in mean arterial pressure of about 3 mm hg compared to ace_inhibitor alone .
effect(e1,e2)	5	45	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	15	19	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	0	5	anticoagulants : flurbiprofen like other nonsteroidal_anti-inflammatory_drugs , has been shown to affect bleeding parameters in patients receiving anti-coagulants , and serious clinical bleeding has been reported .
None(e1,e2)	27	34	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
effect(e1,e2)	14	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	69	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	144	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	7	the inhibition of cyp-2c19 by oxc and mhd , however , is clinically relevant .
None(e1,e2)	59	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	84	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	22	36	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	70	74	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	9	phenytoin : no significant differences were observed in mean phenytoin auc , c max , c min or t max ( although c max increased by 11 % ) when extended phenytoin sodium capsules ( 100 mg tid ) were coadministered with lomefloxacin ( 400 mg qd ) for five days in 15 healthy males .
None(e1,e2)	39	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	1	40	aspirin/ acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	109	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	6	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	28	cytotoxic_agents : enhanced bone marrow suppression by cyclophosphamide and other cytotoxic agents has been reported among patients with neoplastic disease , except leukemia , in the presence of allopurinol .
None(e1,e2)	102	108	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	26	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	4	29	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	0	12	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis_glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	13	23	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	27	31	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	23	25	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
advise(e1,e2)	3	17	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
None(e1,e2)	12	25	cns-active drugs ethanol : sonata 10 mg potentiated the cns-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test ( dsst ) , symbol copying test , and the variability component of the divided attention test for 2.5 hours after ethanol administration .
mechanism(e1,e2)	4	16	however , patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with flolan , which may be clinically significant in patients prone to digoxin toxicity .
None(e1,e2)	0	14	propoxyphene : the concurrent administration of propoxyphene hydrochloride does not affect the bioavailability of meclofenamate_sodium .
None(e1,e2)	27	34	may interact with the following : beta-adrenergic blocking agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
None(e1,e2)	33	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	29	42	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	4	6	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	12	15	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	24	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	25	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone_acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	0	2	diuretics : diclofenac and other nsaids can inhibit the activity of diuretics .
None(e1,e2)	47	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	38	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal_anti-inflammatory_agents ] is contraindicated .
advise(e1,e2)	5	12	literature reports suggest that oral calcium_antagonists may be used in combination with beta-adrenergic_blocking_agents when heart function is normal , but should be avoided in patients with impaired cardiac function .
None(e1,e2)	0	44	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
None(e1,e2)	22	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	17	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	21	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	5	8	aspirin : concurrent administration of aspirin may lower meclofenamate_sodium plasma levels , possibly by competing for protein-binding sites .
None(e1,e2)	0	19	hydrochlorothiazide : in normal volunteers , concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide .
None(e1,e2)	26	38	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	19	106	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
effect(e1,e2)	8	20	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type_anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	0	13	lithium serum concentrations should be monitored closely when initiating or changing therapy with bextra in patients receiving lithium .
None(e1,e2)	57	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	1	methotrexate vioxx 12.5 , 25 , and 50 mg , each dose administered once daily for 7 days , had no effect on the plasma concentration of methotrexate as measured by auc0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis .
None(e1,e2)	0	2	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines , and can be used to treat amphetamine poisoning .
None(e1,e2)	2	8	additionally , anti-malarial_drugs , such as chloroquine and mefloquine , may antagonize the activity of carbamazepine .
None(e1,e2)	41	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	8	amiodarone may suppress certain cyp450 enzymes , including cyp1a2 , cyp2c9 , cyp2d6 , and cyp3a4 .
None(e1,e2)	21	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	12	trough plasma enoxacin levels were also 20 % higher when caffeine and enoxacin were administered concomitantly .
None(e1,e2)	30	36	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	1	27	methotrexate vioxx 12.5 , 25 , and 50 mg , each dose administered once daily for 7 days , had no effect on the plasma concentration of methotrexate as measured by auc0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis .
None(e1,e2)	18	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	22	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	16	20	an alternative non-cyp3a4 substrate hypnotic agent may be considered in patients taking cyp3a4 inducers such as rifampin , phenytoin , carbamazepine , and phenobarbital .
None(e1,e2)	6	20	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic_acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	48	53	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	3	16	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	4	9	other depressasnts such as alcohol , barbiturates , and maois may enhance cns depression when administered with ethchlorvynol .
None(e1,e2)	6	15	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	49	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	0	18	non-selective_mao_inhibitors including tranylcypromine sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao_inhibitors may cause hypertension .
None(e1,e2)	21	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	23	25	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac glycosides and tricyclic anti-depressants .
None(e1,e2)	0	30	quinidine : coadministration of a 10-mg single dose of aripiprazole with quinidine ( 166 mg/day for 13 days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by 112 % but decreased the auc of its active metabolite , dehydroaripiprazole , by 35 % .
None(e1,e2)	31	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	100	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	25	31	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2_agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	6	16	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin_converting_enzyme_inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	3	9	concomitant treatment with thrombolytics ( eg , rt-pa or streptokinase ) may : - increase the risk of bleeding complications - considerably enhance the effect of refludan on aptt prolongation
advise(e1,e2)	3	5	concurrent use of flurbiprofen and aspirin is therefore not recommended .
effect(e1,e2)	11	30	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	3	5	do not mix toradol and morphine in the same syringe .
None(e1,e2)	65	108	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	2	20	terfenadine , astemizole and cisapride are all metabolized by the cytochrome p450iiia4 isozyme , and it has been demonstrated that ketoconazole , a potent inhibitor of iiia4 , blocks the metabolism of these drugs , resulting in increased plasma concentrations of parent drug .
None(e1,e2)	17	22	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	4	13	therefore , monitoring of theophylline plasma levels should be considered and dosage of theophylline adjusted , as required .
None(e1,e2)	28	34	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	7	28	zebeta should be used with care when myocardial_depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	6	19	even when an aminoglycoside and a penicillin -type drug are administered separately by different routes , a reduction in aminoglycoside serum half-life or serum levels has been reported in patients with impaired renal function and in some patients with normal renal function .
None(e1,e2)	26	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	12	in the diamond trials , 1252 patients were treated with tikosyn and diuretics concomitantly of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and diuretics .
None(e1,e2)	0	2	ergotamine or dihydroergotamine acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	22	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	12	22	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
mechanism(e1,e2)	2	10	increasing the felbamate dose to 2400 mg/day increased the steadystate valproate cmin to 96 25 micrograms/ml .
None(e1,e2)	41	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	37	48	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	13	31	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine_sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium_polystyrene_sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
mechanism(e1,e2)	0	14	uricosuric_drugs , such as probenecid and sulfinpyrazone , can inhibit renal tubular secretion of nitrofurantoin .
None(e1,e2)	10	26	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate_mofetil , and muromonab-cd3 .
None(e1,e2)	45	74	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	1	14	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	17	19	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic_antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	5	7	coadministration of itraconazole with oral midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
None(e1,e2)	0	2	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	5	8	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	10	25	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	9	21	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	7	14	antidiabetic drugs : ( oral agents and insulin ) - dosage adjustment of the antidiabetic_drug may be required .
None(e1,e2)	4	6	the administration of local anesthetic_solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
None(e1,e2)	16	20	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	13	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	13	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	41	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	51	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	15	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	28	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	4	6	concurrent administration of low-dose dopamine_hcl and diuretic_agents may produce an additive or potentiating effect on urine flow .
None(e1,e2)	15	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	25	31	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	61	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	90	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	45	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	1	15	anesthetics/sedatives/ hypnotics /opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	0	14	dolasetron_mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	29	35	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	3	8	the effect of ceftibuten on the pharmacokinetics of theophylline administered orally has not been investigated .
effect(e1,e2)	13	27	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline_hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	40	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	31	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	39	65	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
int(e1,e2)	11	31	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	8	22	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	17	19	the use of dextromethorphan hydrobromide may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
None(e1,e2)	12	16	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	9	11	similarly , in the 1-year monthly comparison study , aspirin and nonsteroidal_anti-inflammatory_drugs were taken by 39 % of the 1602 patients .
None(e1,e2)	31	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	19	31	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	8	25	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	11	14	animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl_alcohol , increases the inhibitory effects of chlorpromazine , but does not exhibit monoamine oxidase inhibition .
None(e1,e2)	55	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	7	patients receiving other narcotic_analgesic s , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	9	17	erythromycin : in healthy individuals , plasma concentrations of atorvastatin increased approximately 40 % with coadministration of atorvastatin and erythromycin , a known inhibitor of cytochrome p450 3a4 .
None(e1,e2)	3	23	the pharmacokinetics of nelfinavir are not altered to a clinically significant degree when it is administered with a light meal 1 hour after videx .
None(e1,e2)	1	30	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	34	74	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
effect(e1,e2)	0	9	acitretin : interferes with the contraceptive effect of microdosed progestin -containing minipill preparations .
None(e1,e2)	7	20	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate_analgesics .
None(e1,e2)	0	2	antibiotics ( ampicillin , tetracycline ) : pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these antibiotics on plasma concentrations of synthetic steroids .
None(e1,e2)	5	17	however , co administration of fexofenadine_hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine .
None(e1,e2)	23	35	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	21	23	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	2	6	alternatives to clarithromycin , such as azithromycin , should be considered .
None(e1,e2)	16	26	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	14	16	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	4	18	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl_estradiol and levonorgestrel ( cyp3a4 substrates ) .
None(e1,e2)	65	82	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	5	antidiabetic_drugs ( oral agents and insulin ) diminished antidiabetic effect .
None(e1,e2)	23	28	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	9	19	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	15	36	a study in eight healthy volunteers has shown a 50 % increase in mean peak nimodipine plasma concentrations and a 90 % increase in mean area under the curve , after a one week course of cimetidine at 1,000 mg/day and nimodipine at 90 mg/day .
None(e1,e2)	3	7	pharmacological/pharmacodynamic interactions with carbamazepine concomitant administration of carbamazepine and lithium may increase the risk of neurotoxic side effects .
None(e1,e2)	0	11	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	0	46	diltiazem : in patients with mild to moderate hypertension , administration of aprepitant once daily , as a tablet formulation comparable to 230 mg of the capsule formulation , with diltiazem 120 mg 3 times daily for 5 days , resulted in a 2-fold increase of aprepitant auc and a simultaneous 1.7-fold increase of diltiazem auc .
None(e1,e2)	37	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	14	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	28	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	12	there is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium_channel-blockers , ace inhibitors , and diuretics ( both thiazide-like and loop ) .
None(e1,e2)	0	30	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
effect(e1,e2)	18	35	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine_oxidase_inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic_agonists on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	24	26	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	0	18	digoxin : when starlix 120 mg before meals was administered in combination with a single 1-mg dose of digoxin to healthy volunteers , there were no clinically relevant changes in the pharmacokinetics of either agent .
None(e1,e2)	26	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	3	16	benzodiazepines : combination hormonal_contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	1	9	in tambocor clinical trials , patients who were receiving beta_blockers concurrently did not experience an increased incidence of side effects .
None(e1,e2)	0	14	warfarin : quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	24	58	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	0	3	antacid : when atorvastatin and maalox tc suspension were coadministered , plasma concentrations of atorvastatin decreased approximately 35 % .
None(e1,e2)	11	28	in clinical studies where patients were on chronic theophylline therapy , lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance .
None(e1,e2)	12	17	ethanol / nutrition / herb interactions : food : cns effects of caffeine may be enhanced if combination_hormonal_contraceptives are used concurrently with caffeine .
advise(e1,e2)	6	8	caution should be exercised when administering nabumetone with warfarin since interactions have been seen with other nsaids .
effect(e1,e2)	9	16	fentanyl anesthesia : severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta_blocker and a calcium channel blocker .
effect(e1,e2)	8	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	109	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	52	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	81	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	25	39	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal_anti-inflammatory_agents ] is contraindicated .
None(e1,e2)	57	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	75	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	40	44	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	21	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	8	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	20	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	3	5	pharmacokinetic interactions between nisoldipine and beta-blockers ( atenolol , propranolol ) were variable and not significant .
None(e1,e2)	29	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
advise(e1,e2)	15	25	because of the possible additive effects of drugs that may depress the nervous system , ethanol or triazolam should be used cautiously in combination with tiagabine .
None(e1,e2)	107	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	28	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	38	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	18	23	the depression of cardiac contractility , conductivity , and automaticity as well as the vascular dilation associated with anesthetics may be potentiated by calcium_channel_blockers .
mechanism(e1,e2)	6	21	furthermore , rifampin , phenytoin , phenobarbital , and other inducers of cytochrome p450 3a4 may cause a reduction in plasma bexarotene concentrations .
None(e1,e2)	68	78	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	9	16	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl_estradiol by approximately 30 % and 20 % .
None(e1,e2)	19	32	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	77	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	25	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	74	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	9	the concentrations of sn38 , the active metabolite of irinotecan , were on average 33 % higher in patients receiving bolus-ifl in combination with avastin when compared with bolus-ifl alone .
None(e1,e2)	2	9	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	0	2	caffeine : enoxacin is a potent inhibitor of the cytochrome p-450 isozymes responsible for the metabolism of methylxanthines .
None(e1,e2)	29	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	11	13	tinnitus and decreased hearing have been reported in patients concomitantly receiving itraconazole and quinidine .
None(e1,e2)	14	19	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease_inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	4	34	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	2	14	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa reductase inhibitor class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	12	30	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	10	25	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	12	14	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	23	86	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	52	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	100	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	5	13	the blood pressure effect of sular tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy .
effect(e1,e2)	8	32	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants .when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	18	27	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	0	2	protease_inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
None(e1,e2)	6	45	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	10	30	in another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 3a4 , increased the exposure ( auc ) of des-ciclesonide by approximately 3.6-fold at steady state , while levels of ciclesonide remained unchanged .
None(e1,e2)	59	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	149	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	24	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate mofetil , and muromonab-cd3 .
None(e1,e2)	11	18	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective_beta-adrenergic-blocking_agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	0	7	rifampin : rifampin increases the metabolism of ethinyl_estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
None(e1,e2)	10	24	because oral anticoagulants may interfere with the hepatic metabolism of phenytoin , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .
None(e1,e2)	7	13	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
mechanism(e1,e2)	0	5	cytadren accelerates the metabolism of dexamethasone ;
None(e1,e2)	49	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	35	therefore , it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin_sodium .
None(e1,e2)	0	10	salicylic_acid : combination hormonal contraceptives may increase the clearance of salicylic_acid .
None(e1,e2)	8	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	21	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	28	42	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	14	19	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	13	84	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	20	27	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	11	20	therophylline : a recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of isoniazid .
None(e1,e2)	26	34	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	4	8	the administration of local anesthetic_solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
None(e1,e2)	11	13	antacid : the effect of an aluminum hydroxide- and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	129	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	16	- drugs that may decrease plasma phenytoin concentrations include : carbamazepine , chronic alcohol abuse , reserpine
mechanism(e1,e2)	0	3	fluvoxamine increased mean alosetron plasma concentrations ( auc ) approximately 6-fold and prolonged the half-life by approximately 3-fold .
None(e1,e2)	69	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	34	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	6	cyclosporine : increased activity of both cyclosporine and corticosteroids may occur when the two are used concurrently .
None(e1,e2)	0	27	ace_inhibitors and angiotensin ii receptor antagonists ( hypertension ) - in clinical studies of patients with hypertension , the addition of inspra 50 to 100 mg to ace_inhibitors and angiotensin ii receptor antagonists increased mean serum potassium slightly ( about 0.09-0.13 meq/l ) .
None(e1,e2)	38	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	24	41	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	35	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	78	84	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	6	19	no interaction was noted with the mao-b_inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa /dopa decarboxylase inhibitor ( n=29 ) .
None(e1,e2)	5	17	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
effect(e1,e2)	17	24	phase ii clinical trial data , where iressa and vinorelbine have been used concomitantly , indicate that iressa may exacerbate the neutropenic effect of vinorelbine .
None(e1,e2)	0	4	antacids ( aluminum- or magnesium -containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	46	69	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	13	46	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	23	33	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	12	14	nabilone should be administered with caution to patients who are taking other psychoactive_drugs or cns_depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	19	27	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	7	11	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
mechanism(e1,e2)	6	13	a number of drugs , including ethacrynic_acid , have been shown to displace warfarin from plasma protein ;
None(e1,e2)	2	25	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	5	19	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
advise(e1,e2)	12	24	due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine -containing or ergot-type medications ( like dihydroergotamine or methysergide ) and frova within 24 hours of each other should be avoided ( see a href= frova_od.htm # ci contraindications ) .
None(e1,e2)	11	16	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	34	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	26	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	18	26	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	76	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	7	11	imipramine : coadministration of single doses of sonata 20 mg and imipramine 75 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration .
None(e1,e2)	112	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	15	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8 % , which resulted in an increase of approximately 40 % in the free tiagabine concentration .
None(e1,e2)	9	27	ritonavir - combined administration of a single dose of ritonavir ( 600 mg ) , both a cyp3a4 substrate and a potent inhibitor of cyp3a4 , and escitalopram ( 20 mg ) did not affect the pharmacokinetics of either ritonavir or escitalopram .
None(e1,e2)	119	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	6	antibiotics ( e.g. , erythromycin , trimethoprim and sulfamethoxazole , amoxicillin ) .
None(e1,e2)	16	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	72	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	21	animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl_alcohol , increases the inhibitory effects of chlorpromazine , but does not exhibit monoamine oxidase inhibition .
None(e1,e2)	0	38	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	2	48	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	12	28	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	31	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	127	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	48	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	10	29	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	0	2	antihistamines : amphetamines may counteract the sedative effect of antihistamines .
None(e1,e2)	5	20	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic_acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	6	20	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
None(e1,e2)	12	18	digoxin : in patients with hypercholesterolemia , concomitant administration of lovastatin and digoxin resulted in no effect on digoxin plasma concentrations .
None(e1,e2)	16	43	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	2	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	11	27	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	0	8	antiepileptic_drugs : potential interactions between trileptal and other aeds were assessed in clinical studies .
None(e1,e2)	17	33	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
effect(e1,e2)	14	16	antiepileptic drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic_drugs ( phenytoin , carbamazepine ) .
None(e1,e2)	13	25	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic_medications , or other drugs that produce cns depression .
None(e1,e2)	58	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	11	22	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	7	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	11	29	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	7	10	certain drugs including thiazides , corticosteroids , thyroid_products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	0	3	quinolones , including nalidixic_acid , may enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	29	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	23	148	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	41	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	0	16	eprosartan doses of up to 300 mg b.i.d . have been safely used concomitantly with sustained-release calcium_channel_blockers ( sustained-release nifedipine ) with no clinically significant adverse interactions .
None(e1,e2)	10	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	30	38	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	0	17	pyrantel ( e.g. , antiminth ) - taking piperazine and pyrantel together may decrease the effects of piperazine .
None(e1,e2)	42	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	6	a dose increase of lopinavir / ritonavir to 533/133 mg twice daily with food isrecommended in combination with nevirapine .
None(e1,e2)	10	12	clinical studies with celecoxib have identified potentially significant interactions with fluconazole and lithium .
None(e1,e2)	2	12	thiazides : thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine .
None(e1,e2)	3	13	concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone .
effect(e1,e2)	0	15	quinolones , including cinoxacin , may enhance the effects of oral anticoagulants , such as warfarin or its derivatives .
None(e1,e2)	10	23	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	19	21	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	29	38	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin_b .
None(e1,e2)	15	19	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	32	33	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	3	33	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	9	26	until further data are developed regarding drug interactions when azithromycin and these drugs are used concomitantly , careful monitoring of patients is advised : digoxin elevated digoxin concentrations .
None(e1,e2)	9	19	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
mechanism(e1,e2)	1	16	some quinolones , including ciprofloxacin , have also been shown to interfere with the metabolism of caffeine .
None(e1,e2)	29	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	19	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen .in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	87	97	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	26	antibiotics ( ampicillin , tetracycline ) : pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these antibiotics on plasma concentrations of synthetic steroids .
None(e1,e2)	6	22	potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated , and concomitant use of vardenafil and nitrates is contraindicated .
None(e1,e2)	1	32	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	14	47	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	25	28	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	7	12	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
advise(e1,e2)	10	15	it may be necessary to adjust the dosage of oral anticoagulants upon beginning or stopping disulfiram . since disulfiram may prolong prothrombin time .
effect(e1,e2)	0	5	diphenhydramine_hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	135	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
int(e1,e2)	0	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	45	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	6	19	particular caution is recommended when administering gleevec with cyp3a4 substrates that have a narrow therapeutic window ( e.g. , cyclosporine or pimozide ) .
None(e1,e2)	48	58	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa_reductase_inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	78	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	27	31	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	14	27	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
None(e1,e2)	21	23	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	5	14	concomitant medications were grouped as ace_inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	112	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	12	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic_agents ;
None(e1,e2)	23	35	in renal and cardiac transplant recipients , a reduction of cyclosporine dose ranging from 15 % to 48 % was necessary to maintain cyclosporine trough concentrations similar to those seen prior to the addition of diltiazem .
None(e1,e2)	102	114	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	22	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	28	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic_acid ) , erythromycin , azole antifungals .
None(e1,e2)	20	22	because both of these drugs have negative inotropic properties and the effects of coadministration with tambocor are unknown , neither disopyramide nor verapamil should be administered concurrently with tambocor unless , in the judgment of the physician , the benefits of this combination outweigh the risks .
None(e1,e2)	0	18	warfarin : concomitant administration of daptomycin ( 6 mg/kg once every 24 hours for 5 days ) and warfarin ( 25 mg single oral dose ) had no significant effect on the pharmacokinetics of either drug , and the inr was not significantly altered .
None(e1,e2)	36	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	27	29	if the usual amounts of nondepolarizing relaxants are given , the time for recovery from neuromuscular blockade will be longer in the presence of enflurane than when halothane or nitrous_oxide with a balanced technique are used .
advise(e1,e2)	5	14	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	9	18	ritonavir ( 600 mg b.i.d . ) co-administered with vardenafil 5 mg resulted in a 49-fold increase in vardenafil auc and a 13-fold increase in vardenafil cmax .
None(e1,e2)	24	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	5	diuretics : diclofenac and other nsaids can inhibit the activity of diuretics .
effect(e1,e2)	2	18	warfarin and anticoagulants : increased prothrombin time , with or without clinical bleeding , has been reported when cefixime is administered concomitantly .
advise(e1,e2)	4	21	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	31	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	14	- antidiabetic drugs : ( oral agents and insulin ) dosage adjustment of the antidiabetic_drug may be required
None(e1,e2)	39	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	15	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	26	28	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	80	103	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	4	58	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	12	30	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic drug .
effect(e1,e2)	0	11	phospholine_iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate_insecticide s .
None(e1,e2)	0	9	furosemide : toradol iv/im reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20 % ( mean sodium and urinary output decreased 17 % ) .
None(e1,e2)	46	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	6	rifampin : co-administration of vioxx with rifampin 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50 % decrease in rofecoxib plasma concentrations .
mechanism(e1,e2)	11	20	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
None(e1,e2)	4	17	amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55 % and 33 % , respectively .
None(e1,e2)	64	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	9	23	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	29	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	37	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	0	2	dicumarol and warfarin may decrease hypoprothrombinemic effect .
None(e1,e2)	1	20	- indomethacin : indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide -induced increase in plasma renin activity .
None(e1,e2)	17	60	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin_b12 and folic acid .
None(e1,e2)	0	8	theophylline : a single 10 mg dose of tiagabine did not affect the pharmacokinetics of theophylline at steady state .
mechanism(e1,e2)	0	18	cimetidine at doses of 100 mg bid ( otc dose ) resulted in a 13 % increase in dofetilide plasma levels ( 500 mcg single dose ) .
None(e1,e2)	5	12	propanolol : the pharmacokinetics of almotriptan were not affected by coadministration of propranolol .
None(e1,e2)	4	14	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	11	16	probenecid : the oral combination of probenecid before intramuscular injection of pipracil produces an increase in piperacillin peak serum level of about 30 % .
None(e1,e2)	3	8	may interact with cefamandole_naftate , cephalothin sodium , magnesium_sulfate , prednisolone sodium succinate , and prochlorperazine edisylate .
None(e1,e2)	2	12	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	16	18	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium_channel_blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	1	14	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	21	44	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
effect(e1,e2)	2	13	synergism between xanthine_bronchodilators ( e.g. , theophylline ) , ephedrine , and other sympathomimetic_bronchodilators has been reported .
None(e1,e2)	6	17	trimethoprim alone or in combination with sulfamethoxazole : concomitant use of trimethoprim alone or in combination with sulfamethoxazole is contraindicated .
None(e1,e2)	68	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	4	6	these studies indicate that ketoconazole or erythromycin co-administration enhances fexofenadine gastrointestinal absorption .
effect(e1,e2)	16	21	non-steroidal anti-inflammatory agents : in some patients with compromised renal function who are being treated with non-steroidal_anti-inflammatory_drugs , the co-administration of lisinopril may result in a further deterioration of renal function .
None(e1,e2)	10	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	109	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	36	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	91	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	22	24	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	3	sedative /hypnotics : midazolam , triazolam
None(e1,e2)	3	20	repeated doses of colestipol_hydrochloride given prior to a single dose of propranolol in human trials have been reported to decrease propranolol absorption .
None(e1,e2)	17	25	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	20	29	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
mechanism(e1,e2)	6	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	13	15	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo- benzodiazepines , dihydropyridine_calcium_channel_blockers , certain hmg-coa reductase inhibitors , etc . ) .
None(e1,e2)	17	44	plasma exposure of diazepam ( 10 mg bid ) was increased by 28 % following administration of valdecoxib ( 40 mg bid ) for 12 days , while plasma exposure of valdecoxib ( 40 mg bid ) was not substantially increased following administration of diazepam ( 10 mg bid ) for 12 days .
None(e1,e2)	74	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	7	20	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin_sodium .
None(e1,e2)	8	12	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	76	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	18	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	90	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	49	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	6	gabapentin pharmacokinetic parameters without and with probenecid were comparable .
None(e1,e2)	17	27	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	7	20	calcium channel blocking agents : coadministration of calcium_channel_blockers did not have any effect on either the safety or efficacy of ibutilide in the clinical trials .
None(e1,e2)	0	15	doxazosin_mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide_diuretics , beta-blocking agents , and nonsteroidal anti-inflammatory drugs .
None(e1,e2)	44	85	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	24	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl_estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	18	20	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
mechanism(e1,e2)	6	12	human pharmacokinetic data indicate that oral ketoconazole markedly inhibits the metabolism of cisapride , resulting in a mean eight-fold increase in auc of cisapride .
None(e1,e2)	98	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	8	15	in a single subject given one dose of ciprofloxacin 2 hours after a dose of didanosine -placebo tablets , a greater than 50 % reduction in the auc of ciprofloxacin was observed .
None(e1,e2)	111	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	11	analgesic /anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	28	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	11	40	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
effect(e1,e2)	9	14	lithium carbonate : the anorectic and stimulatory effects of amphetamines may be inhibited by lithium_carbonate .
None(e1,e2)	19	31	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	0	7	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable/dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
None(e1,e2)	0	2	anesthetics /sedatives/ hypnotics /opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
advise(e1,e2)	4	17	therefore , co-administration of tricyclic_antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	14	16	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate analgesics .
effect(e1,e2)	0	4	cyclophosphamide used concurrently with cerubidine may also result in increased cardiotoxicity .
None(e1,e2)	3	41	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	9	11	untreated hypothyroidism may interfere with the growth response to somatrem or somatropin .
mechanism(e1,e2)	19	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	36	44	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	16	19	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	8	16	dosage adjustment may be required if cyclosporine , tacrolimus , or methylprednisolone are given concomitantly with nizoral tablets .
None(e1,e2)	17	32	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	4	29	however , coadministration of escitalopram ( 20 mg ) and ritonavir ( 600 mg ) , a potent inhibitor of cyp3a4 , did not significantly affect the pharmacokinetics of escitalopram .
None(e1,e2)	3	11	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic_acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	15	19	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns_depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	26	44	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	40	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	27	42	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic_antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	25	59	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa_reductase_inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	9	selective_serotonin_reuptake_inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
int(e1,e2)	0	32	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	24	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine_oxidase_(_mao_)_inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	57	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	74	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	1	9	other antiarrhythmic_drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	36	40	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	4	12	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	7	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	18	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	14	20	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	14	29	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	26	35	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	27	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	9	36	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	0	4	ascorbic_acid : doses of ascorbic_acid ( vitamin c ) 1 g/day have been reported to increase plasma concentration of synthetic estrogens by ~47 % , possibly by inhibiting conjugation ;
effect(e1,e2)	19	24	there are rare reports , however , from marketing experiences , of changes in effects of insulin or oral hypoglycemic_agents in the presence of diclofenac that necessitated changes in the doses of such agents .
None(e1,e2)	4	10	drug/laboratory test interferences : dicumarol and indanedione anticoagulants , including anisindione , or their metabolites may color alkaline urine red-orange , which may interfere with spectrophotometrically determined urinary laboratory tests .
None(e1,e2)	18	20	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	8	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	0	7	raptiva should not be used with other immunosuppressive_drugs .
None(e1,e2)	30	46	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	98	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	22	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	22	30	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	27	36	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic_antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	78	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	19	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/ sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	21	33	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	38	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	6	8	in addition to bleeding associated with heparin and vitamin_k_antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	5	14	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central_nervous_system_depressants may have an additive effect .
None(e1,e2)	36	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	0	7	adrenergic_blockers : adrenergic blockers are inhibited by amphetamines .
None(e1,e2)	36	43	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	4	23	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
mechanism(e1,e2)	7	16	after the coadministration of 200 mg oral ketoconazole twice daily and one 20 mg dose of loratadine to 11 subjects , the auc and cmax of loratadine averaged 302 % ( 142 s.d . ) and 251 % ( 68 s.d . ) , respectively , of those obtained after co-treatment with placebo .
None(e1,e2)	10	16	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	48	70	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	21	39	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	6	8	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
None(e1,e2)	35	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	18	23	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim /sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	4	12	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
mechanism(e1,e2)	2	21	cimetidine : albendazole_sulfoxide concentrations in bile and cystic fluid were increased ( about 2-fold ) in hydatid cyst patients treated with cimetidine ( 10 mg/kg/day ) ( n=7 ) compared with albendazole ( 20 mg/kg/day ) alone ( n=12 ) .
None(e1,e2)	13	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	23	69	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	65	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	9	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
mechanism(e1,e2)	2	8	lithium : ibuprofen produced an elevation of plasma lithium levels and a reduction in renal lithium clearance in a study of eleven normal volunteers .
None(e1,e2)	0	9	antacids : nonclinical data demonstrate that the solubility of dasatinib is ph dependent .
effect(e1,e2)	0	15	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
effect(e1,e2)	3	31	cyclosporine : because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine , and because renal excretion is the primary elimination route of fibrate drugs including tricor , there is a risk that an interaction will lead to deterioration .
None(e1,e2)	7	20	therefore , if digoxin is administered with vaprisol , the clinician should be alert to the possibility of increases in digoxin levels .
None(e1,e2)	55	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	23	phenytoin : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenytoin with or without other enzyme- inducing aeds .
None(e1,e2)	26	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	12	22	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	23	52	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic_acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	76	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	21	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	23	65	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	29	31	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	0	4	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	15	37	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative /hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	7	19	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist_analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	12	48	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	83	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	18	26	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	0	8	ethosuximide : amphetamines may delay intestinal absorption of ethosuximide .
None(e1,e2)	9	31	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
None(e1,e2)	26	67	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	3	25	in addition , oxcarbazepine and mhd induce a subgroup of the cytochrome p450 3a family ( cyp3a4 and cyp3a5 ) responsible for the metabolism of dihydropyridine_calcium_antagonists and oral contraceptives , resulting in a lower plasma concentration of these drugs .
None(e1,e2)	9	32	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	0	4	non-steroidal_anti-inflammatory_drugs ( but not aspirin ) : these drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies .
None(e1,e2)	26	33	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	59	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	35	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	81	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	15	adenosine : dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine .
None(e1,e2)	7	11	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	21	34	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	19	26	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	22	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	67	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	21	magnesium/ aluminum -containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/ aluminum -containing antacid products .
effect(e1,e2)	2	14	haloperidol : haloperidol blocks dopamine receptors , thus inhibiting the central stimulant effects of amphetamines .
None(e1,e2)	1	4	certain antibiotics , especially neomycin , streptomycin and kanamycin , have a mild but definite nondepolarizing blocking action which may accentuate neuromuscular block .
None(e1,e2)	2	6	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
mechanism(e1,e2)	15	22	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
None(e1,e2)	38	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	118	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	49	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	19	other interactions : vardenafil had no effect on the pharmacodynamics of glyburide ( glucose and insulin concentrations ) and warfarin ( prothrombin time or other pharmacodynamic parameters ) .
None(e1,e2)	38	62	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	4	19	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen .in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	28	30	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	16	24	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines , and can be used to treat amphetamine poisoning .
None(e1,e2)	66	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	26	60	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	8	24	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	10	34	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	0	12	dolasetron_mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
effect(e1,e2)	2	13	anti-arrhythmics and tricyclic_anti-depressants could exaggerate the prolongation of the qt interval observed with bepridil_hydrochloride .
None(e1,e2)	12	14	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	11	14	dopamine d2 receptor antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
effect(e1,e2)	12	35	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
effect(e1,e2)	6	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	14	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic_agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
None(e1,e2)	15	21	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	1	3	sedative/ hypnotics : midazolam , triazolam
None(e1,e2)	8	33	in patients taking an anticonvulsant ( eg , valproic_acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	11	13	specific studies have confirmed these effects with sevoflurane , isoflurane , propofol , alfentanil , and midazolam .
None(e1,e2)	12	16	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	20	26	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	26	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	14	16	therefore , extreme caution should be exercised when administering dopamine hcl to patients receiving cyclopropane or halogenated_hydrocarbon_anesthetics .
None(e1,e2)	3	18	as with other antihypertensive_agents , the antihypertensive effect of losartan may be blunted by the non-steroidal anti-inflammatory drug indomethacin
mechanism(e1,e2)	10	14	there is a significant increase in exposure to imatinib when gleevec is coadministered with ketoconazole ( cyp3a4 inhibitor ) .
None(e1,e2)	4	23	hormonal contraceptives co-administration of trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components , ethinylestradiol ( ee ) and levonorgestrel ( lng ) .
None(e1,e2)	6	10	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	2	19	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	38	44	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	2	6	furosemide : toradol iv/im reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20 % ( mean sodium and urinary output decreased 17 % ) .
None(e1,e2)	16	19	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central_nervous_system_depressants such as narcotics , non-narcotic analgesics and barbiturates .
None(e1,e2)	19	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	51	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	71	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	21	50	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	1	5	- daunorubicin ( e.g. , cerubidine ) or
None(e1,e2)	0	8	lithium -a drug interaction study of eplerenone with lithium has not been conducted .
None(e1,e2)	3	5	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	5	7	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	28	40	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	12	55	cns-active drugs ethanol : sonata 10 mg potentiated the cns-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test ( dsst ) , symbol copying test , and the variability component of the divided attention test for 2.5 hours after ethanol administration .
None(e1,e2)	20	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	3	8	concomitant administration of kerlone with the oral anticoagulant warfarin has been shown not to potentiate the anticoagulant effect of warfarin .
None(e1,e2)	7	30	erythromycin and clarithromycin ( and possibly other macrolide_antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	8	21	antacids : concomitant administration of magnesium hydroxide and aluminum_hydroxide does not interfere with the rate or extent of the absorption of ketoprofen administered as orudis .
None(e1,e2)	1	28	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	8	32	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine_class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	25	39	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
mechanism(e1,e2)	7	12	calcium antagonists : after repeated co-administration of trileptal , the auc of felodipine was lowered by 28 % [ 90 % ci : 20-33 ] .
None(e1,e2)	0	20	aspirin : vardenafil ( 10 mg and 20 mg ) did not potentiate the increase in bleeding time caused by aspirin ( two 81 mg tablets ) .
effect(e1,e2)	5	12	apomorphine - prior ingestion of diphenidol may decrease the emetic response to apomorphine in the treatment of poisoning .
None(e1,e2)	2	4	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	13	16	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	46	63	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	2	7	use with angiotensln_converting_enzyme_inhibitors : the use of angiotensin_converting_enzyme_inhibitors to control hypertension in patients on azathioprine has been reported to induce severe leukopenia .
None(e1,e2)	10	25	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	43	75	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	2	7	antacids , sucralfate , metal cations , multivitamins quinolones form chelates with alkaline earth and transition metal cations .
None(e1,e2)	17	35	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	6	29	if rifampicin therapy is required , isradipine concentrations and therapeutic effects are likely to be markedly reduced or abolished as a consequence of increased metabolism and higher clearance of isradipine .
None(e1,e2)	39	46	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	16	clearance of hydrodolasetron decreased by about 27 % when dolasetron mesylate was administered intravenously concomitantly with atenolol .
None(e1,e2)	5	11	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	76	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	10	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace inhibitors .
None(e1,e2)	56	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	4	9	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	0	8	dextromethorphan is a substrate for both cyp2d6 and cyp3a4 .
None(e1,e2)	0	12	mao_inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	7	25	warfarin : when healthy subjects were administered starlix 120 mg three times daily before meals for four days in combination with a single dose of warfarin 30 mg on day 2 , there were no alterations in the pharmacokinetics of either agent .
None(e1,e2)	0	7	lorazepam : coadministration of single doses of eszopiclone 3 mg and lorazepam 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug .
None(e1,e2)	20	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	11	22	in bioavailability studies with normal subjects , the concurrent administration of antacids at therapeutic levels did not significantly influence the bioavailability of tranxene tablets .
None(e1,e2)	32	63	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic_acid .
advise(e1,e2)	4	17	a dose increase of lopinavir /ritonavir to 533/133 mg twice daily with food isrecommended in combination with nevirapine .
effect(e1,e2)	34	42	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	24	28	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	30	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
advise(e1,e2)	15	17	theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and pegasys .
None(e1,e2)	10	15	heparin sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
None(e1,e2)	2	4	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	28	33	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	6	9	antacid : the effect of an aluminum_hydroxide - and magnesium_hydroxide -containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	6	18	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	19	59	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	8	23	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic_antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
None(e1,e2)	45	53	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	1	10	- antihypertensives : bumetanide may potentiate the effect of various antihypertensive_drugs , necessitating a reduction in the dosage of these drugs .
None(e1,e2)	11	13	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	1	24	because alosetron is metabolized by a variety of hepatic cyp drug-metabolizing enzymes , inducers or inhibitors of these enzymes may change the clearance of alosetron .
None(e1,e2)	2	18	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	28	33	caution should be exercised if an hmg-coa reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as ketoconazole , spironolactone , and cimetidine .
None(e1,e2)	8	15	diphenoxylate hcl and atropine sulfate may interact with mao_inhibitors in studies with male rats , diphenoxylate_hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day .
effect(e1,e2)	9	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	19	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	20	38	1- nc denotes a mean change of less than 10 % 2- pediatrics 3- mean increase in adults at high trileptal doses in vivo , the plasma levels of phenytoin increased by up to 40 % , when trileptal was given at doses above 1200 mg/day .
None(e1,e2)	7	32	limited clinical experience indicates that requirements for volatile_inhalation_anesthetics are reduced by 30 to 50 % for the first sixty ( 60 ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
None(e1,e2)	2	7	discontinuation of cimetidine in well-controlled patients receiving tricyclic_antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
None(e1,e2)	6	18	rifampin : coadministration of rifampin and mepron suspension results in a significant decrease in average steady- state plasma atovaquone concentrations .
effect(e1,e2)	11	17	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic_acid may potentiate the effects of ganglionic_blocking_agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	7	14	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	23	29	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	77	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	1	7	( thiazide_drugs may increase the responsiveness to tubocurarine . )
None(e1,e2)	4	9	vitamin a and oral retinoids : concomitant administration of vitamin_a and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
None(e1,e2)	0	8	lithium toxicity was usually reversible upon discontinuation of lithium and the ace inhibitor .
None(e1,e2)	13	19	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	4	6	known drug interactions include barbiturates , tranquilizers , and alcohol .
effect(e1,e2)	2	6	administration of epinephrine to patients receiving cyclopropane or halogenated hydrocarbon general anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
None(e1,e2)	23	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	9	14	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate analgesics .
None(e1,e2)	24	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
effect(e1,e2)	5	10	sildenafil citrate - theoretically , l-arginine supplements taken concomitantly with sildenafil_citrate , may potentiate the effects of the drug .
int(e1,e2)	0	20	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	0	48	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	3	14	resins : since bile_acid_sequestrants may bind other drugs given concurrently , patients should take tricor at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption .
None(e1,e2)	44	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	19	29	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	12	31	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	40	59	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	8	13	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	6	24	potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated , and concomitant use of vardenafil and nitrates is contraindicated .
None(e1,e2)	33	20	drugs that inhibit cyp3a4 cyp3a4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethyl zaleplon ( formed via cyp3a4 in vitro ) and its metabolites , 5-oxo-desethylzaleplon and 5-oxo-desethylzaleplon glucuronide , account for only 9 % of the urinary recovery of a zaleplon dose .
None(e1,e2)	3	9	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
effect(e1,e2)	17	20	pharmacologic studies indicate that there may be additive effects in prolonging av conduction when using beta-blockers or digitalis concomitantly with tiazac .
None(e1,e2)	59	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	27	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	66	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	21	aspirin : concomitant administration of aspirin with valdecoxib may result in an increased risk of gi ulceration and complications compared to valdecoxib alone .
None(e1,e2)	49	58	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	44	levothyroxine_sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	3	12	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	10	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	6	35	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	25	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	2	20	magnesium- and aluminum -containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	25	29	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	6	19	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	0	5	intestinal_adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	12	14	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	19	51	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	22	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	0	11	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	38	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	38	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	112	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	37	because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , alcohol and sedative use as part of the history prior to any procedure in which the use of romazicon is planned .
mechanism(e1,e2)	10	12	in a study in normal volunteers , concomitant administration of buspirone_hcl and haloperidol resulted in increased serum haloperidol concentrations .
None(e1,e2)	38	47	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	0	45	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	0	7	anticholinesterases ( neostgmine , physostigmine ) , lignocaine , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .
None(e1,e2)	12	50	this interaction , which has not been investigated using higher doses of fluvoxamine , may be more pronounced if a 300 mg daily dose is co-administered , particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg . if alprazolam is co-administered with fluvoxamine tablets , the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended .
None(e1,e2)	13	18	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	8	20	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	10	anabolic_steroids ( particularly c-17 alkylated androgens such as oxymetholone , methandrostenolone , norethandrolone , and similar compounds ) enhanced tendency toward edema .
None(e1,e2)	3	8	in patients taking diclofenac and lithium concomitantly , lithium toxicity may develop .
mechanism(e1,e2)	2	17	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl_estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	32	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	32	36	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	7	10	oral neomycin inhibits the gastrointestinal absorption of penicillin_v , oral vitamin_b-12 , methotrexate and 5-fluorouracil .
None(e1,e2)	9	12	potassium-sparing diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	11	17	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
effect(e1,e2)	3	12	in europe , nimotop was observed to occasionally intensify the effect of antihypertensive_compounds taken concomitantly by patients suffering from hypertension ;
None(e1,e2)	33	59	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	0	7	mineral_oil -concomitant intake of mineral oil and vitamin_k may reduce the absorption of vitamin k .
None(e1,e2)	0	2	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	19	36	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	41	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	32	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
None(e1,e2)	38	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	45	47	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	4	29	however , co-administration of duloxetine with aluminum- and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	33	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	70	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	24	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	28	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	38	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	15	tiagabine has shown no clinically important potentiation of the pharmacodynamic effects of triazo lam or alcohol .
None(e1,e2)	3	16	the fraction of stadol_ns absorbed is unaffected by the concomitant administration of a nasal vasoconstrictor ( oxymetazoline ) , but the rate of absorption is decreased .
None(e1,e2)	1	8	phenytoin/ phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
None(e1,e2)	0	2	sucralfate and antacids : quinolones form chelates with metal cations .
mechanism(e1,e2)	4	16	some quinolones , including ciprofloxacin , have also been shown to interfere with the metabolism of caffeine .
None(e1,e2)	13	45	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	5	7	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
mechanism(e1,e2)	1	13	if phenytoin or other hepatic enzyme inducers are taken concurrently with norpace or norpace_cr , lower plasma levels of disopyramide may occur .
None(e1,e2)	20	30	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
None(e1,e2)	4	9	the pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by bretylium tosylate .
None(e1,e2)	9	56	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	83	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	18	29	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
advise(e1,e2)	12	31	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	23	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	49	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	5	9	population pharmacokinetic analyses revealed that mtx , nsaids , corticosteroids , and tnf blocking agents did not influence abatacept clearance .
None(e1,e2)	0	17	lotensin has been used concomitantly with beta-adrenergic-blocking agents , calcium-channel-blocking agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
None(e1,e2)	3	13	as with other agents_with_b-blocking_properties , if coreg is to be administered orally with calcium_channel_blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	33	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	19	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
None(e1,e2)	5	22	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	0	2	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
effect(e1,e2)	11	27	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
int(e1,e2)	7	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	0	13	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	34	43	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	1	2	when cholestyramine resin is given for long periods of time , concomitant supplementation with water-miscible ( or parenteral ) forms of fat-soluble vitamins should be considered .
None(e1,e2)	41	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	2	25	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	28	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	2	22	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac_tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	20	28	may interact with the following : beta-adrenergic blocking agents ( these medicines may make your condition worse and prevent the adrenergic_bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
None(e1,e2)	12	15	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	25	35	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	16	38	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic_agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	4	15	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide_diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	0	2	antiarrhythmics : bepridil , lidocaine ( systemic ) and quinidine
mechanism(e1,e2)	4	20	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	32	40	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	12	16	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	15	25	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	10	29	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	15	34	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	45	58	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa_reductase_inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	54	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	36	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
mechanism(e1,e2)	3	13	in vitro , propranolol appears to be displaced from its binding sites by diltiazem .
mechanism(e1,e2)	5	11	antacids containing aluminum hydroxide and magnesium_hydroxide reduce the oral absorption of enoxacin by 75 % .
None(e1,e2)	17	30	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	0	10	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	11	30	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	35	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	10	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	2	5	anticoagulants : flurbiprofen like other nonsteroidal_anti-inflammatory_drugs , has been shown to affect bleeding parameters in patients receiving anti-coagulants , and serious clinical bleeding has been reported .
None(e1,e2)	13	38	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	8	52	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
effect(e1,e2)	29	36	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	46	56	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	13	15	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	29	33	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic_acid has been reported to both increase and decrease ethosuximide levels ) .
mechanism(e1,e2)	13	44	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine_sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	1	7	oral contraceptives : the effect of oral contraceptives on the pharmacokinetics of d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp has not been studied .
None(e1,e2)	24	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	19	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	1	8	and disulfiram when amitriptyline hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	20	40	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	10	32	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
effect(e1,e2)	3	22	toxicology studies of heroin -related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
int(e1,e2)	2	9	therefore , linezolid has the potential for interaction with adrenergic and serotonergic agents .
None(e1,e2)	32	34	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	10	12	garlic capsules garlic capsules should not be used while taking saquinavir ( fortovase ) as the sole protease inhibitor due to the risk of decreased saquinavir plasma concentrations .
mechanism(e1,e2)	13	15	diminished urinary excretion of norfloxacin has been reported during the concomitant administration of probenecid and norfloxacin .
None(e1,e2)	0	2	chlorpropamide : chlorpropamide s plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	45	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	46	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	22	24	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate mofetil , and muromonab-cd3 .
None(e1,e2)	23	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
advise(e1,e2)	8	25	for this reason , the dose of the anticoagulant should be reduced by 30 - 50 % at the start of treatment with bezalip or bezalip retard and then titrated according to the blood clotting parameters
None(e1,e2)	3	9	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	26	38	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	20	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	81	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	36	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	15	17	the auc of ciprofloxacin was decreased an average of 15-fold in 12 healthy subjects given ciprofloxacin and didanosine -placebo tablets concurrently .
None(e1,e2)	15	19	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	28	34	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	88	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	26	concurrent administration of a tnf_antagonist with orencia has been associated with an increased risk of serious infections and no significant additional efficacy over use of the tnf_antagonists alone .
None(e1,e2)	112	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	16	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	22	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	4	10	ethopropazine can interact with chlorpromazine , increasing the metabolism of chlorpromazine .
effect(e1,e2)	0	11	tricyclic_antidepressants have been reported to blunt the hypotensive effect of systemic clonidine .
None(e1,e2)	0	2	theophylline : enoxacin is a potent inhibitor of the cytochrome p-450 isozymes responsible for the metabolism of methylxanthines .
None(e1,e2)	78	96	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	7	8	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	15	21	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate_mofetil .
None(e1,e2)	66	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	8	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
effect(e1,e2)	8	13	clinically significant effects have been reported with the tricyclic_antidepressants when used concomitantly with cimetidine .
None(e1,e2)	14	28	- lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	10	35	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
effect(e1,e2)	16	18	in an analysis of the supraventricular arrhythmia and diamond patient populations , the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes .
None(e1,e2)	5	15	there was no effect of zebeta on prothrombin time in patients on stable doses of warfarin .
None(e1,e2)	17	20	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
mechanism(e1,e2)	6	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	14	24	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	25	27	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	16	19	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
None(e1,e2)	37	46	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	68	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	28	a direct causal relationship has not been established , but physicians should consider the possibility that diclofenac may alter a diabetic patient s response to insulin or oral hypoglycemic_agents .
None(e1,e2)	87	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	21	warfarin : in a short-term controlled study in 14 normal volunteers , ketoprofen did not significantly interfere with the effect of warfarin on prothrombin time .
None(e1,e2)	20	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	12	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	0	2	methotrexate : valdecoxib_10_mg bid did not show a significant effect on the plasma exposure or renal clearance of methotrexate .
None(e1,e2)	79	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	11	16	since the pharmacokinetics of busulfex were studied in patients treated with phenytoin , the clearance of busulfex at the recommended dose may be lower and exposure ( auc ) higher in patients not treated with phenytoin .
None(e1,e2)	51	55	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	29	36	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3_antagonist_class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	4	9	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	71	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	17	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	2	13	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron-containing preparations .
None(e1,e2)	51	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	8	by decreasing the gastrointestinal absorption of primidone , diamox may decrease serum concentrations of primidone and its metabolites , with a consequent possible decrease in anticonvulsant effect .
None(e1,e2)	17	34	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic_drug .
None(e1,e2)	0	8	anticoagulants : potentiation of warfarin-type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	3	14	the effects of ergomar may be potentiated by triacetyloleandomycin which inhibits the metabolism of ergotamine .
None(e1,e2)	78	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	4	aspirin , warfarin , heparin , nsaids
None(e1,e2)	13	17	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
effect(e1,e2)	11	38	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	8	15	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	2	55	cns-active drugs ethanol : sonata 10 mg potentiated the cns-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test ( dsst ) , symbol copying test , and the variability component of the divided attention test for 2.5 hours after ethanol administration .
None(e1,e2)	23	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	71	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	26	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton_pump_inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	10	24	nicardipine hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine_hcl is initiated .
None(e1,e2)	0	29	warfarin : in a study in healthy volunteers , no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin ( 0.7 mg/kg body weight ) were administered during 11 days of multipledose treatment with 5 mg b.i.d . isradipine .
None(e1,e2)	20	29	1- nc denotes a mean change of less than 10 % 2- pediatrics 3- mean increase in adults at high trileptal doses in vivo , the plasma levels of phenytoin increased by up to 40 % , when trileptal was given at doses above 1200 mg/day .
None(e1,e2)	25	35	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin_ii_receptor_antagonists ( acei/arb ) .
None(e1,e2)	0	10	azopt ( brinzolamide ophthalmic suspension ) 1 % contains a carbonic_anhydrase_inhibitor .
None(e1,e2)	32	43	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium_polystyrene_sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	13	15	although increased plasma concentrations ( c max and auc 0-24 hrs ) of desloratadine and 3-hydroxydesloratadine were observed , there were no clinically relevant changes in the safety profile of desloratadine , as assessed by electrocardiographic parameters ( including the corrected qt interval ) , clinical laboratory tests , vital signs , and adverse events .
None(e1,e2)	60	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	66	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	23	77	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	2	4	coadministration of valdecoxib and ortho-novum 1/35 increased the exposure of norethindrone and ethinyl estradiol by 20 % and 34 % , respectively .
mechanism(e1,e2)	2	27	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
None(e1,e2)	111	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	37	alprazolam : when fluvoxamine_maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
None(e1,e2)	9	19	in psoriatic arthritis clinical trials , concomitant medications included mtx in approximately half of the patients as well as nonsteroidal_anti-inflammatory_agents , folic acid and corticosteroids .
None(e1,e2)	8	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	16	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	110	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	65	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	29	probenecid : probenecid , a renal tubular secretion blocking agent , administered at a dose of 500 mg four times a day , did not change the pharmacokinetics of levetiracetam 1000 mg twice daily .
None(e1,e2)	14	16	oral neomycin inhibits the gastrointestinal absorption of penicillin v , oral vitamin b-12 , methotrexate and 5-fluorouracil .
None(e1,e2)	12	20	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic_analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
mechanism(e1,e2)	4	8	hormonal contraceptives co-administration of trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components , ethinylestradiol ( ee ) and levonorgestrel ( lng ) .
None(e1,e2)	1	7	in amiodarone -treated patients who require additional antiarrhythmic therapy , the initial dose of such agents should be approximately half of the usual recommended dose .
None(e1,e2)	0	2	antacids , kaolin -pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	46	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	33	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	15	47	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	0	11	theophylline : grepafloxacin is a competitive inhibitor of the metabolism of theophylline .
None(e1,e2)	55	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	83	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	11	14	edecrin may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin_antibiotics .
None(e1,e2)	55	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	14	prednisone/prednisolone : rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .
None(e1,e2)	5	15	indomethacin - concomitant use of l-glutamine and indomethacin may ameliorate increased intestinal permeability caused by indomethacin .
None(e1,e2)	9	26	intestinal adsorbents ( e. g. , charcoal ) and digestive_enzyme_preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	18	33	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	65	101	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	2	24	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
effect(e1,e2)	6	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	15	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	43	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	18	37	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	13	15	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
None(e1,e2)	4	13	when concomitant treatment with agents_with_b-blocking_properties and clonidine is to be terminated , the b-blocking_agent should be discontinued first .
None(e1,e2)	93	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	32	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	3	24	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	57	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	28	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	6	12	platelet inhibitors : drugs such as acetylsalicylic_acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	25	29	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid_analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	18	45	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	19	26	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	124	138	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	27	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	33	49	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	31	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	63	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	57	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	85	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	7	55	although glucocorticoids have been shown to reduce proleukin -induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
advise(e1,e2)	4	36	in patients on chronic warfarin therapy , the prothrombin time ( inr ) should be closely monitored in the 2-week period , particularly at 7 to 10 days , following initiation of the 3-day regimen of aprepitant with each chemotherapy cycle .
mechanism(e1,e2)	14	16	elevated serum levels of cyclosporine have been reported with the concomitant use of some quinolones and cyclosporine .
effect(e1,e2)	0	19	furosemide has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine .
None(e1,e2)	14	31	the possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril ( captopril tablets , usp ) or initiating therapy with small doses ( 6.25 or 12.5 mg ) .
None(e1,e2)	11	16	therefore , it would be expected that a dosing schedule of cerivastatin_sodium given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin sodium .
None(e1,e2)	21	32	reported examples of this interaction include the following : immunosuppressives : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	137	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	39	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
advise(e1,e2)	10	14	it is recommended that plasma lithium levels be monitored when ketoprofen is coadministered with lithium .
advise(e1,e2)	4	18	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	2	4	magnesium- and aluminum -containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	24	37	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	8	14	effect of other drugs on the pharmacokinetics of clonazepam : literature reports suggest that ranitidine , an agent that decreases stomach acidity , does not greatly alter clonazepam pharmacokinetics .
None(e1,e2)	41	56	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	25	58	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	35	44	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	27	38	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	44	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	9	to avoid phenytoin intoxication , appropriate adjustment of the anticonvulsant should be made .
None(e1,e2)	23	25	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	7	34	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
advise(e1,e2)	20	34	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	24	30	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	8	15	therefore , administration of these agents should precede lomefloxacin dosing by 4 hours or follow lomefloxacin dosing by at least 2 hours .
None(e1,e2)	4	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	36	59	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	28	30	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	100	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	10	12	evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam .
None(e1,e2)	16	23	h2 receptor antagonists : cimetidine coadministration leads to an increased peak plasma concentration and auc of cisapride , there is no effect on cisapride absorption when it is coadministered with ranitidine .
None(e1,e2)	3	22	alcohol - although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic_medications , the use of alcohol by patients taking lexapro is not recommended .
None(e1,e2)	14	35	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	32	35	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	1	9	- methyldopa ( e.g. , aldomet ) use of methyldopa with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood
None(e1,e2)	12	15	although there is no documentation of such , a similar interaction between ethotoin and the coumarin_anticoagulants may occur .
None(e1,e2)	4	11	in patients receiving nonselective monoamine_oxidase_inhibitors ( maois ) ( e.g. , selegiline_hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	32	34	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	27	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	61	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	24	26	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non-narcotic_analgesics and barbiturates .
None(e1,e2)	2	16	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	15	42	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	25	33	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	5	28	in 2 separate studies , fexofenadine_hydrochloride 120 mg twice daily ( 240 mg total daily dose ) was co-administered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy volunteers ( n=24 , each study ) .
None(e1,e2)	25	48	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	77	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	40	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal_anti-inflammatory_drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	19	21	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	75	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	8	20	if antacids are required during omnicef therapy , omnicef should be taken at least 2 hours before or after the antacid .
None(e1,e2)	14	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	5	57	effects of felbatol on low-dose combination_oral_contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	2	12	cns-active drugs ethanol : sonata 10 mg potentiated the cns-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test ( dsst ) , symbol copying test , and the variability component of the divided attention test for 2.5 hours after ethanol administration .
effect(e1,e2)	14	21	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	11	13	mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	0	9	nicardipine_hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine hcl is initiated .
None(e1,e2)	10	13	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	10	17	terfenadine : in a prospective study involving six-healthy-male volunteers , dirithromycin did not affect the metabolism of terfenadine .
effect(e1,e2)	4	11	- the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip retard .
None(e1,e2)	53	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	30	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	59	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	36	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	16	25	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	8	26	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton_pump_inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	18	29	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	0	11	diuretics : diclofenac and other nsaids can inhibit the activity of diuretics .
None(e1,e2)	22	27	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	23	25	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	7	19	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	0	11	digoxin : the concomitant administration of dynacirc ( isradipine ) and digoxin in a single-dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of digoxin .
None(e1,e2)	11	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	25	31	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	41	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	39	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	39	62	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	6	15	additive cns depression may occur when antihistamines are administered concomitantly with other cns depressants including barbiturates , tranquilizers , and alcohol .
None(e1,e2)	3	7	simvastatin and other statins : co-administration of bosentan decreased the plasma concentrations of simvastatin ( a cyp3a4 substrate ) , and its active -hydroxy acid metabolite , by approximately 50 % .
mechanism(e1,e2)	6	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	28	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	31	phenytoin : no significant differences were observed in mean phenytoin auc , c max , c min or t max ( although c max increased by 11 % ) when extended phenytoin_sodium capsules ( 100 mg tid ) were coadministered with lomefloxacin ( 400 mg qd ) for five days in 15 healthy males .
None(e1,e2)	30	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	11	23	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	11	43	quinidine : coadministration of a 10-mg single dose of aripiprazole with quinidine ( 166 mg/day for 13 days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by 112 % but decreased the auc of its active metabolite , dehydroaripiprazole , by 35 % .
mechanism(e1,e2)	2	14	valproate : tiagabine causes a slight decrease ( about 10 % ) in steady-state valproate concentrations .
None(e1,e2)	46	54	diltiazem : in patients with mild to moderate hypertension , administration of aprepitant once daily , as a tablet formulation comparable to 230 mg of the capsule formulation , with diltiazem 120 mg 3 times daily for 5 days , resulted in a 2-fold increase of aprepitant auc and a simultaneous 1.7-fold increase of diltiazem auc .
None(e1,e2)	6	11	antacid : the effect of an aluminum_hydroxide - and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	2	32	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2 agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	1	8	when carbamazepine is added to aripiprazole therapy , aripiprazole dose should be doubled .
None(e1,e2)	35	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	42	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	6	56	plasma levels of several closely related tricyclic_antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	11	15	oral neomycin inhibits the gastrointestinal absorption of penicillin v , oral vitamin_b-12 , methotrexate and 5-fluorouracil .
None(e1,e2)	2	12	coadministration of valdecoxib ( 10 mg bid for 7 days ) with glyburide ( 5 mg qd or 10 mg bid ) did not affect the pharmacokinetics ( exposure ) of glyburide .
None(e1,e2)	0	13	cholestyramine -concomitant intake of cholestyramine and vitamin k may reduce the absorption of vitamin_k .
None(e1,e2)	10	16	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	11	23	abased on reports of narcotic withdrawal syndrome in patients treated with nevirapine and methadone concurrently , and evidence of decreased plasma concentrations of methadone .
None(e1,e2)	40	43	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
advise(e1,e2)	7	10	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	17	22	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns_depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	5	17	patients receiving high doses of salicylates concomitantly with furosemide , as in rheumatic disease , may experience salicylate toxicity at lower doses because of competitive renal excretory sites .
None(e1,e2)	71	121	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	7	16	however , the peak plasma level of metformin was reduced by approximately 20 % when taking acarbose due to a slight delay in the absorption of metformin .
None(e1,e2)	26	32	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	98	159	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	7	33	uricosuric agents : since the excretion of oxipurinol is similar to that of urate , uricosuric agents , which increase the excretion of urate , are also likely to increase the excretion of oxipurinol and thus lower the degree of inhibition of xanthine oxidase .
None(e1,e2)	69	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	71	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	25	27	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	28	45	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	7	13	simvastatin and other statins : co-administration of bosentan decreased the plasma concentrations of simvastatin ( a cyp3a4 substrate ) , and its active -hydroxy acid metabolite , by approximately 50 % .
None(e1,e2)	10	12	valdecoxib caused a statistically significant increase in plasma exposures of r-warfarin and s-warfarin ( 12 % and 15 % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as inr ) of warfarin .
None(e1,e2)	16	20	no significant drug-drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , and nifedipine .
None(e1,e2)	90	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	45	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	4	9	corticosteroids and corticotropin ( acth ) : may potentiate amphotericin_b - induced hypokalemia which may predispose the patient to cardiac dysfunction .
None(e1,e2)	10	20	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	12	25	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	35	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	6	13	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp/ aza and aminosalicylates .
None(e1,e2)	25	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	33	45	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
None(e1,e2)	13	21	reported examples of this interaction include the following : immunosuppressives : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	41	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	8	18	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	127	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	7	27	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	55	61	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	11	12	erythromycin has been reported to significantly alter the metabolism of nonsedating antihistamines terfenadine and astemizole when taken concomitantly .
None(e1,e2)	56	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	38	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	22	32	cimetidine : albendazole sulfoxide concentrations in bile and cystic fluid were increased ( about 2-fold ) in hydatid cyst patients treated with cimetidine ( 10 mg/kg/day ) ( n=7 ) compared with albendazole ( 20 mg/kg/day ) alone ( n=12 ) .
mechanism(e1,e2)	3	7	therefore , if digoxin is administered with vaprisol , the clinician should be alert to the possibility of increases in digoxin levels .
None(e1,e2)	102	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	6	digoxin , methotrexate , cyclosporine : diclofenac , like other nsaids , may affect renal prostaglandins and increase the toxicity of certain drugs .
None(e1,e2)	8	12	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
None(e1,e2)	8	12	when such drugs are withdrawn from patients receiving acarbose in combination with sulfonylureas or insulin , patients should be observed closely for any evidence of hypoglycemia .
None(e1,e2)	18	24	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide_diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	59	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	10	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , fluoxetine , seriraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	15	33	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	63	79	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	25	29	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	13	94	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	5	17	aprepitant increased the auc of midazolam by 25 % on day 4 and decreased the auc of midazolam by 19 % on day 8 relative to the dosing of aprepitant on days 1 through 3 .
None(e1,e2)	79	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	4	8	olanzapine : coadministration of eszopiclone 3 mg and olanzapine 10 mg produced a decrease in dsst scores .
None(e1,e2)	30	36	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	11	19	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
effect(e1,e2)	9	17	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic_antidepressants may produce severe , prolonged hypertension .
None(e1,e2)	9	16	as with other agents with b-blocking properties , if coreg is to be administered orally with calcium_channel_blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	0	29	warfarin : a single 125-mg dose of aprepitant was administered on day 1 and 80 mg/day on days 2 and 3 to healthy subjects who were stabilized on chronic warfarin therapy .
None(e1,e2)	9	19	these agents include medications such as : anticoagulants , platelet_inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac_tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	37	40	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	11	24	use in conjunction with other antiepileptic drugs : the addition of felbatol to antiepileptic drugs ( aeds ) affects the steady-state plasma concentrations of aeds .
None(e1,e2)	14	28	ketoconazole at 400 mg daily ( the maximum approved prescription dose ) co-administered with tikosyn ( 500 mcg bid ) for 7 days has been shown to increase dofetilide cmax by 53 % in males and 97 % in females , and auc by 41 % in males and 69 % in females .
None(e1,e2)	79	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	18	20	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	33	45	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	9	10	glyburide : the concomitant administration of ciprofloxacin with the sulfonylurea glyburide has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	85	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	80	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	62	117	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	4	6	the concomitant administration of bosentan and cyclosporine_a is contraindicated .
mechanism(e1,e2)	2	15	increasing the felbamate dose to 1800 mg/day in six of these subjects increased the steady-state phenytoin cmin to 25 7 micrograms/ml .
None(e1,e2)	12	29	in the diamond trials , 1252 patients were treated with tikosyn and diuretics concomitantly of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and diuretics .
None(e1,e2)	0	12	paroxetine : coadministration of a single dose of sonata 20 mg and paroxetine 20 mg daily for 7 days did not produce any interaction on psychomotor performance .
None(e1,e2)	20	24	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium_channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
effect(e1,e2)	14	18	preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving indinavir in combination with ritonavir than those receiving crixivan 800 mg q8h .
None(e1,e2)	11	20	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac_tromethamine protein binding .
None(e1,e2)	38	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	40	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	28	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	2	10	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	65	99	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	7	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	0	5	adrenergic_agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents , vasopressor or dopaminergic agents .
int(e1,e2)	7	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	16	27	naproxen , naproxen sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
None(e1,e2)	34	46	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	10	18	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	3	10	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
mechanism(e1,e2)	19	36	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	5	ergotamine : concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	5	14	in vitro studies indicate that ertapenem does not inhibit p-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for p-glycoprotein-mediated transport .
None(e1,e2)	0	12	eprosartan has been shown to have no effect on the pharmacokinetics of digoxin and the pharmacodynamics of warfarin and glyburide .
advise(e1,e2)	24	42	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	29	33	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	5	18	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine_oxidase_inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	43	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	12	warfarin : increased inr ( international normalized ratio ) when arava and warfarin were co-administered has been rarely reported .
None(e1,e2)	15	33	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
advise(e1,e2)	2	4	patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine , to approximately 1/3 to 1/4 the usual dose .
None(e1,e2)	32	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	16	30	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	3	10	the auc of eszopiclone was increased 2.2-fold by coadministration of ketoconazole , a potent inhibitor of cyp3a4 , 400 mg daily for 5 days .
None(e1,e2)	9	11	the potential for clinically significant drug-drug interactions posed by dolasetron and hydrodolasetron appears to be low for drugs commonly used in chemotherapy or surgery , because hydrodolasetron is eliminated by multiple routes .
None(e1,e2)	0	5	selective_serotonin_reuptake_inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
effect(e1,e2)	11	26	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	73	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	10	caution should be used when cyp3a4 inhibitors are co-administered with felodipine .
effect(e1,e2)	0	6	diflunisal decreased the hyperuricemic effect of hydrochlorothiazide .
advise(e1,e2)	32	34	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
None(e1,e2)	3	5	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
None(e1,e2)	33	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	15	antiepileptic_drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic_drugs ( phenytoin , carbamazepine ) .
int(e1,e2)	0	22	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	54	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	5	18	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic acid may potentiate the effects of ganglionic_blocking_agents and vasoactive drugs resulting in postural hypotension .
effect(e1,e2)	4	32	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	27	31	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	11	17	potential interactions between taxol , a substrate of cyp3a4 , and protease_inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	35	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	27	34	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl_estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	34	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	7	20	the absorption of tetracycline , furosemide , penicillin_g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol_hydrochloride ;
None(e1,e2)	1	37	because busulfan is eliminated from the body via conjugation with glutathione , use of acetaminophen prior to ( 72 hours ) or concurrent with busulfex may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues .
None(e1,e2)	0	15	probenecid : may decrease renal tubular secretion of ampicillin resulting in increased blood levels and/or ampicillin toxicity .
None(e1,e2)	3	9	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	33	39	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	28	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	11	22	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	58	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	5	8	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	18	25	ritonavir ( 600 mg b.i.d . ) co-administered with vardenafil 5 mg resulted in a 49-fold increase in vardenafil auc and a 13-fold increase in vardenafil cmax .
mechanism(e1,e2)	3	14	benzodiazepines : combination hormonal_contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
advise(e1,e2)	4	21	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2 agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	80	100	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	44	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	39	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	17	51	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	57	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	23	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	57	91	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	18	26	drugs demonstrated to be cyp 3a inhibitors of possible clinical significance on the basis of clinical studies involving alprazolam ( caution is recommended during coadministration with alprazolam ) : coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .
None(e1,e2)	118	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	17	the potential for drug interactions with emtriva has been studied in combination with indinavir , stavudine , famciclovir , and tenofovir disoproxil fumarate .
None(e1,e2)	4	18	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
None(e1,e2)	3	52	effects of other antiepileptic_drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	3	25	concurrent administration of hexalen and antidepressants of the mao inhibitor class may cause severe orthostatic hypotension.cimetidine , an inhibitor of microsomal drug metabolism , increased altretamine s half-life and toxicity in a rat model .
None(e1,e2)	4	9	anticoagulants : potentiation of warfarin -type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	36	38	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
None(e1,e2)	38	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	23	33	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	5	24	antacids : concomitant administration of magnesium_hydroxide and aluminum hydroxide does not interfere with the rate or extent of the absorption of ketoprofen administered as orudis .
None(e1,e2)	0	7	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
None(e1,e2)	23	37	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	10	drugs that interfere with hemostasis ( nsaids , aspirin , warfarin , etc . )
None(e1,e2)	106	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
effect(e1,e2)	6	12	additive cns depression may occur when antihistamines are administered concomitantly with other cns_depressants including barbiturates , tranquilizers , and alcohol .
None(e1,e2)	72	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	12	23	consequently , it is recommended not to exceed a single 2.5 mg vardenafil dose in a 72-hour period when used in combination with ritonavir .
effect(e1,e2)	23	27	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	42	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	18	29	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective_beta-adrenergic-blocking_agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	61	63	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	0	12	warfarin : in a short-term controlled study in 14 normal volunteers , ketoprofen did not significantly interfere with the effect of warfarin on prothrombin time .
None(e1,e2)	68	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	41	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	40	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	5	- hydroxychloroquine ( e.g. , plaquenil ) or
None(e1,e2)	6	21	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	0	9	cholinesterase_inhibitors : dipyridamole may counteract the anticholinesterase effect of cholinesterase_inhibitors , thereby potentially aggravating myasthenia gravis .
None(e1,e2)	1	9	monitor salicylate levels or the therapeutic effect for which aspirin is given ;
None(e1,e2)	30	38	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	12	23	ketoconazole ( 200 mg once daily ) produced a 10-fold increase in vardenafil auc and a 4-fold increase in cmax when co-administered with vardenafil ( 5 mg ) in healthy volunteers .
None(e1,e2)	8	19	concomitant administration of kerlone with the oral anticoagulant warfarin has been shown not to potentiate the anticoagulant effect of warfarin .
None(e1,e2)	12	14	compounds that have been tested in man include antipyrine , digoxin , propranolol , theophylline , and warfarin and no clinically meaningful interactions were found .
mechanism(e1,e2)	0	9	aprepitant has been shown to induce the metabolism of s_(_-_)_warfarin and tolbutamide , which are metabolized through cyp2c9 .
None(e1,e2)	17	27	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	55	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	15	28	when initiating a multi-day course of grepafloxacin in a patient maintained on theophylline , the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments .
None(e1,e2)	13	24	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	72	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	15	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	30	40	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	9	13	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	15	22	clinical studies in healthy volunteers show that the pharmacokinetics of cancidas are not altered by itraconazole , amphotericin b , mycophenolate , nelfinavir , or tacrolimus .
None(e1,e2)	26	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	38	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
effect(e1,e2)	4	18	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	2	37	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
advise(e1,e2)	9	12	this interaction should be given consideration in patients taking celebrex concomitantly with ace-inhibitors .
None(e1,e2)	13	32	reported examples of this interaction include the following : immunosuppressives : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	2	19	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	5	13	it is desirable to monitor tca plasma levels whenever an agent of the tricyclic_antidepressant_class including anafranil is going to be co-administered with another drug known to be an inhibitor of p450 2d6 ( and/or p450 1a2 ) .
None(e1,e2)	10	20	in the same study it was shown that didanosine and stavudine had no significant effect on the intracellular phosphorylation of zalcitabine in peripheral blood mononuclear cells .
None(e1,e2)	30	36	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao_inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
mechanism(e1,e2)	16	28	when ertapenem is co-administered with probenecid ( 500 mg p.o . every 6 hours ) , probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem .
mechanism(e1,e2)	46	57	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	48	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	43	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	46	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	58	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid_products .
effect(e1,e2)	4	28	as with some other nondepolarizing_neuromuscular_blocking_agents , the time of onset of neuromuscular block induced by nuromax is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine .
effect(e1,e2)	3	11	quinolones , including norfloxacin , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .
None(e1,e2)	10	21	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	15	h2_blockers /proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton_pump_inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
int(e1,e2)	0	21	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	6	23	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	5	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace inhibitors , and with some angiotensin ii receptor antagonists .
None(e1,e2)	12	26	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	3	39	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	1	26	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	21	35	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	7	19	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	81	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	6	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	33	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	9	when amiodarone is added to flecainide therapy , plasma flecainide levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .
None(e1,e2)	8	11	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	7	34	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	5	7	ascorbic acid : doses of ascorbic_acid ( vitamin_c ) 1 g/day have been reported to increase plasma concentration of synthetic estrogens by ~47 % , possibly by inhibiting conjugation ;
None(e1,e2)	2	7	co-administration with antifungal_agents such as ketoconazole or itraconazole is not recommended .
None(e1,e2)	4	10	coadministration of entecavir with lamivudine , adefovir dipivoxil , or tenofovir_disoproxil_fumarate did not result in significant drug interactions .
None(e1,e2)	32	43	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	9	11	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
mechanism(e1,e2)	19	27	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
effect(e1,e2)	4	15	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine_oxidase_inhibitors or other antidepressants .
None(e1,e2)	20	36	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	10	24	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	17	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	57	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	47	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	37	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	59	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	29	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	11	52	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	13	ethanol or triazolam : no significant differences were observed in the pharmacokinetics of triazolam ( 0.125 mg ) and tiagabine ( 10 mg ) when given together as a single dose .
effect(e1,e2)	0	7	tricyclic_antidepressants may block the antihypertensive action of guanethidine and similarly acting compounds .
advise(e1,e2)	12	24	because of foscarnets tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
None(e1,e2)	2	15	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
advise(e1,e2)	7	9	itraconazole plasma concentrations should be monitored when itraconazole and isoniazid are coadministered .
None(e1,e2)	6	15	therefore , close monitoring of serum cyclosporin level is recommended and , if necessary , chloroquine should be discontinued .
None(e1,e2)	6	15	the continued need for the other antiarrhythmic agent should be reviewed after the effects of amiodarone have been established , and discontinuation ordinarily should be attempted .
mechanism(e1,e2)	4	17	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl_estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	44	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	4	13	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	8	13	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa reductase inhibitor .
None(e1,e2)	110	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
int(e1,e2)	4	6	possible drug interactions of humorsol with succinylcholine or with other anticholinesterase agents .
None(e1,e2)	26	48	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	26	30	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	0	5	ace_inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of ace inhibitors .
None(e1,e2)	25	27	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	6	10	drugs that interfere with hemostasis ( nsaids , aspirin , warfarin , etc . )
None(e1,e2)	13	27	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	59	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	59	91	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	9	22	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	0	32	selective_serotonin_reuptake_inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
None(e1,e2)	62	105	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	29	31	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	17	20	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	31	34	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	18	29	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	1	5	certain antipsychotic_medications ( such as sertindole ) ;
None(e1,e2)	20	40	in a study in which patients with active ra were treated for up to 24 weeks with concurrent kineret and etanercept therapy , a 7 % rate of serious infections was observed , which was higher than that observed with etanercept alone ( 0 % ) .
None(e1,e2)	12	17	it is , however , possible that concomitant use of other known photosensitizing_agents such as griseofulvin , thiazide_diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	9	13	antihistamines may have additive effects with alcohol and other cns_depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
mechanism(e1,e2)	5	23	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	12	19	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	0	25	estazolam : interaction with drugs that inhibit metabolism via cytochrome p450 3a ( cyp3a ) : the metabolism of estazolam to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other triazolobenzodiazepines is catalyzed by cyp3a .
None(e1,e2)	0	18	ssris : weakness hyperreflexia , and incoordination have been reported rarely when 5-ht1 agonists have been co-administered with ssris ( e. g .
None(e1,e2)	26	40	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	0	8	heparin : no human drug interaction studies with heparin were conducted .
effect(e1,e2)	2	13	if a diuretic is also used , it may increase the risk of lithium toxicity .
None(e1,e2)	9	11	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
effect(e1,e2)	7	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	7	13	dicumarol : it has been reported that allopurinol prolongs the half-life of the anticoagulant , dicumarol .
advise(e1,e2)	8	13	monitoring for amiodarone toxicity and serial measurement of amiodarone serum concentration during concomitant protease_inhibitor therapy should be considered .
None(e1,e2)	76	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	3	phenothiazines - taking piperazine and a phenothiazine together may increase the risk of convulsions ( seizures ) .
None(e1,e2)	4	16	thus patients receiving oral anticoagulants and fluvoxamine tablets should have their prothrombin time monitored and their anticoagulant dose adjusted accordingly .
None(e1,e2)	4	35	it is recommended that buspirone_hydrochloride not be used concomitantly with mao inhibitors because the effects of concomitant administration of buspirone hcl with most other psychotropic drugs have not been studied , the concomitant use of buspirone_hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	15	40	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	54	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	35	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	46	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	9	11	in the large , placebo-controlled osteoporosis treatment study , aspirin and nonsteroidal_anti-inflammatory_drugs were taken by 62 % of the 2946 patients .
None(e1,e2)	20	44	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	16	24	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic_agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	0	6	ranitidine also has no effect on eprosartan pharmacokinetics .
None(e1,e2)	29	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
mechanism(e1,e2)	2	6	absorption of tetracycline is impaired by bismuth_subsalicylate .
None(e1,e2)	24	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	6	18	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
effect(e1,e2)	0	10	folic_acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
None(e1,e2)	77	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
advise(e1,e2)	26	40	since higher doses of ketoconazole ( 400 mg daily ) may result in higher increases in cmax and auc , a single 2.5 mg dose of vardenafil should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily .
None(e1,e2)	48	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	28	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	1	23	because tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
None(e1,e2)	9	41	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop_diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	3	28	ketoconazole ) , macrolide_antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	0	22	ketoconazole : co-administration of bosentan 125 mg b.i.d . and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately 2-fold .
None(e1,e2)	8	15	there is no information regarding the effect on lamivudine pharmacokinetics of higher doses of tmp/ smx such as those used to treat pneumocystis carinii pneumonia .
None(e1,e2)	76	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	25	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	1	15	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
None(e1,e2)	25	30	in a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of prinivil alone were compared to prinivil given concomitantly with indomethacin , the use of indomethacin was associated with a reduced antihypertensive effect , although the difference between the two regimens was not significant .
None(e1,e2)	93	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	27	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	21	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	18	39	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine_oxidase_inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	2	24	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	47	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	8	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	49	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	23	27	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	19	21	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	7	45	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	0	6	vasoconstrictors : d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp should not be used with peripheral vasoconstrictors because the combination may cause synergistic elevation of blood pressure .
effect(e1,e2)	3	19	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	114	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	5	acebutolol , atenolol , and nadolol ( low hepatic clearance or no first-pass metabolism ) are unlikely to be affected .
None(e1,e2)	13	21	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	18	53	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	15	17	hormonal contraceptives : it has not been established if there is a pharmacokinetic interaction between acitretin and combined_oral_contraceptives .
None(e1,e2)	5	11	it is recommended that serum lithium levels be monitored frequently if prinivil is administered concomitantly with lithium .
effect(e1,e2)	2	14	however , iloprost has the potential to increase the hypotensive effect of vasodilators and antihypertensive_agents .
None(e1,e2)	18	25	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	73	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	4	42	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	54	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	18	26	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	0	2	nifedipine : vardenafil 20 mg , when co-administered with slow-release nifedipine 30 mg or 60 mg once daily , did not affect the relative bioavailability ( auc ) or maximum concentration ( cmax ) of nifedipine , a drug that is metabolized via cyp3a4 .
advise(e1,e2)	6	39	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal_anti-inflammatory_agents ] is contraindicated .
None(e1,e2)	2	4	beta-blockers ( metoprolol , propranolol ) serum concentrations and pharmacologic effects may be increased .
None(e1,e2)	6	28	benzthiazide may interact with alcohol , blood_thinner s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	35	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	7	42	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	133	140	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	41	43	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	13	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
mechanism(e1,e2)	2	12	administration of cmi has been reported to increase the plasma levels of phenobarbital , if given concomitantly .
None(e1,e2)	3	5	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
mechanism(e1,e2)	2	10	mercaptopurine/azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid .
None(e1,e2)	18	36	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
mechanism(e1,e2)	12	19	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
advise(e1,e2)	4	53	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	38	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	34	36	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	63	73	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
effect(e1,e2)	2	9	antihypertensives : amphetamines may antagonize the hypotensive effects of antihypertensives .
effect(e1,e2)	1	13	since hydroxyurea may raise the serum uric acid level , dosage adjustment of uricosuric_medication may be necessary
None(e1,e2)	65	94	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	15	28	digoxin : in a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , ketoprofen did not alter the serum levels of digoxin .
None(e1,e2)	16	21	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	28	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	7	47	dexbrompheniramine can interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	73	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	4	17	carbamazepine : coadministration of carbamazepine ( 200 mg bid ) , a potent cyp3a4 inducer , with aripiprazole ( 30 mg qd ) resulted in an approximate 70 % decrease in cmax and auc values of both aripiprazole and its active metabolite , dehydro-aripiprazole .
None(e1,e2)	59	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	25	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	9	13	there are no clinical data on concomitant use of nuromax and other nondepolarizing neuromuscular_blocking_agents .
None(e1,e2)	12	15	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic_analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
mechanism(e1,e2)	12	27	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	12	19	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
mechanism(e1,e2)	11	30	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
None(e1,e2)	24	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	55	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	5	use of antithrombotics aspirin and heparin have been administered concomitantly with and following infusions of activase in the management of acute myocardial infarction or pulmonary embolism .
None(e1,e2)	25	44	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	4	28	grapefruit juice co-administration of felodipine with grapefruit juice resulted in more than 2-fold increase in the auc and cmax , but no prolongation in the half- life of felodipine .
None(e1,e2)	8	38	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer_acetate .
None(e1,e2)	2	21	- a steroid_medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	70	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	57	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	54	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	144	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	42	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	18	22	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
advise(e1,e2)	16	18	accordingly , careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin .
None(e1,e2)	19	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	112	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	29	however , coadministration of escitalopram ( 20 mg ) and ritonavir ( 600 mg ) , a potent inhibitor of cyp3a4 , did not significantly affect the pharmacokinetics of escitalopram .
None(e1,e2)	4	17	in clinical studies , tilade has been co-administered with other anti-asthma medications , including inhaled and oral bronchodilators , and inhaled corticosteroids , with no evidence of increased frequency of adverse events or laboratory abnormalities .
None(e1,e2)	4	7	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	15	23	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	22	28	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	15	17	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
None(e1,e2)	0	12	calcium_antagonist s : after repeated co-administration of trileptal , the auc of felodipine was lowered by 28 % [ 90 % ci : 20-33 ] .
None(e1,e2)	21	43	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	24	26	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	5	9	however , neither phenobarbital nor diazepam appears to affect dantrium metabolism .
None(e1,e2)	26	49	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	85	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	2	14	the oral dexamethasone doses should be reduced by approximately 50 % when coadministered with aprepitant , to achieve exposures of dexamethasone similar to those obtained when it is given without aprepitant .
None(e1,e2)	3	16	metformin : when starlix 120 mg three times daily before meals was administered in combination with metformin 500 mg three times daily to patients with type 2 diabetes , there were no clinically relevant changes in the pharmacokinetics of either agent .
None(e1,e2)	12	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	0	12	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	5	24	therefore , when hydroflumethiazide and nonsteroidal_anti-inflammatory_agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained . )
None(e1,e2)	34	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	13	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	41	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	39	49	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	8	10	cancidas has no effect on the pharmacokinetics of itraconazole , amphotericin_b , or the active metabolite of mycophenolate .
None(e1,e2)	49	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	14	loop diuretics : furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients .
int(e1,e2)	4	6	the extent to which ssri - tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
None(e1,e2)	8	10	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	96	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	7	18	since bacteriostatic drugs , such as the tetracycline_class of antibiotics , may interfere with the bactericidal action of penicillins , it is not advisable to administer these drugs concomitantly .
None(e1,e2)	42	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	39	59	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	16	24	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	23	28	hormonal contraceptives co-administration of trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components , ethinylestradiol ( ee ) and levonorgestrel ( lng ) .
None(e1,e2)	14	35	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	16	23	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	5	11	probenecid : as with other b-lactams , the renal excretion of cephalexin is inhibited by probenecid .
None(e1,e2)	17	30	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	8	13	n=17 ) were not different and neither were gabapentin pharmacokinetic parameters affected by valproic_acid .
None(e1,e2)	55	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	44	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	13	uricosuric_agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
None(e1,e2)	4	31	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	8	29	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
mechanism(e1,e2)	2	8	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron-containing preparations .
None(e1,e2)	30	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	43	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	38	coadministration of almotriptan and the potent cyp3a4 inhibitor ketoconazole ( 400 mg q.d . for 3 days ) resulted in an approximately 60 % increase in the area under the plasma concentration-time curve and maximal plasma concentrations of almotriptan .
None(e1,e2)	32	43	reported examples of this interaction include the following : immunosuppressives : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	34	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	25	34	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	16	22	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	20	27	terfenadine : no clinically significant changes occurred in heart rate or corrected qt intervals , or in terfenadine metabolite or lomefloxacin pharmacokinetics , during concurrent administration of lomefloxacin and terfenadine at steady-state in 28 healthy males .
None(e1,e2)	9	15	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	23	106	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	30	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic_agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	1	15	phenytoin/ phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin_d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
None(e1,e2)	12	14	warfarin : no significant differences were observed in the steady-state pharmacokinetics of r-warfarin or s-warfarin with the addition of tiagabine given as a single dose .
None(e1,e2)	0	4	benazepril , like other ace_inhibitors , has had less than additive effects with beta-adrenergic blockers , presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system
None(e1,e2)	0	17	warfarin - administration of 40 mg/day racemic citalopram for 21 days did not affect the pharmacokinetics of warfarin , a cyp3a4 substrate .
mechanism(e1,e2)	5	19	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	19	41	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
mechanism(e1,e2)	0	35	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	44	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	1	20	magnesium/ aluminum -containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium /aluminum-containing antacid products .
None(e1,e2)	26	28	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	2	4	carbamazepine , clonazepam , ethosuximide
None(e1,e2)	35	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	52	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	23	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	8	28	conversely , decreases in plasma levels of the tricyclic_antidepressants have been reported upon discontinuation of cimetidine which may result in the loss of the therapeutic efficacy of the tricyclic_antidepressant 6 .
None(e1,e2)	14	30	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	20	36	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	11	26	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	62	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	11	skeletal_muscle_relaxants : amphotericin b-induced hypokalemia may enhance the curariform effect of skeletal_muscle_relaxants ( e.g. , tubocurarine ) .
None(e1,e2)	0	9	methotrexate : nsaids have been reported to competitively inhibit methotrexate accumulation in rabbit kidney slices .
None(e1,e2)	8	12	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp /aza and aminosalicylates .
effect(e1,e2)	2	22	magnesium : magnesium -containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin_d by patients on chronic renal dialysis .
None(e1,e2)	6	18	dose adjustment is not recommended . levetiracetam had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or lamotrigine .
None(e1,e2)	4	14	the urinary excretion of meclofenamate_sodium is unaffected by aspirin , indicating no change in meclofenamate_sodium absorption .
mechanism(e1,e2)	3	16	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	14	17	plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	13	19	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	10	15	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	110	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	6	19	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ;
mechanism(e1,e2)	0	14	erythromycin has been reported to significantly alter the metabolism of nonsedating antihistamines terfenadine and astemizole when taken concomitantly .
advise(e1,e2)	13	17	caution is advised when beginning , discontinuing , or changing the dose of diamox in patients receiving primidone .
mechanism(e1,e2)	2	8	ethosuximide : amphetamines may delay intestinal absorption of ethosuximide .
None(e1,e2)	0	23	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
None(e1,e2)	69	78	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	42	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	28	a drug-drug interaction study evaluated the effect of the use of aczone gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim/ sulfamethoxazole ( tmp/smx ) .
None(e1,e2)	110	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	7	concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	11	14	although there are no study data to evaluate the possibility , nitric_oxide_donor_compounds , including sodium_nitroprusside and nitroglycerin , may have an additive effect with inomax on the risk of developing methemoglobinemia .
None(e1,e2)	4	27	coadministration of amprenavir and methadone as compared to a non-matched historicalcontrol group resulted in a 30 % , 27 % , and 25 % decrease in serum amprenavir auc , cmax , andcmin , respectively .
mechanism(e1,e2)	1	17	theophylline vioxx 12.5 , 25 , and 50 mg administered once daily for 7 days increased plasma theophylline concentrations ( auc ( 0- ) ) by 38 to 60 % in healthy subjects administered a single 300-mg dose of theophylline .
None(e1,e2)	43	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	8	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	18	36	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic_agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
None(e1,e2)	26	28	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin_b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	11	27	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine -containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton_pump_inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	38	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	48	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	29	62	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
mechanism(e1,e2)	19	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	18	20	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
None(e1,e2)	18	21	renal clearance measurements of pah can not be made with any significant accuracy in patients receiving sulfonamides , procaine , or thiazolesulfone .
advise(e1,e2)	2	53	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	38	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	9	19	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
effect(e1,e2)	6	13	potassium supplements and potassium-sparing diuretics : fosinopril_sodium can attenuate potassium loss caused by thiazide_diuretics .
None(e1,e2)	2	16	cns-active drugs ethanol an additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol 0.70 g/kg for up to 4 hours after ethanol administration .
None(e1,e2)	10	13	the absorption of tetracycline , furosemide , penicillin g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
None(e1,e2)	23	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	22	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	36	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	2	antacids containing aluminum_hydroxide and magnesium hydroxide reduce the oral absorption of enoxacin by 75 % .
mechanism(e1,e2)	19	24	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	5	16	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	57	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	21	27	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	22	28	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	1	29	since cholestyramine resin may bind other drugs given concurrently , it is recommended that patients take other drugs at least 1 hour before or 4 to 6 hours after cholestyramine resin ( or at as great an interval as possible ) to avoid impeding their absorption .
None(e1,e2)	47	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	11	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
None(e1,e2)	22	24	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	60	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	40	51	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	0	23	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic_acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	71	99	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	19	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	68	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	6	13	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	38	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	14	epinephrine also should be used cautiously with other drugs ( e.g. , digitalis , glycosides ) that sensitize the myocardium to the actions of sympathomimetic drugs .
None(e1,e2)	4	8	therefore , administration of quinolones with antacids containing calcium , magnesium , or aluminum ;
None(e1,e2)	54	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	24	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	19	in patients with chronic hepatitis c treated with pegasys in combination with copegus , pegasys treatment did not affect ribavirin distribution or clearance .
None(e1,e2)	0	27	methotrexate vioxx 12.5 , 25 , and 50 mg , each dose administered once daily for 7 days , had no effect on the plasma concentration of methotrexate as measured by auc0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis .
None(e1,e2)	7	16	ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan , and erythromycin had no clinically significant effect after oral administration .
None(e1,e2)	3	5	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	1	9	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately 30 % and 20 % .
None(e1,e2)	9	24	until further data are developed regarding drug interactions when azithromycin and these drugs are used concomitantly , careful monitoring of patients is advised : digoxin elevated digoxin concentrations .
None(e1,e2)	105	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	30	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
None(e1,e2)	49	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	20	28	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	8	18	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	3	12	patients receiving other narcotic_analgesics , antipsychotics , antianxiety agents , or other cns_depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	40	42	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	0	28	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	36	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	3	28	concomitant administration of targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene , probably at least partially related to cytochrome p450 3a4 inhibition by gemfibrozil .
None(e1,e2)	36	41	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic_antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	9	12	there has been little experience with the coadministration of tambocor and either disopyramide or verapamil .
None(e1,e2)	8	11	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	30	40	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	100	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	12	the administration of local anesthetic_solutions containing epinephrine or norepinephrine to patients receiving monoamine_oxidase_inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .
None(e1,e2)	83	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	27	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/ sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	100	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	22	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	18	antacids : administration of flurbiprofen to volunteers under fasting conditions , or with antacid suspension yielded similar serum flurbiprofen time profiles in young subjects ( n=12 ) .
None(e1,e2)	54	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	12	methadone : coadministration of amprenavir and methadone can decrease plasma levels of methadone .
None(e1,e2)	9	25	benzthiazide may interact with alcohol , blood thinners , decongestant_drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	59	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	2	24	studies with ace_inhibitors in combination with diuretics indicate that the dose of the ace inhibitor can be reduced when it is given with a diuretic .
effect(e1,e2)	9	30	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	11	13	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	56	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	2	7	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	0	16	alcohol : there was no significant difference between aripiprazole coadministered with ethanol and placebo coadministered with ethanol on performance of gross motor skills or stimulus response in healthy subjects .
None(e1,e2)	12	14	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	12	29	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv_protease_inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
advise(e1,e2)	18	36	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	6	25	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	45	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	33	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	22	59	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	45	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	29	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	46	69	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	6	10	if signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly , physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately .
None(e1,e2)	46	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	28	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	80	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	9	non-selective_monoamine_oxidase_(_mao_)_inhibitors - including phenelzine sulfate , tranylcypromine sulfate and pargyline hc1 .
None(e1,e2)	13	15	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	18	20	auranofin should be avoided by patients with a history of serious reaction to any gold medication , including solganal and myochrysine .
None(e1,e2)	33	42	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	24	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl_estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
mechanism(e1,e2)	3	7	furosemide : when aliskiren was co-administered with furosemide , the auc and cmax of furosemide were reduced by about 30 % and 50 % , respectively .
None(e1,e2)	28	56	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	105	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	0	8	lithium : ibuprofen produced an elevation of plasma lithium levels and a reduction in renal lithium clearance in a study of eleven normal volunteers .
None(e1,e2)	2	10	interactions for vitamin_d_analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	7	16	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	13	23	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium_carbonate , and terbutaline .
None(e1,e2)	1	6	- alcohol , barbiturates , or narcotics : potentiation of otthostatic hypotension may occur
None(e1,e2)	4	22	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac_tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
advise(e1,e2)	23	34	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic_drug .
None(e1,e2)	26	38	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	1	5	if antacids are required during omnicef therapy , omnicef should be taken at least 2 hours before or after the antacid .
None(e1,e2)	24	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	38	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	8	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	14	in 5 other schizophrenic patients treated with oral haloperidol and rifampin , discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations .
None(e1,e2)	46	51	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	30	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	23	33	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	16	18	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	28	32	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	7	19	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	51	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	0	25	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
advise(e1,e2)	8	16	it is recommended that the combination of intravenous dantrolene_sodium and calcium channel blockers , such as verapamil , not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established .
None(e1,e2)	37	41	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	23	30	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	31	44	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	67	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	0	12	bile_acid_binding_resins may also interfere with the absorption of oral phosphate supplements and hydrocortisone .
None(e1,e2)	1	13	plasma tca concentrations may need to be monitored and the dose of the tca may need to be reduced if a tca is co-administered with duloxetine .
None(e1,e2)	9	38	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	26	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	71	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	6	9	laboratory tests : the combination of amprenavir and low-dose ritonavir has been associated with elevations of cholesterol and triglycerides , sgot ( ast ) , and sgpt ( alt ) in some patients .
advise(e1,e2)	11	28	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
None(e1,e2)	8	10	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	8	26	although it has not been definitively demonstrated that fluvoxamine is a potent iiia4 inhibitor , it is likely to be , given the substantial interaction of fluvoxamine with alprazolam .
None(e1,e2)	8	37	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	25	27	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	13	19	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	110	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	3	10	aspirin : concomitant aspirin may decrease the metabolic clearance of nicotinic_acid .
None(e1,e2)	91	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	12	immunosuppressive drugs , fibric_acid_derivatives , niacin ( nicotinic acid , erythromycin , azole_antifungals : skeletal muscle .
None(e1,e2)	10	16	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
None(e1,e2)	3	14	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	4	7	phospholine iodide potentiates other cholinesterase_inhibitors such as succinylcholine or organophosphate and carbamate insecticides .
None(e1,e2)	12	37	evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam .
None(e1,e2)	44	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	8	19	additional reductions in blood pressure may occur when flolan is administered with diuretics , antihypertensive agents , or other vasodilators .
None(e1,e2)	16	33	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	1	38	as mhd , the predominant plasma substrate , is only a weak inducer of udp-glucuronyl transferase , it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through udp-glucuronyl transferase ( e.g. , valproic_acid , lamotrigine ) .
effect(e1,e2)	3	14	the use of codeine may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
None(e1,e2)	0	14	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
int(e1,e2)	4	6	a pharmacokinetic interaction between diltiazem and cyclosporine has been observed during studies involving renal and cardiac transplant patients .
effect(e1,e2)	5	13	serious toxicity may result if dextromethorphan is coadministered with monoamine oxidase inhibitors ( maois ) .
None(e1,e2)	2	10	coadministration of viracept and drugs that induce cyp3a may decrease nelfinavir plasma concentrations and reduce its therapeutic effect .
None(e1,e2)	36	43	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium_channel_blockers , antihistamines or h1-blocking agents , tricyclic_antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	18	22	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	10	17	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	33	63	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	6	14	cyclosporine : elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone class .
None(e1,e2)	25	54	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	17	fluoxetine and its active metabolite , norfluoxe-tine , have long half-lives ( 4 to 16 days for norfluoxetine ) , that may affect strategies during conversion from one drug to the other .
None(e1,e2)	10	14	coumarin anticoagulants : in a small clinical trial in which lovastatin was administered to warfarin treated patients , no effect on prothrombin time was detected .
advise(e1,e2)	25	29	experience with co-administration of hmg-coa reductase inhibitors and fentanyl in patients is limited , therefore , consideration should be given to temporarily suspending use of hmg-coa_reductase_inhibitors in patients receiving fentanyl .
None(e1,e2)	98	122	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	16	the concomitant use of vasopressor s , vasoconstricting agents ( such as ergonovine ) and some oxytocic_drugs may result in severe hypertension .
None(e1,e2)	2	16	increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased indinavir metabolism due to efavirenz .
None(e1,e2)	2	5	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
effect(e1,e2)	4	19	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	76	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	16	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	7	43	dexbrompheniramine can interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
mechanism(e1,e2)	8	15	plasma concentrations ( auc 0-24 hrs ) of erythromycin decreased 15 % with coadministration of loratadine relative to that observed with erythromycin alone .
None(e1,e2)	6	38	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
None(e1,e2)	12	14	several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic antidepressants .
None(e1,e2)	17	20	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl_estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	32	46	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	14	22	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer_acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
None(e1,e2)	34	36	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	1	5	other nonsteroidal_anti-inflammatory_agents ( e.g. , aspirin ) may also have this effect .
None(e1,e2)	5	19	given the anticonvulsant properties of carbamazepine , equetrotm may reduce the thyroid function as has been reported with other anticonvulsants .
None(e1,e2)	27	58	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl_estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	68	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	51	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	0	30	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
effect(e1,e2)	14	36	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	26	30	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	32	36	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin_b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	11	13	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	13	35	cimetidine : in a study in healthy volunteers , a one-week course of cimetidine at 400 mg b.i.d . with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations ( 36 % ) and significant increase in area under the curve ( 50 % ) .
None(e1,e2)	15	20	no interaction was noted with the mao-b inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa /dopa decarboxylase inhibitor ( n=29 ) .
None(e1,e2)	14	17	lotensin has been used concomitantly with beta-adrenergic-blocking agents , calcium-channel-blocking agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
None(e1,e2)	13	26	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	4	6	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	91	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	30	34	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	14	18	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	10	32	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
mechanism(e1,e2)	16	44	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	26	32	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	16	19	the physician should be alert for possible combined drug actions , desirable or undesirable , involving cyclophosphamide even though cyclophosphamide has been used successfully concurrently with other drugs , including other cytotoxic drugs .
None(e1,e2)	4	19	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	18	20	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	11	15	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
advise(e1,e2)	1	14	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	21	23	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	2	12	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic_agents ;
None(e1,e2)	1	20	if phenytoin or other hepatic enzyme inducers are taken concurrently with norpace or norpace cr , lower plasma levels of disopyramide may occur .
None(e1,e2)	9	14	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately 30 % and 20 % .
None(e1,e2)	16	32	however , in a follow-up study in normal subjects , single-dose administration of colestipol hydrochloride and propranolol and twice-a-day administration for 5 days of both agents did not affect the extent of propranolol absorption , but had a small yet statistically significant effect on its rate of absorption ;
None(e1,e2)	6	12	flexeril may enhance the effects of alcohol , barbiturates , and other cns_depressants .
None(e1,e2)	12	16	population pharmacokinetic analyses revealed that mtx , nsaids , corticosteroids , and tnf_blocking_agents did not influence abatacept clearance .
None(e1,e2)	21	25	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	37	44	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
None(e1,e2)	13	23	effects of gabitril on other antiepilepsy drugs ( aeds ) : phenytoin : tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy .
None(e1,e2)	56	72	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
effect(e1,e2)	0	6	steroids enhance the renal toxicity of edetate_calcium_disodium in animals . 7 edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc . 7
None(e1,e2)	0	6	antacids and kaolin : antacids and kaolin can reduce absorption of chloroquine ;
None(e1,e2)	6	33	although the magnitude of changes in diazepam plasma exposure when coadministered with valdecoxib were not sufficient to warrant dosage adjustments , patients may experience enhanced sedative side effects caused by increased exposure of diazepam under this circumstance .
None(e1,e2)	36	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	22	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	7	- a steroid_medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	56	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	11	18	patients using cyp3a4 metabolized statins should have cholesterol levels monitored after tracleer is initiated to see whether the statin dose needs adjustment .
None(e1,e2)	22	24	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	10	20	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	20	29	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns_depressants , causing increased cns depression .
None(e1,e2)	14	25	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
None(e1,e2)	6	13	no pharmacokinetic interactions between dexmedetomidine and isoflurane , propofol , alfentanil , and midazolam have been demonstrated .
None(e1,e2)	4	10	drugs that may increase dasatinib plasma concentrations cyp3a4 inhibitors : dasatinib is a cyp3a4 substrate .
None(e1,e2)	0	2	clarithromycin concentration indinavir concentration
advise(e1,e2)	8	26	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	2	7	isoflurane or enflurane administered with nitrous oxide/ oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	14	21	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	59	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	24	39	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium_channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	22	47	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	0	11	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	4	32	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2 agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	12	21	furosemide : in normal volunteers , the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of furosemide .
None(e1,e2)	33	37	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
None(e1,e2)	19	45	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/ sulfamethoxazole or zidovudine .
None(e1,e2)	30	38	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	51	70	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	29	54	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	13	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
advise(e1,e2)	2	4	coadministration of diltiazem with rifampin or any known cyp3a4 inducer should be avoided when possible , and alternative therapy considered .
None(e1,e2)	8	11	the pharmacokinetics and protein binding of fosphenytoin , phenytoin , and diazepam were not altered when diazepam and cerebyx were concurrently administered in single submaximal doses .
None(e1,e2)	0	21	ergot_derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	6	13	propoxyphene : the concurrent administration of propoxyphene_hydrochloride does not affect the bioavailability of meclofenamate_sodium .
None(e1,e2)	24	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	35	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	17	27	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	12	17	such individuals are referred to as poor metabolizers of drugs such as debrisoquin , dextromethorphan , the tricyclic_antidepressants , and clozapine .
mechanism(e1,e2)	4	14	after multiple dosing , interferon_beta-1a ( avonex 30 mcg im once weekly ) reduced tysabri clearance by approximately 30 % .
None(e1,e2)	17	19	although there are no study data to evaluate the possibility , nitric oxide donor compounds , including sodium_nitroprusside and nitroglycerin , may have an additive effect with inomax on the risk of developing methemoglobinemia .
None(e1,e2)	11	20	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	0	14	heparin_sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
None(e1,e2)	8	36	furthermore , caution should be exercised when combining digoxin with any drug that may cause a significant deterioration in renal function , since a decline in glomerular filtration or tubular secretion may impair the excretion of digoxin .
None(e1,e2)	36	40	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
advise(e1,e2)	1	10	if isradipine therapy is initiated in a patient currently receiving cimetidine careful monitoring for adverse reactions is advised and downward dose adjustment may be required .
None(e1,e2)	43	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	38	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	6	14	platelet inhibitors : drugs such as acetylsalicylic_acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	15	23	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	17	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
advise(e1,e2)	4	17	patients who are applying panretin gel should not concurrently use products that contain deet ( n , n-diethyl-m-toluamide ) , a common component of insect repellent products .
mechanism(e1,e2)	16	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	95	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	7	13	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine_oxidase_inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	4	36	however , because some quinolones have been reported to enhance the effects of warfarin or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a quinolone antimicrobial is administered with warfarin or its derivatives .
None(e1,e2)	7	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
mechanism(e1,e2)	10	23	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
mechanism(e1,e2)	16	21	valproate : a recent case study has shown a possible increase in the plasma level of valproate when co administered with isoniazid .
advise(e1,e2)	0	6	sumatriptan and d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp should not be taken within 24 hours of each other..
None(e1,e2)	18	32	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	12	16	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
advise(e1,e2)	4	10	acellular , live and live-attenuated_vaccines should not be administered during raptiva treatment .
None(e1,e2)	6	28	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
advise(e1,e2)	0	24	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	71	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	31	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	0	9	protease_inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
None(e1,e2)	14	20	in vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol .
None(e1,e2)	13	26	omeprazole : the rate and extent of absorption of ciprofloxacin was bioequivalent when proquin_xr was given alone or when proquin xr was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .
mechanism(e1,e2)	5	9	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately 30 % and 20 % .
None(e1,e2)	27	31	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
None(e1,e2)	38	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	31	levothyroxine_sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium_polystyrene_sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	18	32	theophylline - combined administration of racemic citalopram ( 40 mg/day for 21 days ) and the cyp1a2 substrate theophylline ( single dose of 300 mg ) did not affect the pharmacokinetics of theophylline .
None(e1,e2)	35	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	74	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	52	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	19	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	28	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	6	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	43	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	6	15	carbamazepine - combined administration of racemic citalopram ( 40 mg/day for 14 days ) and carbamazepine ( titrated to 400 mg/day for 35 days ) did not significantly affect the pharmacokinetics of carbamazepine , a cyp3a4 substrate .
effect(e1,e2)	5	9	during controlled hypotensive anesthesia using labetalol_hcl in association with halothane , high concentrations ( 3 % or above ) of halothane should not be used because the degree of hypotension will be increased and because of the possibility of a large reduction in cardiac output and an increase in central venous pressure .
None(e1,e2)	2	6	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	14	17	compounds that have been tested in man include antipyrine , digoxin , propranolol , theophylline , and warfarin and no clinically meaningful interactions were found .
None(e1,e2)	2	20	diuretic : hydrochlorothiazide , given concomitantly with ketoprofen , produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone .
None(e1,e2)	38	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	15	17	ethanol : clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol .
None(e1,e2)	15	19	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
mechanism(e1,e2)	3	10	studies showed that diltiazem increased the auc of midazolam and triazolam by 3-4 fold and the cmax by 2-fold , compared to placebo .
None(e1,e2)	0	8	probenecid : concomitant administration of toradol oral and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels ( total auc increased approximately threefold from 5.4 to 17.8 m g/h/ml ) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .
None(e1,e2)	6	11	nitrates : the concomitant use of bepridil with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris .
None(e1,e2)	26	35	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	5	10	caution should be used when nsaids are administered concomitantly with methotrexate .
None(e1,e2)	0	17	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
None(e1,e2)	11	30	a drug-drug interaction study evaluated the effect of the use of aczone gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim/sulfamethoxazole ( tmp/ smx ) .
None(e1,e2)	56	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	2	20	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	3	16	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e. g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
mechanism(e1,e2)	3	11	serum concentration of digoxin and digitoxin may increase when patients take antithyroid_agents .
None(e1,e2)	3	26	oral hypoglycemics : bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic_agents .
mechanism(e1,e2)	18	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	8	since invirase is coadministered with ritonavir , the ritonavir label should be reviewed for additional drugs that should not be coadministered .
None(e1,e2)	11	18	the pharmacokinetics and protein binding of fosphenytoin , phenytoin , and diazepam were not altered when diazepam and cerebyx were concurrently administered in single submaximal doses .
None(e1,e2)	4	6	vasopressors , such as dopamine and isoproterenol ;
mechanism(e1,e2)	7	18	urinary alkalinizing agents ( acetazolamide , some thiazides ) increase the concentration of the non-ionized species of the amphetamine molecule , thereby decreasing urinary excretion .
None(e1,e2)	85	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	valproate : felbatol causes an increase in steady-state valproate concentrations .
None(e1,e2)	54	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	22	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace inhibitors during therapy with lithium .
None(e1,e2)	78	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	36	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	40	45	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic_antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	18	20	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	12	25	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	6	8	the steady state plasma concentrations of imipramine and desipramine have been reported to be increased an average of 31 % and 20 % , respectively , by the concomitant administration of alprazolam tablets in doses up to 4 mg/day .
None(e1,e2)	4	10	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	39	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	32	alcohol - although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic medications , the use of alcohol by patients taking lexapro is not recommended .
None(e1,e2)	71	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	36	insulin : a clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulins ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	90	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	27	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
mechanism(e1,e2)	18	29	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	11	17	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
effect(e1,e2)	3	10	- antihypertensives : bumetanide may potentiate the effect of various antihypertensive_drugs , necessitating a reduction in the dosage of these drugs .
None(e1,e2)	10	15	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	6	18	administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of amiodarone and desethylamiodarone .
None(e1,e2)	10	12	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp /aza and aminosalicylates .
None(e1,e2)	0	13	metformin : in a single-dose interaction study in niddm subjects , decreases in glyburide auc and cmax were observed , but were highly variable .
None(e1,e2)	0	35	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	18	37	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
mechanism(e1,e2)	0	4	ethopropazine can interact with chlorpromazine , increasing the metabolism of chlorpromazine .
None(e1,e2)	23	79	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	16	oral contraceptives rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl_estradiol and norethindrone .
None(e1,e2)	39	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	51	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	13	14	quinolones , including nalidixic acid , may enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	4	19	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
effect(e1,e2)	9	17	it is possible that the cardiovascular action of other calcium_channel_blockers could be enhanced by the addition of nimotop .
None(e1,e2)	31	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	26	pregnancy : category x : use with ribavirin ( see contraindications ) significant teratogenic and/or embryocidal effects have been demonstrated in all animal species exposed to ribavirin .
mechanism(e1,e2)	10	27	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	10	15	in controlled clinical trials , however , beta blockers including metoprolol were concurrently administered with felodipine and were well tolerated .
None(e1,e2)	5	10	may interact with wthionamide ( trecator-sc ) and isoniazid ( nydrazid ) .
None(e1,e2)	91	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	28	30	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	41	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	27	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	0	12	stavudine and zidovudine ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against hiv .
None(e1,e2)	39	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	15	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	2	12	stavudine and zidovudine ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against hiv .
mechanism(e1,e2)	6	8	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .
None(e1,e2)	34	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	21	27	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	91	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	3	6	in patients receiving nalfon and a steroid concomitantly , any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal .
None(e1,e2)	6	14	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	4	29	ganciclovir : administration of videx 2 hours prior to or concurrent with oral ganciclovir was associated with a 111 ( 114 ) % increase in the steady-state auc of didanosine ( n = 12 ) .
None(e1,e2)	7	12	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic_acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	0	5	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	16	22	doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide_diuretics , beta-blocking agents , and nonsteroidal_anti-inflammatory_drugs .
None(e1,e2)	4	8	in patients taking an anticonvulsant ( eg , valproic_acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	12	33	when initiating a multi-day course of grepafloxacin in a patient maintained on theophylline , the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments .
None(e1,e2)	41	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	18	mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic_antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	6	9	coadministration of entecavir with lamivudine , adefovir_dipivoxil , or tenofovir_disoproxil_fumarate did not result in significant drug interactions .
None(e1,e2)	22	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	35	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	12	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
None(e1,e2)	63	73	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	4	14	a single dose of pravastatin had no clinically important effect on the pharmacokinetics of fenofibric_acid .
None(e1,e2)	69	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	104	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	38	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	52	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	21	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate_mofetil .
None(e1,e2)	15	18	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	49	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	10	14	there is a single case report , which suggests that sucralfate may interfere with anagrelide absorption .
None(e1,e2)	3	7	ketoconazole ) , macrolide_antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	22	27	alcohol - although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic_medications , the use of alcohol by patients taking lexapro is not recommended .
effect(e1,e2)	10	51	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	3	quinolones , including norfloxacin , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .
None(e1,e2)	65	72	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	2	16	because the tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
None(e1,e2)	0	19	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	25	29	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	0	15	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
None(e1,e2)	7	45	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	15	17	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	19	30	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	6	20	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	13	45	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
advise(e1,e2)	6	8	therefore , the concomitant administration of tracleer and glyburide is contraindicated , and alternative hypoglycemic agents should be considered .
None(e1,e2)	12	16	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	5	22	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8 % , which resulted in an increase of approximately 40 % in the free tiagabine concentration .
None(e1,e2)	0	4	tetracyclines : since both acitretin and tetracyclines can cause increased intracranial pressure , their combined use is contraindicated .
None(e1,e2)	13	19	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type_1c_antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	70	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	33	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	1	desloratadine 3-hydroxydesloratadine
effect(e1,e2)	5	20	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic_agonists .
None(e1,e2)	2	13	warfarin : quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	57	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	100	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	11	21	the clinical significance of this reduction is not known , hence zalcitabine is not recommended to be ingested simultaneously with magnesium/ aluminum -containing antacids .
None(e1,e2)	0	8	antibiotics ( e.g. , erythromycin , trimethoprim and sulfamethoxazole , amoxicillin ) .
None(e1,e2)	37	49	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
advise(e1,e2)	1	25	if antacid therapy is needed , the antacid dose should be administered at least 2 hours prior to or 2 hours after the dose of sprycel .
None(e1,e2)	52	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	6	43	particular caution is necessary when using romazicon in cases of mixed drug overdosage since the toxic effects ( such as convulsions and cardiac dysrhythmias ) of other drugs taken in overdose ( especially cyclic antidepressants ) may emerge with the reversal of the benzodiazepine effect by flumazenil .
None(e1,e2)	0	21	aspirin : concomitant administration of aspirin with valdecoxib may result in an increased risk of gi ulceration and complications compared to valdecoxib alone .
mechanism(e1,e2)	7	14	cyclosporine : modest increases in mean trough cyclosporine concentrations were observed following initiation of carvedilol treatment in 21 renal transplant patients suffering from chronic vascular rejection .
None(e1,e2)	13	18	although the clinical significance is not known , it is not recommended that cefditoren_pivoxil be taken concomitantly with h2_receptor_antagonists .
None(e1,e2)	13	25	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate_calcium_disodium interferes with the action of zinc insulin preparations by chelating the zinc . 7
None(e1,e2)	51	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	20	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
None(e1,e2)	39	53	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	42	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	35	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	12	hiv_protease_inhibitors : the effect of amprenavir on total drug concentrations of other hiv_protease_inhibitors in subjects receiving both agents was evaluated using comparisons to historical data .
None(e1,e2)	8	17	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	15	20	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac_tromethamine protein binding .
effect(e1,e2)	8	19	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic_agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	65	94	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	17	41	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	80	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	35	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
advise(e1,e2)	8	13	serum lithium levels should be monitored frequently if inspra is administered concomitantly with lithium .
None(e1,e2)	10	32	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
effect(e1,e2)	3	20	- indomethacin : indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide -induced increase in plasma renin activity .
None(e1,e2)	21	42	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	13	studies with ace_inhibitors in combination with diuretics indicate that the dose of the ace_inhibitor can be reduced when it is given with a diuretic .
None(e1,e2)	6	13	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
None(e1,e2)	16	19	ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan , and erythromycin had no clinically significant effect after oral administration .
None(e1,e2)	57	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	15	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	11	22	the concomitant use of other cyp3a4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .
None(e1,e2)	87	134	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	50	60	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	14	18	agents having vasodilator activity : data on the effect of concomitant use of other vasodilators in patients receiving captopril for heart failure are not available ;
None(e1,e2)	15	57	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum_hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid_products .
None(e1,e2)	5	22	concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .
None(e1,e2)	50	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	36	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	28	51	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	0	16	lithium : nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
None(e1,e2)	87	128	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	17	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	44	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	0	15	aprepitant has been shown to induce the metabolism of s ( - ) warfarin and tolbutamide , which are metabolized through cyp2c9 .
None(e1,e2)	29	43	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	2	45	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	18	29	total body clearance of simulect was reduced by an average 22 % and 51 % when azathioprine and mycophenolate_mofetil , respectively , were added to a regimen consisting of cyclosporine , usp ( modified ) and corticosteroids .
None(e1,e2)	7	22	tissue culture and animal studies indicate that elspar can diminish or abolish the effect of methotrexate on malignant cells.14 this effect on methotrexate activity persists as long as plasma asparagine levels are suppressed .
None(e1,e2)	12	26	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	8	20	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot_derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	17	19	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine_oxidase_inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	0	16	beta-blockers : in controlled clinical studies , adrenergic beta-receptor blockers have been frequently administered concomitantly with nicardipine_hcl .
mechanism(e1,e2)	9	28	drug interactions with antacids administration of 120 mg of fexofenadine_hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	17	21	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	65	79	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	21	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	16	19	the physician should be alert for possible combined drug actions , desirable or undesirable , involving ifosfamide even though ifosfamide has been used successfully concurrently with other drugs , including other cytotoxic drugs .
None(e1,e2)	18	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	4	17	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine_oxidase_inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	19	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	4	25	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	59	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	30	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	18	20	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	80	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	17	this indicates that gabapentin does not undergo renal tubular secretion by the pathway that is blocked by probenecid .
None(e1,e2)	4	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	13	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	13	the mean minimum lithium concentration increased 15 % and the renal clearance of lithium was decreased by 19 % during this period of concomitant drug administration .
None(e1,e2)	20	26	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
effect(e1,e2)	14	27	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	38	45	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	32	38	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	83	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	23	41	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	23	30	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac glycosides and tricyclic_anti-depressants .
None(e1,e2)	6	33	caffeine : two hundred mg of caffeine ( equivalent to 1 to 3 cups of american coffee ) was administered to 16 normal , healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd .
None(e1,e2)	10	14	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	13	26	the results of assays using red cells from healthy subjects to determine whether ceftibuten would cause direct coombs reactions in vitro showed no positive reaction at ceftibuten concentrations as high as 40 g/ml .
None(e1,e2)	2	21	phenobarbital or primidone : no formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or primidone .
None(e1,e2)	0	11	anticholinesterases ( neostgmine , physostigmine ) , lignocaine , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .
mechanism(e1,e2)	4	18	ketoconazole : coadministration of ketoconazole ( 200 mg/day for 14 days ) with a 15-mg single dose of aripiprazole increased the auc of aripiprazole and its active metabolite by 63 % and 77 % , respectively .
None(e1,e2)	15	21	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	5	19	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8 % , which resulted in an increase of approximately 40 % in the free tiagabine concentration .
advise(e1,e2)	9	16	at least 3 weeks should elapse between discontinuation of dexfenfluramine and initiation of treatment with a mao_inhibitor .
effect(e1,e2)	8	49	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	26	47	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic_acid , and acetaminophen .
None(e1,e2)	0	13	cholestyramine : the influence of the bile-acidsequestering agent cholestyramine on the pharmacokinetits of cerivastatin_sodium was evaluated in 12 healthy males in 2 separate randomized crossover studies .
None(e1,e2)	115	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	15	41	on the basis of the metabolism of bexarotene by cytochrome p450 3a4 , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 3a4 would be expected to lead to an increase in plasma bexarotene concentrations .
None(e1,e2)	0	5	anabolic_steroids ( particularly c-17 alkylated androgens such as oxymetholone , methandrostenolone , norethandrolone , and similar compounds ) enhanced tendency toward edema .
None(e1,e2)	11	27	warfarin : the effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin .
None(e1,e2)	66	148	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	42	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide_class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	14	24	an in vivo interaction study in humans demonstrated that a single 1mg dose of anagrelide administered concomitantly with a single 900 mg dose of aspirin was generally well tolerated .
None(e1,e2)	14	20	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	5	7	pharmacokinetic interactions between nisoldipine and beta-blockers ( atenolol , propranolol ) were variable and not significant .
None(e1,e2)	22	25	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	32	34	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	26	50	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	36	40	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
advise(e1,e2)	5	7	therefore , concomitant use of toradol and probenecid is contraindicated .
None(e1,e2)	17	20	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	8	37	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	0	14	uricosuric_agents : since the excretion of oxipurinol is similar to that of urate , uricosuric_agents , which increase the excretion of urate , are also likely to increase the excretion of oxipurinol and thus lower the degree of inhibition of xanthine oxidase .
None(e1,e2)	21	27	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	31	44	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	21	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	1	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	44	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	20	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	22	24	sumatriptan - there have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a selective_serotonin_reuptake_inhibitor ( ssri ) and sumatriptan .
None(e1,e2)	0	18	theophylline - combined administration of racemic citalopram ( 40 mg/day for 21 days ) and the cyp1a2 substrate theophylline ( single dose of 300 mg ) did not affect the pharmacokinetics of theophylline .
effect(e1,e2)	43	45	an encephalopathic syndrome ( characterized by weakness , lethargy , fever , tremulousness and confusion , extrapyramidal symptoms , leukocytosis , elevated serum enzymes , bun , and fbs ) followed by irreversible brain damage has occurred in a few patients treated with lithium plus haldol .
None(e1,e2)	0	1	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	69	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	32	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	12	18	although increased plasma concentrations ( auc 0-24 hrs ) of loratadine and/or descarboethoxyloratadine were observed following coadministration of loratadine with each of these drugs in normal volunteers ( n = 24 in each study ) , there were no clinically relevant changes in the safety profile of loratadine , as assessed by electrocardiographic parameters , clinical laboratory tests , vital signs , and adverse events .
None(e1,e2)	57	59	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	7	digoxin : studies of concomitant administration of flurbiprofen and digoxin to healthy men ( n= 14 ) did not show a change in the steady state serum levels of either drug .
None(e1,e2)	9	18	concomitantly administered iron-fortified infant formula ( 2.2 mg elemental iron /6 oz ) has no significant effect on cefdinir pharmacokinetics .
None(e1,e2)	2	5	antacids or h_2_receptor_antagonists : when dirithromycin is administered immediately following antacids or h 2 -receptor antagonists , the absorption of dirithromycin is slightly enhanced .
None(e1,e2)	0	11	ketoconazole : ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin_d .
None(e1,e2)	33	39	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	8	18	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	27	34	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	11	19	another oral azole antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
None(e1,e2)	15	32	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
mechanism(e1,e2)	19	29	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	15	non-selective_mao_inhibitors including tranylcypromine sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	10	28	since there have been isolated reports of patients with elevated digoxin levels , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	9	38	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin_b .
None(e1,e2)	0	8	morphine : toradoliv/im has been administered concurrently with morphine in several clinical trials of postoperative pain without evidence of adverse interactions .
mechanism(e1,e2)	0	8	acarbose has been shown to change the bioavailabillty digoxin when they are co-administered , which may require digoxin dose adjustment .
effect(e1,e2)	12	15	nonsteroidal anti-inflammatory drugs ( nsaids ) : the concomitant administration of a nonsteroidal_anti_inflammatory_drug with a quinolone may increase the risks of cns stimulation and convulsions .
None(e1,e2)	16	45	the following specific interactions have been reported : itraconazole co-administration of another extended release formulation of felodipine with itraconazole resulted in approximately 8-fold increase in the auc , more than 6- fold increase in the cmax , and 2-fold prolongation in the half- life of felodipine .
None(e1,e2)	14	29	the possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril ( captopril tablets , usp ) or initiating therapy with small doses ( 6.25 or 12.5 mg ) .
None(e1,e2)	31	37	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
int(e1,e2)	6	23	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
effect(e1,e2)	4	22	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	45	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	1	3	using calcium_acetate with digitalis_glycosides ( heart medicine ) may cause hypercalcemia ( too much calcium in the blood ) , which could increase the chance of developing an irregular heartbeat .
None(e1,e2)	0	25	warfarin : co-administration of bosentan 500 mg b.i.d . for 6 days decreased the plasma concentrations of both s-warfarin ( a cyp2c9 substrate ) and r-warfarin ( a cyp3a4 substrate ) by 29 and 38 % , respectively .
None(e1,e2)	20	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	95	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	33	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	20	24	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	112	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	29	in the diamond trials , 1252 patients were treated with tikosyn and diuretics concomitantly of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and diuretics .
None(e1,e2)	21	26	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate calcium disodium interferes with the action of zinc_insulin preparations by chelating the zinc . 7
mechanism(e1,e2)	0	9	urinary_acidifying agents decrease blood levels and increase excretion of amphetamines .
None(e1,e2)	22	32	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	12	45	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	17	19	more than 600 parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa / dopa_decarboxylase_inhibitor .
None(e1,e2)	12	23	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	25	38	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine_oxidase_inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
mechanism(e1,e2)	2	16	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron -containing preparations .
effect(e1,e2)	10	14	compounds in these categories result in a decreased efficacy of bromocriptine_mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
mechanism(e1,e2)	10	31	however , a crossover study in healthy subjects receiving either tagamet 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( theo-dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .
None(e1,e2)	72	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	15	antiarrhythmic_agents_,_class_i ( such as flecainide , lidocaine , or quinidine ) : concurrent use with arbutamine may have a proarrhythmic effect .
None(e1,e2)	14	29	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	14	16	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	22	25	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta-blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac_glycosides is advised .
None(e1,e2)	10	16	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	41	52	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	78	126	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	11	29	in healthy volunteers , the pharmacokinetics of a 1-mg dose of butorphanol administered as stadol ns were not affected by the coadministration of a single 6-mg subcutaneous dose of sumatriptan .
None(e1,e2)	0	18	methadone levels may be decreased ; increased dosages may be required to prevent symptoms of opiate withdrawal . methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly .
effect(e1,e2)	5	17	anticoagulants : flurbiprofen like other nonsteroidal_anti-inflammatory_drugs , has been shown to affect bleeding parameters in patients receiving anti-coagulants , and serious clinical bleeding has been reported .
None(e1,e2)	31	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	43	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	4	21	short-acting beta2-agonists : aerosol bronchodilators of the short-acting adrenergic stimulant type may be used for relief of breakthrough symptoms while using formoterol .
None(e1,e2)	0	15	aripiprazole dose should be reduced to one-half of its normal dose when concomitant administration of quinidine with aripiprazole occurs .
None(e1,e2)	34	54	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
effect(e1,e2)	19	23	calcium channel blockers : isolated cases of conduction disturbance ( rarely with hemodynamic compromise ) have been observed when coreg is co-administered with diltiazem .
None(e1,e2)	34	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	8	24	clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in inr or warfarin dose ( baseline vs. end of the clinical studies ) , and the need to change the warfarin dose during the trials due to changes in inr or due to adverse events was similar among bosentan- and placebo-treated patients .
None(e1,e2)	30	36	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	1	14	- anabolic_steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	22	27	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
None(e1,e2)	8	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	15	because there are no data on the compatibility of novolog and crystalline zinc_insulin preparations , novolog should not be mixed with these preparations .
advise(e1,e2)	1	9	all vasopressors should be used cautiously in patients taking monoamine_oxidase_(_mao_)_inhibitors .
None(e1,e2)	0	25	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
effect(e1,e2)	4	27	diuretics : patients on diuretics , especially those with intravascular volume depletion , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril_sodium .
None(e1,e2)	44	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	39	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	36	48	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	26	39	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	39	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	26	32	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	14	28	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	1	13	serum theophylline concentrations increase when grepafloxacin is initiated in a patient maintained on theophylline .
None(e1,e2)	15	30	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	2	5	nucleoside analogues didanosine co-administration of copegus and didanosine is not recommended .
None(e1,e2)	151	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	19	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	49	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	3	6	concomitant use of isocarboxazid and other psychotropic_agents is generally not recommended because of possible potentiating effects .
None(e1,e2)	51	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	9	19	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	12	41	interactions with other cns agents : concurrent use of levo-dromoran with all central_nervous_system_depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
mechanism(e1,e2)	0	9	ketoconazole tablets may alter the metabolism of cyclosporine , tacrolimus , and methylprednisolone , resulting in elevated plasma concentrations of the latter drugs .
None(e1,e2)	0	18	warfarin : anticoagulant activity should be monitored , particularly in the first few days after initiating or changing vioxx therapy in patients receiving warfarin or similar agents , since these patients are at an increased risk of bleeding complications .
None(e1,e2)	28	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	30	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	3	29	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	25	38	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	5	11	effects of other drugs on aliskiren based on in-vitro studies , aliskiren is metabolized by cyp 3a4 .
None(e1,e2)	55	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	27	warfarin : the effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin .
None(e1,e2)	41	82	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	119	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	13	antacid : the effect of an aluminum hydroxide- and magnesium_hydroxide -containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	102	113	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	120	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	14	15	the net effect of these interactions is summarized in the following table : aed aed felbatol
None(e1,e2)	49	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	3	12	organic nitrates - l-arginine supplements theoretically may potentiate the effects of organic nitrates if taken concomitantly .
None(e1,e2)	7	13	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot_alkaloid_class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	3	13	simvastatin and other statins : co-administration of bosentan decreased the plasma concentrations of simvastatin ( a cyp3a4 substrate ) , and its active -hydroxy acid metabolite , by approximately 50 % .
None(e1,e2)	11	15	mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic_agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	16	29	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	18	23	an alternative non-cyp3a4 substrate hypnotic agent may be considered in patients taking cyp3a4 inducers such as rifampin , phenytoin , carbamazepine , and phenobarbital .
None(e1,e2)	7	9	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
mechanism(e1,e2)	6	21	plasma exposure ( auc ) to valdecoxib was increased 62 % when coadministered with fluconazole and 38 % when coadministered with ketoconazole .
None(e1,e2)	65	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	81	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	11	13	colestipol : plasma concentrations of atorvastatin decreased approximately 25 % when colestipol and atorvastatin were coadministered .
None(e1,e2)	37	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	24	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	1	3	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	39	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	15	probenecid : may decrease renal tubular secretion of ampicillin resulting in increased blood levels and/or ampicillin toxicity .
None(e1,e2)	12	33	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	0	2	hmg-coa_reductase_inhibitors : lovastatin , simvastatin
None(e1,e2)	37	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	20	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
None(e1,e2)	4	7	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	2	9	- oral contraceptives ( birth control pills ) containing estrogen or
None(e1,e2)	3	22	antimycobacterial agents : rifampin contraindicated since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .
None(e1,e2)	8	22	these medications have included heparin , warfarin , beta-adrenergic_receptor_blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	27	39	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
None(e1,e2)	84	94	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	0	2	antacids containing magnesium , aluminum , or calcium ;
None(e1,e2)	5	12	population pharmacokinetic analyses revealed that mtx , nsaids , corticosteroids , and tnf_blocking_agents did not influence abatacept clearance .
None(e1,e2)	0	23	dexamethasone : steady-state trough concentrations of albendazole sulfoxide were about 56 % higher when 8 mg dexamethasone was coadministered with each dose of albendazole ( 15 mg/kg/day ) in eight neurocysticercosis patients .
None(e1,e2)	0	4	diltiazem , nifedipine , verapamil
None(e1,e2)	14	16	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	23	39	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	16	21	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	18	27	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	109	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	13	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	2	10	azopt ( brinzolamide ophthalmic suspension ) 1 % contains a carbonic_anhydrase_inhibitor .
effect(e1,e2)	11	22	other cns depressant drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	17	33	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	2	16	prednisone/prednisolone : rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .
effect(e1,e2)	2	11	phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine .
None(e1,e2)	15	34	- antidiabetics , oral ( diabetes medicine you take by mouth ) use of oral antidiabetics with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics
None(e1,e2)	23	68	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	5	7	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	11	34	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	13	19	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	28	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	6	local and some general anesthetics , antiarrhythmic_agents and other drugs that interfere with neuromuscular transmission should be used cautiously , if at all , in patients with myasthenia gravis ;
None(e1,e2)	5	12	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	15	22	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	8	14	phenytoin : if acitretin is given concurrently with phenytoin , the protein binding of phenytoin may be reduced .
None(e1,e2)	46	85	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	17	ketoconazole ) , macrolide_antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	71	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	96	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	76	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	2	10	if a diuretic is also used , the risk of lithium toxicity may be increased .
None(e1,e2)	11	23	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	0	16	antihypertensive_medications , other , especially diazoxide , or preanesthetic and anesthetic agents used in surgery or skeletal-muscle_relaxants , nondepolarizing , used in surgery
None(e1,e2)	14	32	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	28	134	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	4	7	cyclosporine : administration of nonsteroial_anti-inflammatory_drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
None(e1,e2)	12	14	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium_channel_antagonists , angiotensin_converting_enzyme_inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
advise(e1,e2)	3	5	concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .
None(e1,e2)	10	21	furosemide : in normal volunteers , the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of furosemide .
mechanism(e1,e2)	0	2	diamox modifies phenytoin metabolism with increased serum levels of phenytoin .
None(e1,e2)	114	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	1	5	- quinidine ( e.g. , quinidex ) or
None(e1,e2)	26	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	85	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	105	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	29	hiv protease inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
None(e1,e2)	13	23	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	15	31	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	19	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	17	30	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	38	40	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	6	29	furthermore it has been proposed that isoniazid resulted in induction of p-450iie1 in the patients liver which , in turn , resulted in a greater proportion of the ingested acetaminophen being converted to the toxic metabolites .
None(e1,e2)	12	36	other quinolones have demonstrated moderate to marked interference with the metabolism of caffeine , resulting in a reduced clearance , a prolongation of plasma half-life , and an increase in symptoms that accompany high levels of caffeine .
None(e1,e2)	32	34	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	14	16	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	19	79	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	0	18	antiepileptic_drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic drugs ( phenytoin , carbamazepine ) .
None(e1,e2)	32	34	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
mechanism(e1,e2)	14	23	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	29	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	12	28	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	15	25	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	50	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	30	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	16	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	11	25	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a 30 % increase in the rate of flecainide elimination .
None(e1,e2)	42	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	18	22	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
None(e1,e2)	29	34	may interact with the following : beta-adrenergic blocking agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
int(e1,e2)	0	26	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	83	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	15	17	aripiprazole dose should be reduced to one-half of its normal dose when concomitant administration of quinidine with aripiprazole occurs .
None(e1,e2)	11	23	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	20	35	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	8	21	since the therapeutic range of theophylline is narrow theophylline serum levels should be monitored closely , and appropriate dosage adjustments of theophylline should be made .
None(e1,e2)	30	44	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine_oxidase_(_mao_)_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	6	9	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	23	42	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	5	10	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
effect(e1,e2)	1	10	oral contraceptives may be less effective while you are taking lymecycline .
None(e1,e2)	16	23	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	4	36	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	20	23	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
advise(e1,e2)	16	29	should it be decided to discontinue therapy in patients receiving beta-blockers and clonidine concurrently , the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of clonidine .
None(e1,e2)	22	30	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic_acid ( niacin ) , tolbutamide , phenytoin or warfarin .
advise(e1,e2)	18	31	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	11	21	h-2 antagonists : in studies with human volunteers , co-administration of cimetidine or ranitidine with ibuprofen had no substantive effect on ibuprofen serum concentrations .
None(e1,e2)	10	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	67	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	6	fluoxetine , ocs , sertraline , diltiazem , macrolide antibiotics ( exercise caution ) .
mechanism(e1,e2)	1	8	because antacids may interfere with the absorption of anticholinergic_agents , simultaneous use of these drugs should be avoided .
None(e1,e2)	14	20	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	79	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	26	omeprazole : no clinically significant changes in lomefloxacin pharmacokinetics ( auc , c max , or t max ) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole ( 20 mg qd ) in 13 healthy volunteers .
None(e1,e2)	27	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
advise(e1,e2)	18	47	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	4	9	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	22	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	27	29	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	16	18	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	55	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	32	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	16	22	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	8	16	the pharmacokinetics and protein binding of fosphenytoin , phenytoin , and diazepam were not altered when diazepam and cerebyx were concurrently administered in single submaximal doses .
None(e1,e2)	0	22	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	5	7	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	52	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	34	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
effect(e1,e2)	13	25	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline_hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
advise(e1,e2)	18	20	although the clinical significance of these effects is not known , caution is advised in the co-administration of beta-agonists with non-potassium_sparing_diuretics .
None(e1,e2)	35	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	9	there was no apparent pharmacokinetic interaction between zaleplon and ibuprofen following single dose administration ( 10 mg and 600 mg , respectively ) of each drug .
None(e1,e2)	37	40	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	38	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	48	62	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	15	31	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral_agents , including protease inhibitors , macrolide antibiotics , and azole antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	8	12	these effects have been observed with co-administration of itraconazole ( a potent cyp3a4 inhibitor ) .
advise(e1,e2)	32	43	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	42	47	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic_acid , and acetaminophen .
mechanism(e1,e2)	2	15	geocillin ( carbenicillin_indanyl_sodium ) blood levels may be increased and prolonged by concurrent administration of probenecid .
None(e1,e2)	16	18	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	10	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	32	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	8	39	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	12	19	repeating the study with 6 healthy male volunteers in the absence of glibenclamide did not detect an effect of acitretin on glucose tolerance .
effect(e1,e2)	14	25	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	12	20	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	15	28	concomitant administration of targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene , probably at least partially related to cytochrome p450 3a4 inhibition by gemfibrozil .
None(e1,e2)	3	14	mao inhibitors , narcotic_analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic_agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	14	16	consequently , it is recommended that fluvoxamine not be used in combination with either terbinafine , astemizole , or cisapride .
None(e1,e2)	6	12	other antiarrhythmic drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	9	13	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	6	9	intestinal adsorbents ( e. g. , charcoal ) and digestive_enzyme_preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	116	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	17	aspirin /acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	1	6	phenytoin/ phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
None(e1,e2)	5	30	effects of felbatol on low-dose combination_oral_contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	0	4	fluoxetine , fluvoxamine , paroxetine , sertraline ) .
None(e1,e2)	32	38	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	3	16	concomitant administration of diltiazem with carbamazepine has been reported to result in elevated serum levels of carbamazepine ( 40 % to 72 % increase ) , resulting in toxicity in some cases .
None(e1,e2)	0	31	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
advise(e1,e2)	11	16	close supervision and careful adjustment of the dosage are required when nortriptyline_hydrochloride is used with other anticholinergic_drugs or sympathomimetic drugs .
effect(e1,e2)	3	7	cardiac effects of dopamine are antagonized by beta-adrenergic_blocking_agents , such as propranolol and metoprolol .
None(e1,e2)	57	65	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	35	45	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	13	30	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	37	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	13	20	cimetidine - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram auc and cmax of 43 % and 39 % , respectively .
None(e1,e2)	2	13	anticonvulsants ( phenytoin ) : steady state plasma exposure ( auc ) of valdecoxib ( 40 mg bid for 12 days ) was decreased by 27 % when co-administered with multiple doses ( 300 mg qd for 12 days ) of phenytoin ( a cyp 3a4 inducer ) .
None(e1,e2)	37	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	19	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	106	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	23	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	69	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	29	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	88	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	23	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa_reductase_inhibitor .
None(e1,e2)	16	19	fentanyl anesthesia : severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta_blocker and a calcium_channel_blocker .
None(e1,e2)	19	21	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone / ethinyl_estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	0	21	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	0	4	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	1	4	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	3	11	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
effect(e1,e2)	0	15	diphenhydramine_hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	19	31	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	18	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	5	7	aspirin : concomitant administration of aspirin with valdecoxib may result in an increased risk of gi ulceration and complications compared to valdecoxib alone .
None(e1,e2)	1	15	sublingual nitroglycerin may be taken if necessary for the control of acute angina attacks during bepridil therapy .
None(e1,e2)	5	25	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	16	18	therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	19	21	intestinal adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	21	34	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace_inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	32	39	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	13	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
advise(e1,e2)	12	20	adequate monitoring of theophylline plasma concentrations should be considered when therapy with vioxx is initiated or changed in patients receiving theophylline .
None(e1,e2)	23	91	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	38	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
effect(e1,e2)	8	10	theophylline-related adverse effects have occurred in patients when theophylline and enoxacin were coadministered .
effect(e1,e2)	8	20	patients receiving other narcotic analgesics , antipsychotics , antianxiety_agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	14	18	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	62	90	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	53	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	58	83	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic_acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
effect(e1,e2)	2	27	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao_inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	0	7	magnesium : magnesium-containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin d by patients on chronic renal dialysis .
mechanism(e1,e2)	2	25	treatment with pegasys once weekly for 4 weeks in healthy subjects was associated with an inhibition of p450 1a2 and a 25 % increase in theophylline auc .
None(e1,e2)	27	43	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	3	33	concomitant administration of fenofibrate ( equivalent to 145mg tricor ) with pravastatin ( 40 mg ) once daily for 10 days has been shown to increase the mean cmax and auc values for pravastatin by 36 % ( range from 69 % decrease to 321 % increase ) and 28 % ( range from 54 % decrease to 128 % increase ) , respectively , and for 3 -hydroxy-iso-pravastatin by 55 % ( range from 32 % decrease to 314 % increase ) and 39 % ( range from 24 % decrease to 261 % increase ) , respectively in 23 healthy adults .
mechanism(e1,e2)	0	6	diuretic_agents reduce the renal clearance of lithium and add a high risk of lithium toxicity .
None(e1,e2)	0	16	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	0	15	antacids or h 2 receptor antagonists : when dirithromycin is administered immediately following antacids or h_2_-receptor_antagonists , the absorption of dirithromycin is slightly enhanced .
None(e1,e2)	12	28	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	54	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	19	non-selective mao inhibitors including tranylcypromine_sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao_inhibitors may cause hypertension .
None(e1,e2)	5	15	other drug interactions cimetidine , erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of mhd .
None(e1,e2)	15	21	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	31	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	13	17	compounds in these categories result in a decreased efficacy of bromocriptine mesylate : phenothiazines , haloperidol , metoclopramide , pimozide .
None(e1,e2)	3	11	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	2	23	coadministration of crixivan and other drugs that inhibit cyp3a4 may decrease the clearance of indinavir and may result in increased plasma concentrations of indinavir .
effect(e1,e2)	12	22	it has been reported that results of studies in animals indicate that dopamine -induced ventricular arrhythmias during anesthesia can be reversed by propranolol .
None(e1,e2)	51	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	13	15	caution should also be applied for other sympathomimetics , and for aminophylline and theophylline and tricyclic_antidepressants , which may also precipitate arrhythmias .
None(e1,e2)	38	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	11	18	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	24	26	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal_antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	22	25	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	15	29	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	25	42	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	10	18	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	10	13	antidiabetic agents ( insulin , sulfonylureas ) : requirements for insulin or oral antidiabetic_agents may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
None(e1,e2)	30	40	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
mechanism(e1,e2)	0	11	propantheline and diphenoxylate , by decreasing gut motility , may increase digoxin absorption .
effect(e1,e2)	0	12	beta_blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine .
None(e1,e2)	0	15	phenytoin /phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin_d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
advise(e1,e2)	11	13	these results would seem to dictate against the clinical use of methotrexate with elspar , or during the period following elspar therapy when plasma asparagine levels are below normal .
None(e1,e2)	9	16	specific studies have confirmed these effects with sevoflurane , isoflurane , propofol , alfentanil , and midazolam .
advise(e1,e2)	5	7	therefore , concurrent use of aspirin and ketoprofen is not recommended .
effect(e1,e2)	9	11	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	21	23	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	6	21	intestinal adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	96	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	0	14	benazepril , like other ace inhibitors , has had less than additive effects with beta-adrenergic_blockers , presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system
None(e1,e2)	0	13	antacids or h 2 receptor antagonists : when dirithromycin is administered immediately following antacids or h 2 -receptor antagonists , the absorption of dirithromycin is slightly enhanced .
None(e1,e2)	71	128	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	2	16	- a steroid_medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
mechanism(e1,e2)	2	4	co-administration of probenecid with acyclovir has been shown to increase the mean half-life and the area under the concentration-time curve .
None(e1,e2)	9	23	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	0	9	antacid : the effect of an aluminum hydroxide- and magnesium_hydroxide -containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
effect(e1,e2)	10	31	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	9	11	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	1	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	8	10	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
advise(e1,e2)	0	10	disulfiram should be used with caution in those patients reveiving phenytoin and its congeners .
None(e1,e2)	0	10	warfarin : quinolones may enhance the effects of the oral anticoagulant , warfarin , or its derivatives .
None(e1,e2)	27	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	16	hydrochlorothiazide : a study in normal healthy volunteers has shown that concomitant administration of dynacirc ( isradipine ) and hydrochlorothiazide does not result in altered pharmacoktnetics of either drug .
None(e1,e2)	4	13	( concurrent use with thiazide_diuretics is not recommended , as they may provoke lithium toxicity because of reduced renal clearance . )
None(e1,e2)	0	26	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	12	32	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	38	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	28	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	12	21	caution should be exercised when the following drugs are administered concomitantly with lodosyn ( carbidopa ) given with levodopa or carbidopa- levodopa combination products .
None(e1,e2)	9	11	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	27	40	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
mechanism(e1,e2)	11	33	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	12	14	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease_inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	0	13	theophylline : in three pharmacokinetic studies including 46 normal , healthy subjects , theophylline clearance and concentration were not significantly altered by the addition of lomefloxacin .
None(e1,e2)	0	20	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
mechanism(e1,e2)	10	39	drugs that inhibit both aldehyde oxidase and cyp3a4 cimetidine : cimetidine inhibits both aldehyde oxidase ( in vitro ) and cyp3a4 ( in vitro and in vivo ) , the primary and secondary enzymes , respectively , responsible for zaleplon metabolism .
None(e1,e2)	125	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	22	31	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	11	16	the mean qt c interval ( msec ) was 369 with terfenadine alone and 367 with terfenadine plus dirithromycin .
None(e1,e2)	65	96	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	14	26	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	6	13	hctz 50 mg qd or hctz/ triamterene 50/100 mg qd was co-administered with tikosyn ( 500 mcg bid ) for 5 days ( following 2 days of diuretic use at half dose ) .
None(e1,e2)	0	2	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
None(e1,e2)	47	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	26	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
mechanism(e1,e2)	3	10	plasma concentrations of azole_antifungal_agents are reduced when given concurrently with isoniazid .
None(e1,e2)	22	32	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac_tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	6	23	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	24	36	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	62	119	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	13	15	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
mechanism(e1,e2)	6	23	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	8	10	however , in vivo drug interaction studies of ketoconazole with vitamin_d have not been investigated .
None(e1,e2)	0	4	methadone : coadministration of amprenavir and methadone can decrease plasma levels of methadone .
None(e1,e2)	30	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	7	35	dopamine antagonists : since apomorphine is a dopamine_agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	15	41	a study in eight healthy volunteers has shown a 50 % increase in mean peak nimodipine plasma concentrations and a 90 % increase in mean area under the curve , after a one week course of cimetidine at 1,000 mg/day and nimodipine at 90 mg/day .
None(e1,e2)	34	36	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	26	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
int(e1,e2)	11	21	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	21	23	therefore , there is a potential for an interaction with other drugs that are metabolized by cyp 1a2 ( e.g. , amitriptyline , tacrine , and zileuton ) .
None(e1,e2)	0	19	coumarin_anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	21	28	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	22	26	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	12	14	it is desirable to monitor tcaplasma levels whenever an agent of the tricyclic_antidepressant_class including anafranil is going to be co-administered with another drug known to be an inhibitor of p450 2d6 ( and/or p450 1a2 ) .
None(e1,e2)	13	20	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	20	27	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	2	13	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
effect(e1,e2)	24	26	serious anticholinergic symptoms ( severe dry mouth , urinary retention , blurred vision ) have been associated with elevations in the serum levels of tricyclic_antidepressants when cimetidine is added to the drug regimen .
None(e1,e2)	6	20	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
effect(e1,e2)	5	24	micro-dosed progesterone preparations : micro-dosed progesterone preparations ( minipills that do not contain an estrogen ) may be an inadequate method of contraception during accutane therapy .
None(e1,e2)	12	17	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	28	91	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	0	27	anagrelide demonstrates some limited inhibitory activity towards cyp1a2 which may present a theoretical potential for interaction with other coadministered medicinal products sharing that clearance mechanism e.g . theophylline .
None(e1,e2)	30	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	150	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	9	21	as with other agents with b-blocking properties , if coreg is to be administered orally with calcium channel blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	4	8	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	10	12	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	2	29	co-administration of myobloc and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
None(e1,e2)	5	11	in controlled clinical trials of augmentin_xr , 22 patients received concomitant allopurinol and augmentin xr .
effect(e1,e2)	16	37	epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic_drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an nsaid or aspirin potentiated the risk of bleeding .
None(e1,e2)	78	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	cholestyramine and charcoal administration of cholestyramine or activated charcoal in patients ( n=13 ) and volunteers ( n=96 ) resulted in a rapid and significant decrease in plasma m1 ( the active metabolite of leflunomide ) concentration .
None(e1,e2)	29	39	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic antidepressants
mechanism(e1,e2)	5	34	cholestyramine and charcoal administration of cholestyramine or activated charcoal in patients ( n=13 ) and volunteers ( n=96 ) resulted in a rapid and significant decrease in plasma m1 ( the active metabolite of leflunomide ) concentration .
None(e1,e2)	46	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	9	theophylline : ethinyl estradiol may inhibit the metabolism of theophylline , leading to increased plasma concentrations .
None(e1,e2)	4	9	increased plasma concentrations of terfenadine , astemizole , and cisapride cause qt prolongation and have been associated with torsades de pointes-type ventricular tachycardia , sometimes fatal .
None(e1,e2)	24	30	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic_acid ( niacin ) , tolbutamide , phenytoin or warfarin .
effect(e1,e2)	12	26	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid -associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	72	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	11	anesthetics/sedatives/hypnotics/ opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	12	29	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	20	22	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	4	17	however , co-administration of duloxetine with aluminum- and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	41	48	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	8	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	7	when given concomitantly with felodipine , the tacrolimus blood concentration should be followed and the tacrolimus dose may need to be adjusted .
None(e1,e2)	3	6	drug/laboratory test interactions cephalosporins , including cefotaxime_sodium , are known to occasionally induce a positive direct coombs test .
None(e1,e2)	4	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	16	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	17	64	in a placebo-controlled trial in normal volunteers , the administration of a single 1 mg dose of doxazosin on day 1 of a four-day regimen of oral cimetidine ( 400 mg twice daily ) resulted in a 10 % increase in mean auc of doxazosin ( p=0.006 ) , and a slight but not statistically significant increase in mean cmax and mean half-life of doxazosin .
None(e1,e2)	29	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	14	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	44	46	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic_acid , and acetaminophen .
None(e1,e2)	41	73	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	5	8	patients who are treated with zyvox and concomitant serotonergic_agents should be closely observed for signs and symptoms of serotonin syndrome ( e.g. , cognitive dysfunction , hyperpyrexia , hyperreflexia , incoordination ) .
None(e1,e2)	46	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	20	43	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	34	59	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	28	48	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	25	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	40	50	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	17	like isoflurane , desflurane does not predispose to premature ventricular arrhythmias in the presence of exogenously infused epinephrine in swine .
None(e1,e2)	39	46	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	59	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	31	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	21	39	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	8	14	while all the selective serotonin reuptake inhibitors ( ssris ) , e. g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	52	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	12	19	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
None(e1,e2)	0	5	sedative /hypnotics : midazolam , triazolam
None(e1,e2)	0	21	enoxacin does not affect the clearance of the active s-isomer , and changes in clotting time have not been observed when enoxacin and warfarin were coadministered .
None(e1,e2)	56	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	3	- lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	13	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	16	24	a similar association , though less marked , has been suggested with barbiturates , phenyl-butazone , phenytoin_sodium , carbamazepine and possibly with griseofulvin , ampicillin , and tetracyclines ( 72 )
None(e1,e2)	33	44	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	30	although increased plasma concentrations ( c max and auc 0-24 hrs ) of desloratadine and 3-hydroxydesloratadine were observed , there were no clinically relevant changes in the safety profile of desloratadine , as assessed by electrocardiographic parameters ( including the corrected qt interval ) , clinical laboratory tests , vital signs , and adverse events .
None(e1,e2)	71	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	29	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	116	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	15	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	14	27	effect of other drugs on the pharmacokinetics of clonazepam : literature reports suggest that ranitidine , an agent that decreases stomach acidity , does not greatly alter clonazepam pharmacokinetics .
None(e1,e2)	7	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	13	26	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac_glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	31	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	76	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	20	45	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	5	30	lithium - coadministration of racemic citalopram ( 40 mg/day for 10 days ) and lithium ( 30 mmol/day for 5 days ) had no significant effect on the pharmacokinetics of citalopram or lithium .
None(e1,e2)	7	24	oral anticoagulants interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants .
None(e1,e2)	16	26	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic_agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	27	29	a drug-drug interaction study evaluated the effect of the use of aczone gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim / sulfamethoxazole ( tmp/smx ) .
mechanism(e1,e2)	8	11	concomitant administration of fenofibrate ( equivalent to 145mg tricor ) with pravastatin ( 40 mg ) once daily for 10 days has been shown to increase the mean cmax and auc values for pravastatin by 36 % ( range from 69 % decrease to 321 % increase ) and 28 % ( range from 54 % decrease to 128 % increase ) , respectively , and for 3 -hydroxy-iso-pravastatin by 55 % ( range from 32 % decrease to 314 % increase ) and 39 % ( range from 24 % decrease to 261 % increase ) , respectively in 23 healthy adults .
None(e1,e2)	55	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	9	11	in a study of 12 schizophrenic patients coadministered oral haloperidol and rifampin , plasma haloperidol levels were decreased by a mean of 70 % and mean scores on the brief psychiatric rating scale were increased from baseline .
None(e1,e2)	6	18	platelet inhibitors : drugs such as acetylsalicylic_acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
mechanism(e1,e2)	13	24	in vivo studies : nitrates : the blood pressure lowering effects of sublingual nitrates ( 0.4 mg ) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1 , 4 and 8 hours were potentiated by a 20 mg dose of vardenafil in healthy middle-aged subjects .
None(e1,e2)	13	15	use in conjunction with other antiepileptic drugs : the addition of felbatol to antiepileptic_drugs ( aeds ) affects the steady-state plasma concentrations of aeds .
None(e1,e2)	13	19	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
effect(e1,e2)	4	18	although not studied with alosetron , inhibition of n-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
None(e1,e2)	7	14	caution in using concomitant drugs such as beta-blockers ( ophthalmic and systemic ) , anti-hypertensives and/or cardiac glycosides is advised .
None(e1,e2)	0	47	warfarin : eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of ( r ) - or ( s ) -warfarin , nor were there any changes in the pharmacodynamic profile ( prothrombin time ) following a single 25 mg oral dose of warfarin
None(e1,e2)	18	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	18	22	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	16	33	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	59	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	111	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	29	60	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	3	13	the use of antacids should be considered in place of h2 blockers or proton_pump_inhibitors in patients receiving sprycel therapy .
None(e1,e2)	1	4	some quinolones , including ciprofloxacin , have been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly .
None(e1,e2)	17	19	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	22	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	3	because heparin , aspirin , or activase may cause bleeding complications , careful monitoring for bleeding is advised , especially at arterial puncture sites .
None(e1,e2)	13	27	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	12	18	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	0	8	nonsteroidal_anti-inflammatory_agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	36	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	10	non-steroidal_anti-inflammatory_drugs : in some patients , the administration of a non-steroidal_anti-inflammatory_agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium-sparing and thiazide diuretics .
None(e1,e2)	19	81	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	44	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	28	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	9	30	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	31	62	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic_antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	32	43	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	20	22	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic_acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	30	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	4	25	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	4	8	concomitant administration with racemic citalopram citalopram - since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
None(e1,e2)	51	62	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	21	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	70	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	13	25	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	2	13	ethanol or triazolam : no significant differences were observed in the pharmacokinetics of triazolam ( 0.125 mg ) and tiagabine ( 10 mg ) when given together as a single dose .
None(e1,e2)	13	22	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	29	35	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2_antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	0	8	beta-blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin .
None(e1,e2)	50	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	19	24	in addition to the interactions noted above , chronic ( 2 weeks ) oral cordarone administration impairs metabolism of phenytoin , dextromethorphan , and methotrexate .
None(e1,e2)	6	14	administration of epinephrine to patients receiving cyclopropane or halogenated hydrocarbon general anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
None(e1,e2)	65	98	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	15	23	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
None(e1,e2)	0	15	methotrexate : ketoprofen , like other nsaids , may cause changes in the elimination of methotrexate leading to elevated serum levels of the drug and increased toxicity .
None(e1,e2)	8	15	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	41	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	33	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
effect(e1,e2)	4	39	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	0	7	cyclosporine : modest increases in mean trough cyclosporine concentrations were observed following initiation of carvedilol treatment in 21 renal transplant patients suffering from chronic vascular rejection .
None(e1,e2)	26	36	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
effect(e1,e2)	10	16	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	11	32	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	0	7	atorvastatin : atorvastatin increases the auc for norethindrone and ethinyl estradiol .
None(e1,e2)	6	10	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	12	16	in vitro studies have shown that precipitation occurs when eye drops containing thimerosal are mixed with latanoprost .
None(e1,e2)	45	53	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	7	diuretic : hydrochlorothiazide , given concomitantly with ketoprofen , produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone .
None(e1,e2)	56	58	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa_reductase_inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	8	14	a drug interaction study was performed in which erbitux was administered in combination with irinotecan .
None(e1,e2)	116	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	6	19	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
None(e1,e2)	13	45	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	34	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
